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ABSTRACT 
 
KNOWLEDGE AND ATTITUDES REGARDING CERVICAL CANCER SCREENING 
AMONG WOMEN LIVING WITH HIV/AIDS IN MALAWI: 
A CROSS-SECTIONAL STUDY 
May 2019 
 
 
Jasintha T. Mtengezo, B.S.N.M., Kamuzu College of Nursing, Malawi 
M.P.H., College of Medicine, Malawi 
Ph.D., University of Massachusetts Boston 
Directed by Professor Dr, Haeok Lee 
 
Cervical cancer is the third most frequent cancer among women worldwide and about 
265,672 women die from the disease annually. Abnormal cervical cells caused by human 
papillomavirus are more common in HIV-positive women than in HIV-negative women due 
to their compromised immune system. Malawi, in Sub-Saharan Africa, is one of the countries 
with the highest rates of cervical cancer and HIV in the world. The incidence of cervical 
cancer and deaths can be reduced by 80% if women go for screening. There are limited 
studies about cervical cancer screening behavior, level of knowledge and attitudes regarding 
cervical cancer and screening among Malawian HIV positive women. The purposes of this 
Situation-Specific guided study were to determine the prevalence of cervical cancer 
screening, level of knowledge and attitudes regarding cervical cancer and screening; and to 
examine factors associated with screening behavior among Malawian HIV-positive women. 
A cross-sectional survey was conducted with Malawian women living with HIV infection 
aged 18-50 from HIV support organizations in one district in Malawi. Two stage 
proportionate stratified cluster random sampling method
 
was used to select 291 respondents. 
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A face-to-face interviewer-administered survey was conducted after obtaining women‟s 
informed consent. Data were analyzed using SPSS. Univariate descriptive statistics were used 
to describe respondents‟ data. Bivariate and multivariate logistic regression models were used 
to identify independent variables associated with cervical cancer screening. The adjusted 
Odds Ratios (OR) and their corresponding 95% CI were used to measure the strength of 
associations between knowledge and attitudes, and cervical cancer screening. A two-tailed p-
value of < .05 was considered statistically significant. 
The prevalence of cervical cancer screening rate was 27.8% among 291 Malawi 
women living with HIV infection. The findings showed that women had a high knowledge 
level (M = 25.63, SD = 6.35) and positive attitude (M = 5.05, SD = 1.43) towards screening. 
The factors independently associated with cervical cancer screening in HIV positive women 
were occupation, OR = 5.12 (95% CI: 1.07, 24.43), knowledge OR =1.10 (95% CI: 1.02, 
1.19), attitude, OR = 1.36 (95% CI: 1.04, 1.76), and access to screening services OR = 1.21 
(95% CI: 1.01, 1.44). The cervical cancer screening rate among HIV positive women in 
Malawi is still low. There is need for developing health education messages culturally 
tailored to women living with HIV infection in Malawi to promote cervical cancer screening 
uptake. 
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CHAPTER 1 
 
INTRODUCTION 
 
This study assessed the cervical cancer screening rate, level of knowledge and 
attitudes regarding cervical cancer and screening; and examined factors associated with 
cervical cancer screening among Malawian HIV-positive women to prevent and control 
cervical cancer among this at-risk population. The study is guided by the Situation-Specific 
framework in the context of HIV positive women in Malawi developed from the findings of a 
pilot qualitative study conducted by the researcher (Mtengezo & Lee, 2018). This chapter 
provides the background of the problem, problem statement, significance of the study, 
purpose of the study, research questions, aims of the study, preliminary study findings, and 
conceptual framework used in the thesis. 
Background 
Cervical cancer is the third most frequent cancer among women worldwide and every 
year 527,624 women are diagnosed with cervical cancer, and 265,672 of them die from the 
disease (Ferlay et al., 2012). Eighty-five percent of cervical cancer cases and 87 % of the 
cervical cancer deaths occur in less developed countries (WHO/ICO, 2010). Malawi as a 
developing country and is one of the countries with the highest incidence rates of cervical 
cancer and mortality in the world (Ferlay et al., 2012). Evidence has revealed that from 2007 
to 2010, cervical cancer was the most common type of cancer accounting for 45.4% of all 
new cases of cancers among women in Malawi (Msyambodza et al., 2012). The cause of 
most cervical cancers is human papillomavirus (HPV) infection and the disease is more likely 
to occur in women over age 40 years (Malawi Ministry of Health [MOH], 2017). The HPV 
slowly causes cellular changes called pre-cancerous lesions or cervical intraepithelial 
neoplasia (CIN) in the surface tissue of the cervix before the development of cancer (Ferlay 
et al., 2012). The CIN lesions are graded depending on severity: CIN I, CIN II, and III. The 
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CIN I have low-grade squamous intraepithelial lesions which often clear up without 
treatment. CIN II and III have high-grade squamous intraepithelial lesions which continue to 
grow and eventually develop into cancer (Ferlay et al., 2012). However, women with HIV-
infection experience more rapid progression to cervical cancer and have a higher risk of 
developing the disease than do HIV-negative women, due to a compromised immune system 
(Ferlay et al., 2012; UNAIDS, 2013; WHO, 2010). The National Center for infectious 
diseases division of HIV/AIDS, classified cervical cancer as an AIDS-defining illness as it is 
directly related with the deterioration of the immune system (Cichocki, 2017). After a woman 
has developed cervical cancer, there are limited treatment options. The WHO recommends: 
1) Primary prevention by giving HPV vaccinatiom for young adolescent women. 2) 
Secondary prevention of early detection by screening and treatment of precancerous cervical 
lesions. 3) Tertiary prevention by treating cervical cancer to reduce morbidity and mortality 
(Ferlay et al., 2012).   
Evidence has indicated that vaccinations are over 95% effective in preventing HPV 
infection and minimizing the cervical cancer incidence (Arbyn, Xu, Simoens, & Martin-
Hirsch, 2018). The Malawi Government started an HPV vaccination pilot project in 2013 in 
two districts (Zomba and Rumphi) in the country and but has not yet been rolled out due to 
insuffient funding (MOH, 2017). This vaccination program  targeted  9-13 year old youths 
prior to sexual debut (MOH, 2015). Cervical cancer screening was found to be associated 
with overall mortality reduction rate of 83% if every woman attended screening frequently 
(Landy, Pesola,  Castanon, & Sasieni, 2016). Therefore, screening is important for all women 
but it is particular important for women infected with HIV. 
Malawi is a landlocked country in Sub-Saharan Africa (Refer to Attachment A) with a 
population of approximately 17.9 million (MDHS, 2017). According to a 2010 WHO report, 
about 86% of the countries‟ total population lives in the rural areas; 65% are living in poverty 
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with 27% in extreme poverty (WHO, 2010). The country has a low life expectancy of 58 
years for men and 60 years for women (WHO, 2010). Some of the contributing factors to low 
life expectancy include communicable diseases including HIV/AIDS. Malawi‟s HIV 
prevalence rate is among the highest in the world (8.8%), with infected women aged 15-49 
estimated at 10.8% as compared to 6.4% among men (MDHS, 2017). Further, the WHO 
report has also indicated that HIV prevalence is highest in women at age 40-44 (19.8%), 
higher in women living in urban areas (22.7%) than women living in rural areas (10.5%). The 
use of antiretroviral therapy has extended survival for women living with HIV/AIDS but 
HIV-infected individuals are prone to opportunistic infections, cervical abnormalities, and 
other sexually transmitted infections (UNAIDS, 2013). Delayed detection of HPV in HIV-
infected women is linked to invansive, inoperable cervical cancer with higher mortality from 
cervical cancer than from HIV/AIDS (Firnhaber et al., 2016; Kafuruki, Rambau, Massinde, & 
Masalu, 2013; Reddy et al., 2015). The WHO report indicates that every year, 3,684 women 
are diagnosed with cervical cancer in Malawi and over 2,300 die from the disease (Ferlay et 
al., 2012, Masamba, 2015). The main risk factors for high cervical cancer incidence and 
mortality in Malawi include high HIV (10.0%) and HPV (33.6%) rates, insufficient 
prevention and treatment, delayed detection, and inadequate availability of healthcare 
services (Masamba, 2015; MDHS, 2017; MOH, 2017). The other risk factors include early 
onset of sexual intercourse, multiple sexual partners, increased parity, and co-mobidity of 
sexually transmitted diseases (Gadduci, Barsotti, Cosio, Domenici, & Riccardo, 2011; MOH, 
2017). Further, the Malawi Ministry of Health report has indicated that the low literacy rate 
contributes to early marriage and early sexual practice, which is a contributing factor for 
cervical cancer (MOH, 2017). The literacy rate is estimated at 75% for women and 83% for 
men (MDHS, 2017). The United Nations Educational Scientific and Cultural Organizations‟ 
(UNESCO) 2015 report indicated that globally, 100 million children do not finish primary 
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education. Education attainment is directly related to health-related behaviors and attitudes. 
Individuals with high educational attainment can understand their health needs, read and 
follow health care instructions, advocate for their health care and the health care of their 
families. They can also communicate effectively with healthcare providers.  In Malawi, 
studies have reported that cultural practices may also contribute to school drop-out including 
initiation ceremonies causing school absenteesism or the practice of early marriages 
(Behrman, 2014). Therefore, cervical cancer and HIV/AIDS are considered priority diseases 
in the health care delivery system of Malawi.  
In Malawi, health care services are delivered by public and private sectors. The public 
sector provides services free of charge while the private not-for-profit health facilities provide 
services for free for some services such as antiretroviral therapy (ART), HIV care, under five 
childhood vaccinations and charge user fees for other services (MOH, 2017. The services are 
delivered at three levels that include primary, secondary, and tertiary levels, with these 
services linked through a comprehensive referral system (Refer to Table 1).  
Table 1  
 
Levels of health care services in Malawi 
 
 Primary Level Secondary Level Tertiary Level 
Total Facilities 453 health centers, 
dispensaries, health 
posts 
63 (28 District Hospitals and 35 CHAM 
hospitals) 
4 Central Hospitals 
Role -Provide primary 
health care services.  
-Provide specialized services to patients 
referred from the primary health care 
level, through outpatient and inpatient 
services and community health services.  
-Provide highly 
specialized 
services.  
Personnel -Medical assistants, 
nurses and midwives 
-Obs/Gynae specialists, Medical Doctors, 
clinical officers, nurses and midwives 
-Specialists, 
Medical Doctors, 
clinical officers, 
nurses and 
midwives 
VIA Services -Encourage women 
to go for VIA 
-Perform VIA 
-Refer to District 
Hospital 
-Perform VIA 
-Perform Cryotherapy and LLETZ (takes 
biopsy). 
- Gynecologists perform Hysterectomy. 
-Refer cancer suspects to Central Hospital 
-Perform VIA and 
Cryotherapy 
- Offers cancer 
treatment- 
radiotherapy and 
chemotherapy 
(Gynecologists) 
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The primary level consists of community initiatives, health posts, dispensaries, 
maternity facilities, health centers, community and rural hospitals. The primary level provides 
promotive and preventive care for some curative services such as provision of ART for 
HIV/AIDs, malaria, tuberculosis, and neglected diseases treatment. The services are provided 
by community-based cadres such as Health Surveillance Assistants (HSAs), nurse 
technicians, and medical assistants. The secondary levels are referral facilities from primary 
level facilities. They include all district and mission hospitals where both inpatient and 
outpatient services are provided by nurses, clinical officers, and medical officers. The tertiary 
level consists of central hospitals that provide referral health services for their respective 
regions for secondary level hospitals. They serve as training health facilities and they provide 
a wide range of preventive, diagnostic, and therapeutic services.  
Cervical cancer prevention and control strategies are done at all three levels of health 
care services. There are 503 health facilities in Malawi (373 Government and 129 private or 
Non-Governmental). In 2015, there were only 129 functional cervical cancer-screening sites 
across the country and 32 (25%) had functional cryotherapy (MOH, 2017). Additionally, 
there were 391 trained cervical cancer screening service providers of whom only 272 (69.6%) 
were providing screening services.  
Screening is a secondary prevention level of cervical cancer. It has the potential to 
detect abnormal conditions that can be treated before cancer develops (WHO, 2010). There 
are several types of screening tests for cervical cancer globally including liquid-based 
cytology (Pap smear), HPV DNA testing, and visual inspection with acetic acid (VIA) 
(WHO, 2010).  The VIA was the initial screening test, and it was replaced by cervical 
cytology because of its low specificity (Bhattacharyya, Nath, & Deka, 2015; WHO, 2010). 
Specificity is the proportion of all those without the disease (cancer) that the VIA correctly 
identifies as negatives. Low specificity results in resources being spent on unnecessary 
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treatment of women who are free of precancerous lesions in a single visit approach. It is also 
less accurate among post-menopausal women as the squamo-columnar junction cannot be 
seen (Bhattacharyya et al., 2015). As such, the CDC (US) recommends that women aged 21–
65 be screened for cervical cancer and precancerous lesions by Pap smear testing every three 
years due to its high sensitivity and specificity. The developed countries approach cervical 
cancer prevention by screening for CIN and early invasive cervical cancers using the Pap 
smear (CDC [US], 2016). However, there are infrastructure problems and insufficient human 
and financial resources to implement the cervical cytology prevention approach in developing 
countries (Ogunwale et al., 2016). Thus, over 80% of cervical cancer in sub-Saharan African 
countries is diagnosed late (Ferlay et al., 2012). Studies indicated that VIA was useful and a 
feasible alternative screening test for precancerous and cancerous lesions (Hasanzadeth, 
Esmaeili, Tabaee, & Samadi, 2011; Kitchener & Symonds. 1999; McIntoch, 1999). Women 
need access to screening services to address the burden of cervical cancer in resource limited 
countries, therefore, the CDC recommends cervical cancer screening using VIA in 
developing countries (WHO, 2010).  The VIA has low and wide range of specificity (64-
95%) compared to Pap smear (93-98%) (Refer to Table 2). 
      Table 2 
 
       Differences between VIA and Pap Smear  
  
Variable               VIA Pap Smear Reference 
Sensitivity 65-89% 52-80%  
(Bhattacharyya et al., 2015; CDC, 
2010; Hasanzadeth et al., 2011; 
Kitchener & Symonds, 1999. Lince-
Deroche, Phiri, Michelow, Smith, & 
Firnhaber, 2015; McIntoch, 
Blumenthal, & Blouse, 2001; 
McIntoch, 1999). 
Specificity 64-95% 93-98% 
Cost $3.16-17.05/case $8.17-
187.52/case 
Providers Nurses, clinicians, medical 
officers and Obstetricians 
Cytotechnologists 
Places Can be done in remote 
places 
In hospitals 
Age in 
years 
30-50 21-65 
Safety  Yes Yes 
Practical Yes No 
Affordable Yes No 
Effective Yes Yes 
Available Yes No 
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The wide range of specificity (64-95%) between studies (Bhattacharyya et al., 2015; 
Lince-Deroche, Phiri, Michelow, Smith, & Firnhaber, 2015; McIntoch, 1999) may be due to 
the high incidence of suspected acetowhite epithelium, which might be inflammation, 
immature metaplasia or latent HPV infection. This may also indicate the lack of skills and 
knowledge of those performing the VIA and interpreting the results. There is need to train 
nurses and clinicians at grassroots level to maximize the sensitivity and specificity of VIA. 
The recent studies have demonstrated that both VIA and Pap smear tests are useful in 
detecting CIN which is true precancerous lesions (Bhattacharyya et al., 2015; Hasanzadeth et 
al., 2011; WHO, 2010). In addition, the VIA is most cost-effective at $3.16- $17.05 per true 
CIN2+ case detected compared to Pap smear at $8.17-$187.52 depending on the country 
(Bhattacharyya et al., 2015; Lince-Deroche et al.,  2015). Therefore, the VIA approach is 
recommended because it is less costly and much more practical to implement in resource-
limited settings (CDC, 2010; McIntoch, Blumenthal, & Blouse, 2001).   
The VIA can be done by all trained health care providers including nurses and can be 
done even in remote places within the community as it is minimally reliant on infrastructure 
(Sankaranarayanan & Wesley, 2001). The VIA test is simple and easy to perform, test results 
are available immediately, requires only one visit, can be integrated into primary health care 
services, and is a suitable alternative to Pap smear to diagnose and prevent cervical cancer 
lesion in resource limited countries (Sankaranarayanan & Wesley, 2001; McIntoch et al., 
2001). Pap smear screening is costly, needs infrastructure and trained manpower to make and 
interpret the slides. Malawi has very few pathologists and oncology nurses and social workers 
to offer the Pap smear approach, therefore, the VIA is the best approach.  
Problem Statement 
Evidence has shown that HIV-positive women are at higher risk of having pre-
cancerous lesions and progress faster to develop cervical cancer than HIV-negative women 
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(Kamanga et al., 2013; Msyamboza, Phiri, Sichali, Kwenda, & Kachali, 2016; Sinayobye et 
al., 2014; Ursu et al., 2015) (Refer to Table 3).  
  Table 3  
 
Prevalence of Pre-cancerous Lesions   
 
Author Place of Study CIN + in HIV-Positive 
Women 
CIN + in HIV-Negative 
Women 
Kamanga et al., (2013); 
Msyamboza et al., (2016) 
Malawi 14.4 - 33% 7 -7.3% 
Sub-Saharan Africa 
Hawes et al., (2003); 
Moodley et al., (2006) 
Sinayobye et al., 2014 
Senegal, South 
Africa, Kenya, 
Rwanda 
34% - 50% 
 
1.4% -13% 
Developed Countries 
Whitham et al., (2017); 
Ursu et al., (2015) 
New York 
Romania (Europe) 
8.3- 45% 
 
1.8- 35.2% 
 
 
Women with HIV infection are about 2 to 5 times more likely to have pre-cancerous 
lesions than HIV-negative women because: 1) HIV-infected women are more likely to have 
persistent HPV infections. 2) Persistent HPV infection is a requisite in the progression of pre-
cancerous lesions to invasive cervical cancer (Ferlay, et al., 2012).  This emphasizes that 
cervical cancer screening is important for all women, but it is particularly a public health 
priority among HIV-infected women worldwide.  
Significance of the Study 
 
Evidence has shown that Malawi has a high burden of cervical cancer and HIV rates 
(Ferlay et al., 2012; MOH, 2017). The incidence of cervical cancer and deaths can be reduced 
by 80% if coverage, quality, and follow-up of screening are high (Ferlay et al., 2012). 
Vaccinations are also effective in preventing HPV infection but the program is not yet rolled 
out in Malawi due to funding, therefore, screening is the only efficient way of early detection 
and treatment of the pre-invasive cancer before it develops to disease. Malawi adopted the 
VIA approach to screen for cervical cancer in 2004. Despite the availability of screening 
services, the WHO report indicates that screening coverage for all women aged 18 and above 
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in Malawi was as low as 2.6% (WHO, 2010). Data from the WHO report is based on record 
review and this could have missing information making the screening rate statistic unreliable. 
However, a recent study has indicated that the cumulative screening rate for all 
women in Malawi by 2015 was 26.5% and in HIV-positive women it was 15.9% 
(Msyamboza et al., 2016). The Malawi cervical cancer screening guidelines recommend that 
HIV-positive women should have annual cervical screening at their baseline evaluation, 
thereafter, annually for those with normal results (MOH, 2005). Despite these 
recommendations aimed at addressing HIV-positive women‟s increased risk of developing 
cervical cancer, the screening rate is still low even though HIV positive women visit ART 
clinics regularly. The possible reasons for the low screening rate may be due to the 
availability of screening services that may not be integrated with ART; service providers are 
not trained to do screening; clinics do not have equipment and supplies needed and other 
reasons which need to be studied. The 2015 statistic is based on record review from the 
National Cancer Control program and secondary data analysis is viewed as too subjective as 
the information recorded from the reports may be incomplete as documents get misfiled. 
Additionally, in Malawi health booklets are kept by individuals and sometimes people lose 
them, thus affecting validity or truthfulness of the findings (Polit & Beck, 2011). There is no 
empirical evidence to quantify HIV-positive women‟s screening rate, levels of knowledge 
and attitudes regarding cervical cancer and screening; and factors associated with cervical 
cancer screening among HIV-positive women in Malawi, hence, the significance of this 
study. The results of this study will inform cancer screening programs to develop targeted 
health education messages which will lead to behavioral modifications and prevention of 
cervical cancer among HIV-positive women. Additionally, early detection of cervical cancer 
can lead to a positive prognosis that can result in reduced health costs and  alleviate the 
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suffering of the individual HIV-positive women, their partners, families, and the population 
at large.  
Purpose of the Study 
 
The study has two purposes: First, to determine the prevalence of cervical cancer 
screening, the level of knowledge and attitude regarding cervical cancer and screening; 
second, to determine factors associated with cervical cancer screening behavior among 
Malawian HIV positive women. 
Research Questions 
 
The study answers the following the research questions: 
1. What is the status of cervical cancer screening behavior, knowledge level and 
attitudes regarding cervical cancer and screening among Malawian women with HIV 
infection? 
2. Is there a relationship between socio-demographic characteristics, knowledge, 
attitude, social support networks, and access to health care and cervical cancer 
screening behavior among Malawian women living with HIV infection?   
Specific Aims 
 
The specific aims to answer the above research questions include: 
1. To describe cervical cancer screening behavior and level of knowledge and attitude 
among Malawian women with HIV infection  
2. To explore factors (socio-demographic characteristics, knowledge, attitudes, social 
support networks, and access to health care) associated with cervical cancer screening 
behavior among Malawian women living with HIV infection. 
3. To examine whether knowledge and attitudes are independently associated with 
cervical cancer screening after controlling for other determinants of cervical cancer 
screening. 
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Conceptual Model 
 
The conceptual models and theories are sets of abstract concepts that are meant to be 
generalized across populations (Fawcett & Garity, 2009). However, such generalizable 
models and theories are not sufficiently specific to serve as evidence for the development of 
practice guidelines (Meleis, 2012). Im and Meleis (1999) proposed that Situation-Specific 
theory serves as evidence required for direct development of practice guidelines and 
prescriptions for interventions for populations of interest. Therefore, the situation specific 
theory was developed based on a preliminary qualitative pilot study by the researcher.  
Preliminary Study Results 
 
The qualitative pilot study was conducted to inform the current quantitative study as 
there was no empirical evidence regarding knowledge and attitude about screening among 
Malawian HIV infected women. The purpose of the pilot study was to explore barriers and 
facilitators regarding cervical cancer screening among Malawian HIV-positive women. The 
study was funded by the University of Massachusetts Boston, Office of Global Programs. 
Data were collected through in-depth interviews with HIV-positive women aged 18 and 
above. Thirteen participants were purposely selected from a hospital HIV clinic. For the 
demographic characteristics of the participants in the pilot study, refer to Table 4.  
Table 4  
 
Preliminary Results: Demographic Characteristics  
 
Variable n % 
Cervical cancer Screening   
 Yes 2 15.4 
No 11 84.6 
Marital status   
 Married 6 46.2 
Other 7 53.8 
Source of 
information   
 Fellow women 6 46.1 
Multiple sources 3 23.1 
Radio 2 15.4 
HIV Clinic 2 15.4 
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Mean (SD) Range 
Age in years 34.15 (8.87) 22-52  
No. of children 3.3 (2.59) 0-8 
No. of years since  
HIV diagnosis 5.23 (2.98) 
 
1-11  
 
Interviews were audiotaped, and field notes were taken. Data were analyzed using 
thematic analysis (Braun & Clarke, 2006). The data were coded by the researcher and the 
mentor independently to ensure conformability. The codes were compared and consensus was 
reached for major themes from the study. The pilot study identified four factors influencing 
cervical cancer screening behavior (Refer to Table 5).  
Table 5  
 
Pilot Study: Factors Influencing Screening 
 
Major Themes Subthemes Example 
knowledge 
regarding cervical 
cancer and 
screening 
risk factors, signs and 
symptoms, and 
prevention of cervical 
cancer 
“The procedure of cervical cancer is painful” (Respondent 
5). 
“I have no information about it and how to prevent it.” 
(Respondent 5). 
“All women are equally at risk of having cervical cancer 
not just HIV positive women.” (Respondent 7). 
Attitudes Social cultural factors “… some husbands cannot stay without sex for one week” 
(Respondents 11). 
“It can give us double stress and burden as we already 
have HIV that has no cure, the same with cancer. It is 
better to stay without knowing that I have cancer as I am 
already HIV positive” (Respondents 2,3). 
Social influence Family members, health 
care providers, and 
friends 
“My daughter in-law told me that the procedure is not 
painful and encouraged me to go for testing” (Respondent 
1).  
“… I have never heard from doctors talking about cervical 
cancer….” (Respondent 5). 
“The doctors told my friend not to have sex for one week 
after the procedure. (Respondents 11). 
access to health 
care services 
Distance, cost, waiting 
time, and gender of the 
service provider. 
“… although the screening services are free, we pay for 
transport. It is better if doctors examine us as we are 
starting ARV…to save transport money and time” 
(Respondent 9).  
“It took me the whole morning… and I returned back 
home without being screened” (Respondent 9). 
“I returned without screening as there was  a male 
provide”, 
 
In Table 5, the study results indicated that some HIV-positive women had limited 
knowledge regarding cervical cancer and screening services. In addition, women feared the 
positive result as there is no treatment for cancer and it can be a double burden: that is having 
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HIV and cervical cancer. This shows that women do not know that cervical cancer is a 
preventable disease and can be treated if diagnosed at an early stage. The study results 
indicated that there was need to examine the level of knowledge and attitude at an individual 
level regarding cervical cancer and screening among HIV positive women in Malawi. The 
results also indicated that women get information about cervical cancer and screening from 
their social networks like health care providers, friends, and family members which influence 
their decsion to undergo screening. This suggests the importance of further exploration of 
social networks of women living with HIV-infection to develop a targeted intervention to 
increase screening behavior to prevent cervical cancer. Further, the report indicated that 
fragmentation of the HIV and cervical cancer services was a major barrier to cervical cancer 
screening. Some women were not comfortable being examined by a male service provider 
when they were not in labor. This indicates that the gender of the healthcare provider 
performing the cervical cancer screening appeared to be a barrier to access screening services 
for some of the participants. Refusing to be examined by men reflects cultural unacceptability 
of reproductive health services like cervical cancer screening to be provided by male service 
providers. Therefore, access to screening services needed to be explored further.  
In conclusion, the pilot study findings clarified variables of interest and assisted in 
formulating the Situation-Specific theory in the context of HIV positive women in Malawi, 
literature review, and the design of the study to quantify the variables related to cervical 
screening behavior. 
Situation-Specific Theory. The Situation-Specific Theory (Refer to Figure 1) 
concepts and methodological approaches consider the uniqueness of Malawian HIV positive 
women in examining the screening rate and factors influencing cervical cancer screening.  
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Figure 1.  Situation-Specific Framework: Cervical Cancer Screening among HIV Positive 
            Women. 
The concepts of the theory are cervical cancer screening, individual factors, social 
support networks, and access to health care. The conceptual framework shows a 
multidimensional nature of cervical cancer screening behavior. In the situation-specific 
theory, the cervical cancer screening decision is conceptualized as more than just an 
individually rational decision but also includes social influences and access to health care. 
The demographic characteristics are unchangeable external factors that directly and indirectly 
influence behavior towards cervical cancer screening. 
Cervical cancer screening. This is the outcome variable of the study. Screening 
involves checking the cervix for signs of cancer when there are no symptoms (Ferlay et al., 
2012). According to the framework, screening is measured by the woman‟s receipt of vaginal 
examination by a health care provider (doctor, clinician or nurse) using a speculum to view 
the cervix, clean it, and then apply acetic acid or take a smear from the cervix to detect early 
signs of cancer. In this study, the woman‟s self-report of receiving screening was verified by 
the review of women‟s health passport record of cervical cancer screening as the preliminary 
study findings revealed that many women confuse digital vaginal examination with 
screening. This gave reliable data regarding screening behavior as self-report on screening 
status was verified by record review. 
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Individual factors. This refers to the knowledge and attitudes that women living with 
HIV infection have that influence cervical cancer screening behavior. Knowledge is a 
necessary component of health behavior change, but on its own, it is not sufficient to bring 
about cervical cancer screening behavior change without attitude change. Knowledge is 
defined as information that individuals have that influence what they do in relation to a topic 
under study (WHO, 2015). In this study, knowledge is defined as the awareness about 
cervical cancer risk factors, signs and symptoms and screening to prevent cervical cancer.  
Attitudes refer to abstract learned reaction or response in a certain way to certain 
situations (WHO, 2015). Women have different attitudes regarding cervical cancer and 
cervical cancer screening as influenced by their beliefs, perceptions, emotions, and 
misconceptions. In this study, attitudes refers to social cultural factors that women living with 
HIV infection hold such as beliefs, feelings, and fears that influence cervical cancer screening 
behavior.  
Social support network factors. The common definition of a social support network 
encompasses all social networks and social support that the individual receives from three 
different sources that include family, friends, and significant others (Malde et al., 2015; 
Zimet et al., 1988). Support networks are important to women‟s well-being for decision 
making about their health behavior. In this study, social support network refers to social 
influence and social support that women living with HIV get from family members, friends, 
and health care providers. 
Family. A family is made up of parents, partners, children, uncles, aunts, cousins and 
grandparents that provide support in time of need. They are related to one another by blood. 
Culturally, Malawians believe in extended families for financial, emotional, and social 
support.  
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Friends. Friends are important to women‟s decision making about their health 
behavior. Friends recommend and bring moral and financial support regarding screening. 
Friends are a source of information for cervical cancer and influence screening behavior. It 
includes friends, church members, neighbors, and HIV support group members if they 
recommend  
Health care providers.  The social support that women living with HIV receive from 
health care providers such as nurses, clinicians, and non-professional staff influences their 
decision regarding cervical cancer screening behavior. Health care workers serve as a source 
of information for cervical cancer and screening services as well as providing emotional 
social support and cervical cancer screening services to HIV-positive women which is 
valuable in fighting stigma and cervical cancer in the country. 
Access to health care factors. Access refers to factors that facilitates or hinders 
women to receive screening services that include affordability, availability, accessibility, 
accommodation, and acceptability (WHO, 2002). In the framework, access refers to the 
distance to screening sites, transport, waiting time, and gender and age of the service provider 
in relation to the definition of access by WHO.  
 Affordability. It refers to the ability to pay for transport to go for cervical cancer 
screening services when the woman wants to be screened, The health care services in 
Malawi is free, 
 Availability. Refers to the geographic distance  to travel to health care facility for 
screening services 
 Accessibility. Refers to waiting time and previous experience with health care 
providers in health facilities and screening sites 
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 Accommodation. Refers to the perception of adequacy of health care provider‟s 
operation in terms of skills, supplies or drugs and individual women perceptions 
regarding cervical cancer disease and commitment for preventive services. 
 Acceptability. Refers to women‟s comfort with health care provider‟s characteristics 
and privacy at the screening sites. 
The Situation-Specific theory concepts guided integrated literature review in the context 
of HIV positive women in Malawi as described in Chapter 2. 
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CHAPTER 2 
 
LITERATURE REVIEW 
 
This chapter provides an overview of the review of existing literature relevant to the 
concepts of the Situation Specific Theory for Malawian women living with HIV infection 
(Mtengezo & Lee, 2018). An integrative literature review was conducted following the 
concepts identified from qualitative pilot study to assess the status of cervical cancer 
screening behavior, knowledge level, attitudes and factors influencing cervical cancer 
screening among HIV-infected women. The aim of the literature search was to review what 
others have done before to build upon these works on cervical cancer screening among HIV-
infected women.  
Medline, Cumulative Index to Nursing and Allied Health Literature Complete, 
PsycINFO, SocINDEX, and Google Scholar were searched. Search terms included “cervical 
cancer screening,” “VIA,” “screening,” “Pap Smear.” “HIV-positive women,” “knowledge,” 
“attitude,” “practices,” “developing countries,” “developed countries,” “Africa,” “Sub-
Saharan Africa,” and “Malawi." Due to the scarcity of peer reviewed articles in Malawi, other 
gray literature from Government reports were included. Findings were categorized within the 
context of the concepts of the Situation Specific Theory feasible within Malawian context. 
The search yielded twenty-six articles as depicted in the search strategy flow diagram 
(Refer to Attachment B). After setting limits, twenty relevant studies were summarized in an 
evidence-based table (Refer to Attachment C). Of the twenty studies, eight were conducted in 
Malawi but not specifically on HIV-positive women. Four of the eight studies conducted in 
Malawi were qualitative studies, two were document review studies, one was a quantitative 
study, and another one was a mixed methods study. Twelve studies were conducted on HIV-
positive women (Six in Sub-Saharan Africa and six in developed countries). Nine of the 
twelve studies were conducted in Sub-Saharan Africa and developed countries, nine were 
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quantitative studies, two were mixed methods studies, and one was a qualitative study. The 
results of the search show limited evidence of well-designed studies that have been done with 
HIV-positive women regarding their knowledge and attitude both in developing and 
developed countries and none were found from Malawi.  
All the concepts of the Situation Specific framework were used to guide the 
classification of the concepts extracted from literature. The link of the concepts, middle-range 
theory and the empirical (CTE) indicators are shown in the CTE structure (Attachment D). 
The findings of the literature review are summarized within the Situation-Specific framework 
concepts of Malawian HIV-positive women which include cervical cancer screening, 
knowledge, attitudes, social networks, social support, and access to health care services. 
Cervical Cancer Screening 
 
Malawi adopted a single visit approach to cervical cancer screening “screen and treat” 
using VIA and cryotherapy (Refer to Table 6) in 2004 (Malawi, MOH, 2015).  
Table 6  
 
    VIA Test and Cryotherapy  
 
V
IA
 T
E
S
T
 
Step 1: Provide counselling on VIA test and obtain consent. 
Step 2: Inspect and palpate the abdomen and external genitalia. 
Step 3: Perform a speculum exam to view the cervix clearly. 
Step 4: Apply a 3-5% acetic acid solution (vinegar) to the cervix. 
Step 5: Observe for cervical change(s) after at least 1 minute. 
Step 6: Discuss the results with the woman. If the results are positive and eligible for 
cryotherapy, counsel and offer cryotherapy. 
C
R
Y
O
T
H
E
R
A
P
Y
 
 
Step 7: 
 
Provide counsel on cryotherapy and obtain consent. 
Step 8: Perform a speculum exam to view the cervix again (repeat VIA if necessary) 
Step 9: Perform the double-freeze cryotherapy technique. 
Step 10: Provide post-treatment and follow-up instructions to the woman. 
 
The process of VIA involves vaginal speculum examination, followed by visual 
inspection of the cervix for one minute after cleaning with a 3-5% acetic acid solution which 
can be ordinary table vinegar or iodine (MOH, 2015). The test shows changes in the 
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epithelial cervix cells as white blotches if abnormal precancerous cells are present. Then the 
provider either treats immediately with cryotherapy by freezing the lesions with liquid 
nitrogen to destroy them or refers the patient for further treatment (MOH, 2015). Women 
with grade 3 lesions and more serious lesions require further treatment to include surgery. 
Cervical cancer screening using VIA and cryotherapy in “screen and treat” approach is 
feasible in Malawi and other low resource countries (Refer to Table 6) for the steps. 
According to Malawi, Ministry of Health guidelines, the VIA targets 30-45-year-old women 
(Malawi, MOH, 2015). This is because the VIA depends on visualization of the squamo-
columnar junction (Sankaranarayanan & Wesley, 2001; McIntoch et al., 2001). Further, it is 
indicated that after menopause, the squamo-columnar junction usually recedes into the 
endocervical canal and cannot be seen. In a few countries, including Malawi, a downshift in 
age for invasive cervical cancer and age for screening with VIA has been observed due to 
HIV co-infection among 15-49 year old women (Ferlay et al., 2012). Therefore, screening 
has been done with VIA and positive rate and cancer suspects have been detected in women 
aged 29 or less (Msyamboza et el., 2016). The VIA is practical and harmless, and effective in 
reducing the cervical cancer burden (CDC, 2010).  
Cervical cancer screening recommendations for women living with HIV are different 
from screening guidelines for HIV-negative women (Refer to Figure 2).  
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Figure 2.  The VIA and Cryotherapy Protocol in Malawi 
 
The HIV-positive women require more frequent screening as they have increased risk 
of developing cervical cancer than HIV-negative women. In Malawi, the MOH recommends 
rescreening HIV-infected women annually and HIV-negative women every three years after 
the initial test (MOH, 2015). Precancerous conditions normally progress slowly into cervical 
cancer, but with HIV-infection, it progresses faster. Therefore, frequent screening in HIV-
positive women has the potential to identify abnormal conditions before such progression. A 
single screening can reduce cervical cancer mortality among HIV-positive women (Atashili 
et al., 2011; Maseko, Chirwa, & Muula, 2015). Regular screening has been shown to decrease 
the probability of death from cervical cancer between 80 to 90% (Arbyn et al., 2018; 
Mandelblatt et al., 2002; Sasien, Adams, & Cuzick, 2003).   
Several studies were found that evaluated the cervical cancer screening rate among 
HIV-positive women in developing and developed countries (DalMaso et al., 2010; Ezechi, 
Gab-Okafor, Ostergrem & Odbery, 2013; Maree & Moitse, 2014; Matangaidze, 
Ramalivhana, Mbambo-Kekana, Ndaimani, & Mhlanga, 2016; Msyamboza et al, 2016; 
Rosser, Njoroge, & Huchko, 2015; Sichanh et al., 2014). It is evident from these studies that 
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there is variation in the prevalence of cervical cancer screening rate among HIV positive 
women in developed and developing countries (Refer to Table 7).  
 Table 7  
 
       Prevalence of screening rate among HIV+ women 
 
Author Country Screening Rate 
Msyamboza et al., 2016 Malawi 15.9% 
Low-resource countries 
Ezechi et al., 2013; Maree & Moitse, 2014; 
Matangaidze, et al., 2016; Rosser et al., 2015; 
Sichanh, et al., 2014 
Nigeria, South Africa, 
Zimbabwe, Kenya, and Lao 
PDR 
 
3.9 – 84.0 % 
 
Developed countries 
Dal Maso, et al., 2010; Wigfall et al., 2013 Italy, USA 83.0 - 90.9% 
 
In resource-limited countries, including Malawi, few HIV-positive women, as low as 
3.9% in Nigeria, undergo cervical cancer screening although they are at increased risk of 
developing cervical cancer (Sichanh et al., 2014). However, evidence has also shown that if 
there are targeted interventions for HIV-positive women, the screening rate increases (Rosser 
et al., 2015). For example, in Kenya, the Family AIDS Care and Education Services and HIV 
program piloted the cervical cancer screening and prevention program at one HIV clinic. The 
program provided free screening services to all women residing in the study area. This 
program recruited HIV-positive women to assess cervical cancer knowledge, personal risks, 
and screening behavior. The program evaluation found that 84% of HIV- positive women 
underwent cervical cancer screening (Rosser et al., 2015). Some studies conducted in the US 
and Italy also indicated a high screening rate for women living with HIV infection. For 
example, the study in Italy evaluated the history of Pap smear in HIV- positive women in 
relation to the socio-demographic and organizational factors associated with adherence to 
cervical cancer screening (DalMaso et al., 2010). The study found that 90.9% of HIV-
positive women had an initial Pap smear but only 66% underwent all the recommended Pap 
smear follow-up tests.  
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Evidence from literature revealed that screening was measured by a woman‟s self-
report of receipt of cervical cancer screening by either VIA or Pap smear approach (DalMaso 
et al., 2010; Ezechi et al., 2013; Maree & Moitse, 2014; Matangaidze et al., 2016; 
Msyamboza et al, 2015; Rosser et al., 2015; Sichanh et al., 2014). The women were asked a 
single question: if they had ever been screened. Self-report is a method of collecting 
information about an individual‟s health status and utilization of health care services. 
Evidence has shown that self-reports may be used when medical records are unavailable 
particularly for shorter recall periods (Short et al., 2009). Self-reports tend to give higher 
rates than medical record review. The factors affecting accuracy of self-report information 
may include education and health status (Short et al., 2009). Healthier women with higher 
education are more likely to report accurate information than less healthywomen with low 
education. Women living with HIV infection may be either sick or healthy but screening is 
critical for all HIV-positive women. Therefore, factors influencing cervical cancer screening 
were also reviewed in the literature. The results from the literature have been classified based 
on the situation-specific concepts: individual factors, social support networks, and access to 
health care (Mtengezo & Lee, 2018).  
Individual Factors 
 
In the pilot study, individual factors are operationalized as the understanding that 
HIV-positive women have about cervical cancer and screening and how it influences their 
screening behavior (Mtengezo & Lee, 2018). Several qualitative studies were conducted in 
Malawi about cervical cancer screening, but were not specifically with women living with 
HIV infection (Chadza et al., 2012; Maseko et al., 2015; Fort, Makin, Siegler, Ault, & 
Rochat, 2011). Most of these studies explored individual factors contributing to delay in 
seeking cervical cancer services in Malawi. The major theme found was that women had 
limited knowledge regarding cervical cancer and screening. Further, the literature indicated 
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that women had heard about cervical cancer but did not know what the disease was all about 
(Ports, Reddy, & Rameshbabu, 2013). A mixed methods study was conducted to assess client 
satisfaction after undergoing screening  and this study found that satisfaction was predicted 
by having previous knowledge of the VIA test with 98% of these women reporting 
knowledge of the disease seriousness as their motivation for getting screened to know their 
status (Maseko, Chirwa, & Mvula, 2014). However, the majority (80%) had limited 
knowledge about how the disease was caused, and 71.8% had no idea of how the VIA 
screening test was done. Further, the study revealed that young women thought that they 
might not have children after undergoing VIA as the procedure burns the womb (Ports et al., 
2013). Another document review study was conducted to identify barriers to utilization of 
cervical cancer screening in low and middle-income countries including Peru, Mexico, South 
Africa, Kenya and Malawi (Maseko et al., 2015). The study found that lack of awareness and 
knowledge about risks and prevention of cervical cancer were related to age and marital 
status of participants.  Married women had a higher recognition of cervical cancer risk factors 
than those who had never been married. Also, women who were older and had higher income 
or heard of cervical cancer were more likely to utilize prevention services than young women 
with little income. Since there are no studies conducted in Malawi to understand HIV-
posivtive women‟s knowledge related to cervical cancer screening, a review of published 
studies extended to other developing and developed countries.  
The published studies conducted in South Africa, Zimbabwe, Kenya, Nigeria, US, and 
Lao PDR in Asia on HIV-infected women‟s cervical cancer-screening knowledge indicated 
conflicting results. Some studies indicated that women had inadequate knowledge about 
cervical cancer screening although they all were at risk for cervical cancer (Matangaidze et 
al., 2016; Wake et al., 2009; Sichnh et al., 2014). Women reported that they did not undergo 
screening because of lack of knowledge about the examination (Matangaidze et al., 2016; 
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Wake, Rebe, & Burch, 2009). The results of these studies suggest that knowledge is 
associated with screening and is an important factor for behavior change; for example, 
women who had heard of cervical cancer and screening, also had a higher screening rate 
(Rosser, et al., 2015; Wigfall, et al., 2015). Interestingly, some studies, found that women had 
knowledge about cervical cancer (78.7%) and screening (62.9%), but for being screened, the 
rate was still as low as 22.3% (Maree & Moitse, 2014). If women have knowledge about 
cancer and screening, why is the screening rate low? Do they have the correct information? 
Other studies indicated that some women had heard of cervical cancer and screening but had 
inadequate knowledge of screening usefulness (Sichanch, 2014; Wake, et al., 2009). In 
addition, most studies conducted in Sub-Saharan Africa, did not use instruments that were 
culturally sensitive within their setting as they used instruments that were validated in 
developed countries like the USA for all women and not HIV-positive women. Some 
components of knowledge between the link of HPV and HIV were missing. The finding 
could mean that knowledge in previous studies was not measured accurately leading to 
conflicting results or that knowledge is not the only factor that influences their screening 
behaviors. For women to make informed decisions about cervical cancer screening, they need 
to have the correct knowledge about cervical cancer and screening. Limited knowledge 
contributes to delay in seeking cervical cancer screening and treatment services. No study in 
Malawi was found that measured the level of knowledge regarding cervical cancer screening 
in HIV-positive women. The study that was conducted regarding knowledge was the MDHS 
(2017) report that shows that knowledge about diseases such as HIV/AIDS increases with 
higher education level attainment. Educated people are more likely to access health care 
services compared to those with little or no education. Education and knowledge about 
diseases is therefore an important determinant of health to consider in behavioral studies. 
Therefore, knowledge regarding cervical cancer and screening in HIV- positive women needs 
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to be further explored given their increased risk of developing cervical cancer. Knowledge is 
a necessary component of health behavior change, but on its own, it is not sufficient to bring 
about cervical cancer screening behavior change without an attitude change at an individual 
level. 
Women have different attitudes regarding cervical cancer screening. Various studies 
have been conducted to evaluate HIV-positive women‟s attitudes regarding cervical cancer 
and screening in different countries using different instruments (Ezechi et al., 2013; Maree & 
Moitse, 2014; Matangaidze et al, 2016; Bynum et al., 2013). In Malawi, only a few 
qualitative studies were found in the literature on attitudes regarding cervical cancer 
screening (Chidyaonga-Maseko, Chirwa, & Muula, 2015; Fort et al., 2011; Munthali, 
Ngwira, & Taulo, 2015). In qualitative studies on perceptions of cervical cancer screening 
among women in Malawi, it was found that women had misconceptions about the VIA 
procedure which prevented some women from going for the service (Chidyaonga-Maseko et 
al., 2015; Munthali et al., 2015; Ports et al., 2013). Women had misperceptions that the VIA 
procedure causes cancer as health workers use acid during the process which burns the 
cervix. Some studies revealed that women felt that it was not appropriate to discuss 
reproductive health issues with young women (Chidyaonga-Maseko et al., 2015). Some 
women when they are healthy think they do not need any preventive interventions like 
exposure to the VIA process and visit the hospital only when they are sick (Munthali et al., 
2015). Consequently, they delay in seeking care services including cervical cancer screening. 
In cross-sectional studies conducted in South Africa and Kenya to determine the knowledge 
level of women regarding cervical cancer and screening, it was found that most did not 
undergo screening as they feared the procedure because they had heard that it was painful 
(Maree & Moitse, 2014; Rosser et al., 2015; Sichnh et al., 2014). These study results indicate 
that many women have incorrect information about screening which may have led to 
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increased risk of developing cervical cancer because low levels of knowledge and negative 
attitudes contribute to low screening behavior. However, studies conducted in Nigeria, 
Zimbabwe, US and South Africa indicated that 77.4 -84.9% of women had intentions of 
undergoing screening in the future (Ezechi et al., 2013; Matangaidze, et al., 2016; Wake et 
al., 2009). Based on women‟s intentions to undergo screening in the future, these studies 
conclude that most women have positive attitudes regarding cervical cancer screening, as 
they perceive cancer as a dangerous disease. Intentions do not mean that women will undergo 
screening. No study has been conducted to measure the beliefs, feelings, and fears of HIV-
positive women regarding cervical cancer and screening in Malawi. There is need to establish 
whether attitude at an individual level influences screening behavior among Malawian HIV-
positive women. 
Social Support Networks 
Social support networks have various definitions in the literature. Social support 
consists of social relationships that can provide material, emotional, informational and 
instrumental resources (Kadushin, 2011; Malde et al., 2015; Mtengezo & Lee, 2018; Zimet, 
Dahlem, Zimet, & Farley, 1988). Various studies investigated the relationship between social 
support and depression in pregnant or postpartum mothers and they have shown that social 
support networks influence various behavior changes (Lubben et al., 2006; Stewart, Umar, 
Tomenson, & Creed, 2014; Nakigudde, Musisi, Ehnvall, Airaksinen, & Agren, 2009). This 
literature review found limited studies conducted on the relationship between social influence 
and screening behavior among HIV-positive women in developing and developed countries 
(Ezechi et al., 2013; Maree & Moitse, 2014; Wigfall et al., 2015). The social influence was 
also related to social cultural factors that influence cervical cancer screening (Williams, 
Moneyham, Kempt, Chamot, & Scarinci, 2015). In a pilot study, it was found that social 
networks include spouse, parent, child, in-laws, relatives, friend, church members, neighbors, 
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health care providers, and HIV support group members.  Social support network has 
multidimensional constructs and is influenced by family members, friends, and health care 
providers (Mtengezo & Lee, 2018). 
Family. From the literature, no study was found that examined family as a social 
influence for cervical cancer screening behavior. In other behavior studies, like HIV/AIDS, 
family and social support networks play an important role in stigma after HIV diagnosis and 
in the utilization of preventive health care services (Malawi Network of People Living with 
HIV and AIDS [MANET+], 2012). Both cervical cancer and HIV/AIDs are sexually 
transmitted diseases and both are linked to having multiple sexual partners. Therefore, there 
is stigma within the family and this remains the largest barrier to individual and public action 
to preventive services. This may suggest that when HIV-positive women go for screening 
services, they are indirectly disclosing that they have multiple sexual partners and may be 
stigmatized by family members. This may suggest the importance of studying the role of 
family members in preventive services.  
Other studies have also shown that people living with HIV/AIDS (PLHA), have 
actual or imagined fear or worry of negative societal attitudes and possible discrimination 
was arising from having HIV an infection (Kamen et al., 2015; MANET+, 2012; Neuman & 
Obermeyer, 2013).  Fear or self-stigma included both the concern of exposure to 
stigmatization and the potential internalization of the unfavorable beliefs and feelings related 
to the stigmatized HIV condition (Rueda et al., 2012). The PLHA know how their social 
networks including families stigmatize them, and they react by accepting society's negative 
judgment of their identity as an HIV-positive person and that they will die. The amount of 
stigma PLHA already have experienced from the societal networks, read about or heard of, 
affects their decisions and future actions in preventive services. There are variations in 
reactions as some PLHA self-blame for the HIV positive status while others feel they got the 
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HIV infection because of their partners' infidelity and blame their partners (Neuman & 
Obermeyer, 2013).  The PLHA also have negative decisions about HIV care, treatment, 
support and preventive services. Decisions that HIV-positive women make include not taking 
medication, and missing hospital appointments (Bedell, Van-Lettow, & Landes, 2014). When 
women miss their medication, they compromise their immune system and may risk higher 
rates of human papilloma infection, and some other types of cancers (WHO, 2010). Providing 
preventive health services is critical in HIV-positive women to prevent cancer. The 
preventive services may include breast, colorectal and cervical screening, and sexually 
transmitted infections testing, and counseling on sexual behaviors (WHO, 2010). 
Understanding information flow within a network can serve as a useful tool in predicting the 
most influential social networks that can be targeted for information, education, and 
communicating cervical cancer preventive messages. The pilot qualitative study revealed that 
HIV-positive women seek information regarding cervical cancer from families, friends, and 
health care providers.  
Friends. A study was conducted in the US to examine associations between women 
living with HIV/AIDS, cervical cancer prevention knowledge and abnormal Pap test history 
(Wigfall et al., 2015). The authors found that women who had members of their social 
network who had an abnormal Pap test history knew about cervical cancer screening and 
follow-up care for a woman who is HIV-positive and the screening rate for these women was 
83% (Wigfall et al., 2015). The results of the study may suggest that friends offer advice, 
direction, and information that influence their social networks to adapt behavior change 
interventions. On the other hand, the results could mean that friends rely on each other and 
share joys, sorrows or problems and influence each other. 
 Health care providers. Various studies have shown that health care providers are 
important when it comes to decision making about health behavior (Maree & Moitse, 2014; 
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Ezechi et al., 2013). In a study conducted in South Africa to determine what women treated 
with HIV/AIDS knew about cervical cancer and screening found nurses and doctors as the 
most likely sources of information (Maree & Moitse, 2014). The study conducted in Nigeria 
to assess the willingness and acceptability of cervical cancer screening among HIV-positive 
women found that religious denial (14.0%) was the most common reason given for refusal to 
take the test (Ezechi et al., 2013). The studies may indicate that health care providers are 
sources of information to influence cervical cancer screening behavior.  
Access to Health Care Services 
The success of any prevention program is linked with the quality and accessibility of 
health services. In literature, the dimensions of access include barriers and facilitators  
relating to cervical cancer screening such as affordability, availability, accessibility, 
accommodation, and acceptability (Maseko et al., 2015; Maseko et al., 2014; Munthali et al., 
2015; WHO, 2002).  
 Accessibility. In literature, accessibility refers to barriers and facilitators regarding 
access to screening services but not specifically on HIV-positive women (Maseko et al., 
2015; Maseko et al., 2014; Munthali et al., 2015). The results of the studies in the literature 
indicated that the accessibility of health care services is linked to previous experience with 
resources, service providers, and waiting time (Maseko et al., 2015; Maseko et al., 2014; 
Munthali et al., 2015). The study results have indicated that women can access preventive 
health care services if the waiting time to receive the service is short time and if they are 
treated with respect by the service providers. There must be more screening sites and trained 
health care providers to provide the screening services for the women not to wait for a long 
time. A recent study conducted on cervical cancer screening behavior and challenges in 
Malawi found that the screening sites increased from 75 to 130 from 2011 to 2015 and are 
free and available in most district public health facilities but women still wait for a long time 
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to be screened such that some to go back home without being screened (Msyamboza et al., 
2016). Even though the screening sites have been increased, they are still too few as the 
estimated total number of health facilities in Malawi is over 500. When creating demand by 
advocating for screening services, the health facilities must be able to supply the demand by 
training more service providers and opening more screening sites would reduce waiting time. 
 Accommodation.  Accommodation refers to the perception of adequacy of provider‟s 
operation in terms of skills and supplies or drugs (WHO, 2002). In a study conducted on 
health workers‟ perceptions about health system challenges in implementing cervical cancer 
screening services in Malawi, health workers reported that lack of supplies like vinegar and 
space made it inconvenient for women to go for screening (Maseko et al., 2015; Munthali et 
al., 2015). Further, it was reported that in some health facilities, there was inadequate space, 
and they alternate services or provide the service only once a week or women wait until other 
people finish other procedures to start providing cervical cancer services. Few members of 
staff were trained and committed to the provision of cervical cancer screening and early 
treatment services (Maseko et al., 2014; Munthali et al., 2015). In another study, it was 
reported that women made several hospital visits to seek care despite their limited resources; 
unfortunately, drugs were sometimes prescribed without proper assessments (Chadza et al., 
2012).  
 Acceptability. Acceptability refers to privacy and comfortability with the health care 
provider (WHO, 2002). A qualitative study conducted in Malawi, found that using male 
service providers hindered the use of screening services because women did not want male 
providers to see their private parts except when they were in labor (Munthali et al., 2015). 
Some husbands and certain cultures do not want women‟s private parts exposed to a male 
service provider when not in labor. The use of male service provision in preventive health 
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services is multidimensional concept and may present a barrier that needs to be explored 
among HIV positive women.  
Availability. Availability refers to distance to screening sites (WHO, 2002).  Long 
distance to the health facilities is also a major barrier for women to access cervical cancer 
screening services. In three qualitative studies the participants stated that the hospital where 
they provided screening services were  too far (Chadza et al., 2012; Lee, Makin, & Mtengezo, 
2015; Ports et al., 2013),.  Ports and colleagues (2013) reported that the average time to walk 
to the nearest clinic was 45 minutes. Maseko and colleagues (2014) found that participants 
covered a distance between one and five kilometers to reach the screening centers. Maseko 
and colleagues (2015) found that only 33.3% (7/21) of the health facilities provided both 
screening and cervical cancer treatment services. Cervical cancer services were offered at 
primary, secondary and tertiary level. At tertiary level, the access of health care is often 
misunderstood and confusing in the country especially in the districts that offer all three 
levels of care like Lilongwe. There is a policy that women must visit the health center for 
primary care and the health care providers must refer an individual to a district hospital for 
secondary care and the district must refer to a central hospital for tertiary care. Even if a 
woman lives close to district hospital or central hospital, she cannot access health care there 
directly. Even though the district is in an urban area, some health clinics are far from the 
district and central hospital. Therefore, women may visit the clinics when the disease is at an 
advanced stage (Chadza et al., 2012; Lee et al., 2015; Ports et al., 2013). 
 Affordability. Affordability refers to the ability to pay for cervical cancer screening 
services (WHO, 2002). In Malawi, public health services are free. Maseko and colleagues 
(2015) reported that there are no user fees to access cervical cancer screening and treatment 
in public health facilities; however, women are required to purchase health passports if they 
do not have one, which may be a barrier to receiving cervical cancer screening. Christian 
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Health Association of Malawi (CHAM) facilities charge a consultation fee. The CHAM 
health services are available in urban and rural areas and provide 85% of health care in the 
rural areas. These CHAM health facilities are close to where the women live, but because 
they charge the consultation fee, few women access care at CHAM facilities. Even if the 
consultation fee is minimal, women travel a long distance to access free services in a public 
hospital even though the use of public transportation might be more than the consultation fee 
even though in an urban area. When women do not have money to pay for the medical 
services at private hospitals or transport to the free government hospitals, they just stay at 
home and visit the health facility when cancer is in the advanced stage. Studies conducted in 
Kenya and Nigeria found that women pay for cervical cancer screening services and the costs 
varied from country to country (Ezech et al., 2013; Rosser et al., 2015). However, even in 
some developing countries like Malawi, where there are no user fees, and HIV-positive 
women access the ART clinics for their treatment monthly or every three months, the 
screening rate for HIV-positive women is very low (15.9%). The findings indicate that there 
are policy and systematic challenges to cervical cancer screening like resources, gender of 
provider, availability of service providers and time taken to access screening services. Most 
studies have focused on physical and economic access to health care. However, a more 
evidence-based definition of access to care is missing that links the success of any preventive 
disease efforts directly with the quality and accessibility of the services. Therefore, it is 
important to assess HIV-positive women's dimensions of health care access and how they 
may influence cervical cancer screening behavior while considering their socio-cultural 
factors. 
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Summary of Literature Review 
The literature review findings demonstrated that the prevalence of cervical cancer 
screening rate among HIV positive women mostly were by women‟s self-report of the receipt 
of screening. In this study, the woman‟s self-report of receiving screening was verified by 
record review. This gave reliable baseline data regarding screening rate among HIV positive 
women in Lilongwe, Malawi. Limited studies in both developed and developing countries 
have shown that women with low levels of knowledge and negative attitude regarding 
screening are unlikely to access screening services. There are also limited empirical studies in 
the literature regarding the correlates of cervical cancer screening among women living with 
HIV infection for hypothesis testing. There was also no instrument to measure the situation 
specific concepts in the context of Malawian women living with HIV infection. If there are 
no standardized instrument to measure specific variables of interest, evidence has indicated 
that qualitative studies inform the development of a quantitative tailored instrument (Lee et 
al., 2015). Therefore, the literature review findings and preliminary qualitative study results 
assisted in developing a culturally sensitive instrument to inform a cross-sectional 
correlational study design for this study. The detailed methodology of the study and 
instrument development is outlined in research methodology, chapter 3. 
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CHAPTER 3 
 
RESEARCH DESIGN AND METHODS 
 
This chapter describes the research methodology used for this study. It highlights the 
study design, study population, setting, sampling method, data collection procedures, and 
data statistical analysis. 
Design 
 
The study used a cross-sectional health survey design to examine the prevalence of 
cervical cancer screening, level of knowledge and attitudes regarding cervical cancer and to 
determine factors (individual factors, social support networks, and access to health care) 
related to cervical cancer screening behavior.  
Study Setting 
 
The study was conducted in both rural and urban HIV support groups in Lilongwe, 
Malawi. Lilongwe is a district in the central region of Malawi.  The district covers an area of 
6,159 square kilometers and has a population of 1,346,360. The district is the capital city of 
Malawi and is considered an urban district.  Despite being an urban district, the district has 
diverse levels of people with different socio-economic status in urban and rural settings. The 
district covers all three levels of the health care delivery system within the city including the 
primary, district, and tertiary levels giving a good representation of the target population 
across the district. In addition, the HIV prevalence is two times higher in urban areas than in 
rural areas, 17.4% versus 8.9% (MDHS, 2017). The district HIV prevalence rate is 9.2% and 
has many HIV support group dealing with people living with HIV/AIDS (UNAIDS, 2014). 
Most HIV support groups were established to support people living with HIV/AIDS to live a 
quality productive life. They are membership organizations and the members are in all 
districts of Malawi. For example, the National Association of People Living with HIV/AIDS 
in Malawi (NAPHAM) was establised in 1993 by a small group of PLHIV who observed that 
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their needs were not being met. The organization fights stigma and discrimination, advocates 
for supportive environments for PLHIV, and facilitates localized support groups for those 
who are infected and affected by HIV and AIDS. Another organization is the Coalition of 
Women Living with HIV/AIDS (COWLHA) and it unites different groups of women as a 
civil society force in dealing with issues on gender and women‟s rights in the context of HIV 
and AIDS that impact the lives of women living with HIV and AIDS in Malawi.  
Study Population 
 
The study targeted Malawian HIV-positive women in support groups in Lilongwe 
District. The inclusion criteria was: HIV positive women in HIV support groups aged 18 and 
above with a cervix, active members of HIV support organizations, willing to participate in 
the study, and able to speak Chichewa or English. The inclusion criteria included women 
aged 18 and above as Malawi‟s HIV prevalence is highest among women aged 15-49 years 
(12.9%). The HPV infection occurs shortly after the onset of sexual debut. Evidence has 
indicated that 35% of the women are infected within 2 years of initiating sexual activity 
(Collins et al., 2002; Kjaer et al., 2001). In addition, the screening data has revealed that VIA 
positives and cancer suspects were detected in 2.3% in women aged 29 or less, and 1.2% in 
women over 45 years (Msyamboza et al., 2016). This is a large population in a high 
prevalence rate country for cervical cancer and HIV. The exclusion criteria included women 
who had a total hysterectomy, women with known allergy to acetic acid, and women who had 
cervical cancer screening before HIV diagnosis. 
Sampling Method 
        Sampling frame: The sampling frame was the HIV Support group registry at the 
Lilongwe District Aids Coordinating Office that was used to identify all HIV support groups 
in Lilongwe District. There are six HIV membership support organizations in Lilongwe that 
support Malawian women living with HIV/AIDs. There are eighty-four support groups, and 
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the membership varies between 20-100 in each support group. In total, there are over 4,200 
HIV-positive women and men in Lilongwe District and among these members, 3,360 (80%) 
are women aged 18 and above.  
Sample size: The outcome variable was cervical cancer screening which was 
measured by the receipt of cervical cancer screening after HIV diagnosis. The sample size 
calculation was estimated by using G-power and sample size calculator based on the 
prevalence of the outcome variable of interest (Rosner, 2011). In Malawi, the cervical cancer 
screening coverage for HIV positive women is 15.9% (Msyamboza et al, 2016). Using 15.9% 
as the maximum expected prevalence of cervical cancer screening rate among HIV-positive 
women, a margin of error equal to 0.05 in 95% confidence interval, a minimum sample size 
of 206 participants was needed to be selected from a population of 3,360 HIV positive 
women in support groups in Lilongwe District.  
Formula : 206
05.0
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• The margin of error: 0.05 (5%) =Chance to tolerate wrong conclusion 
• The CI: 95% 
• Population (3,360) : use infinite 100,000 since the actual size is not known- drop and 
join 
• Prevalence of screening rate in HIV Positive women: 15.9% (previous studies) 
• Z= Standard normal variate = 1.96 at 5% type 1 error 
• D = Absolute error of precision 
Considering that 70% would agree to participate  in the study and 10% missing data, 
291 women meeting the criteria in the selected HIV support groups were invited to 
participate in the study.  
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 Sampling: Two staged proportionate stratified cluster random sampling method was 
used to select subjects proprtionally to the population size of HIV positive women in urban 
and rural geographical areas and by agegroup (Refer to Figure 3).  
 
 
 
 
 
 
Stage 1 
 
 
 
 
 
 
 
 
  Stage 2 
 
 
 
 
 
 
 
 
 
 
 
 
 In proportionate stratified sampling, the examined population is divided into distinct 
subgroups, called strata and a predefined percentage of participants are selected in each 
stratum (Levin & Kanza, 2014). The population of interest was HIV positive women 
attending HIV support groups in Lilongwe District  which was approximately 3,360 women. 
The population was stratified by geographic location: Urban and Rural of Lilongwe District 
(Refer to Figure 4). 
 
 
4200 HIV positive men and 
women (84 support groups) 
3360 HIV positive women, 
>18 (84 HIV support groups) 
175 (Cluster random sampling: 10 support 
groups) 
116 (Cluster random sampling: 5 support 
groups)   
Exclude Men, women 
under 18, those with total 
hysterectomy and allergic 
to acetic acid 
40% Age-group 18-
29 
             70 
60% Age-group >30  
             105  
291 Invited and completed the study 
40% Age-group 18-29 
               46  
60% Age-group >30 
           70 
Urban (60%): N= 2016 Rural (40%): N= 1344 
Figure 3. Two Stage Proportionate Stratified Cluster Random Sampling 
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Figure 4. Urban and Rural Area of Lilongwe District. 
 
and by age-group. The age group was divided into two groups: 18-29 and 30 and above in 
each stratum.  The HIV positive women were identified through a register obtained from 
Lilongwe District Health Office in the capital of Malawi. The sample size was calculated by 
using a percentatge of the proportionate of each stratum. For example 60% of the participants 
were of the age-group between 39-50 and 40% age group 18-29 to ensure that the number of 
selected subjects for the sample from each age-group was proportionate. The same was done 
for geographical allocation. The sample size (291) was multiplied by 60% (291*0.6 = 175) 
for Urban and by 40% (291*0.4 = 116) for Rural. Simple random sampling was used to select 
10 support groups as clusters in 4 Traditional Authorities in urban area and 5 support groups 
in 3 traditional authorities in rural area.  Simple random sampling was done by writing all the 
names of the HIV support groups on a small paper and putting them in a ballot box; the 
proportinate of the support groups were selected by picking papers randomly from the ballot 
box. All women meeting the criteria, in the randomly selected support groups were invited to 
participate in the study until the sample size was reached. Stratified random sampling reduces 
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potential for human bias in the selection of subjects to be included in the sample and provides 
the sample that is highly representative of the popultation being studied. 
Measurement 
 
The questionnaire for this study was purpose-designed based on the specific needs of 
this study within the Malawian context. The instrument development process followed the six 
stages as stipulated by Lee and colleagues (2015) which include: conducting literature 
review; conducting qualitative study; selecting items; translating; conducting cognitive 
interviews; and conducting the full-scale survey (Lee et al., 2015).  
The questionnaire was developed basing on literature review (Mtengezo & Lee, 2018; 
UCL, 2011; WHO, 2002; WHO, 2008; Zimet et al., 1988) with modifications in line with 
research questions and qualitative study findings to fit the local context of Malawian women 
living with HIV infection. The qualitative study was conducted by the researcher to learn 
how women living with HIV in Malawi conceptualize and describe cervical cancer screening 
to have a culturally relevant tool by using the language that women living with HIV 
understand. Items for the survey were selected based on the situation specific conceptual 
framework concepts and middle range theories from the literature review. The terms used in 
the survey were based on the language women use in Malawi. For example, the term 
“screening” to local Malawians is called “examination” so women were asked if they had 
been “examined for cervical cancer”.  In addition, cervical cancer in the local language is 
called „Khansa la khomo lachiberekero”. After development, the instrument was given to 
committee members and cervical cancer clinical experts to conform to content and face validity 
of the developed instrument. 
Translation of the instrument. In Malawi, about 75% of women and 83% of men 
are literate (MDHS, 2017). In addition, 12% of women aged 15-49 have no education and 6 
in 10 women have only attended primary education and are not fluent in English. Therefore, 
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the developed English instrument was translated into the local language, Chichewa, so that 
the questionnaire was easily understood by the women. The WHO recommends an approach 
that makes use of forward and back translations, input from experts, and pretesting with 
target populations to ensure that the translated instrument valid and reliable (WHO, n.d).  
During forward translation, two independent translators who were bilingual experts and 
familiar with the study content, and everyday language, culture, and health of Malawians 
translated the developed instrument into Chichewa then it was back translated into English. 
The two versions were compared for conceptual equivalence and synthesized. However, 
during the translation process, the translators could make their own assumptions as to what 
was and was not important, and they might have missed something that was important. 
Therefore, the tool was tested by conducting cognitive interviews to refine the study 
questionnaire. 
Pre-testing the instrument. Cognitive interviews were done by conducting focus 
group interviews with five HIV positive women. Cognitive interviewing is a popular method 
for obtaining construct validity on the survey questions to check for factual information, 
wording, clarity, ambiguity in the translated questionnaire, and to ensure that the respondents 
interpreted the items in the manner intended (Lee et al., 2015; Willis & Artino, 2013). During 
interviews, women were asked to think-aloud what certain terms meant and were requested to 
rephrase the questions in their own words. Participants were asked about the terms that were 
not clear and if there were alternative terms that they preferred.  The responses were used to 
assess understanding and cultural appropriateness of the questionnaire for adaptation. The 
survey tool was adjusted accordingly, and the researcher made corrections to the instrument. 
The changes in the questionnaire were on the attitude scale, when 1 item “afraid of 
discomfort” was merged with “afraid of pain” as women expressed that according to their 
understanding, pain and discomfort meant the same. Therefore, the final version for the 
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attitude scale had six items and not seven. Also, on the access scale, 2 questions were deleted. 
One question on affordability “no money for service fee” as women indicated that the 
services are free in Malawi and the question was not applicable. The other question that was 
deleted was on acceptability “I do not want people that I know to see me”. Women indicated 
that being HIV positive and on drugs means they already visit the clinic. The results from the 
pre-test also helped to check the internal and external validity of the questionnaire. Therefore, 
the final instrument had 83 items and covered the following 6 major domains of the study 
(Refer to Table 8): Demographic characteristics with 8 items, cervical cancer screening 
behavior with 5 items, knowledge with 31 items, attitudes with 6 items, social support 
networks with 11 items, and access to health care with 12 items. Internal consistency of the 
instrument was assessed using cronbach alpha.  
    Table 8  
 
     Study Concepts, Variables and Measures  
 
Concepts Variables Measures 
  Definition Scale Instrument 
Demographic  
characteristics 
 
Education 1 = never attended or     
primary level 
2 = secondary/ 
university level 
Ordinal Developed 
Religion 1= Christian 
2= Others 
Nominal 
Occupation 1 = not working 
2 = working 
Nominal 
Income 1 = <$100 
2 = < $100 
Ordinal 
Age Age in years Interval 
Marital Status 0= single 
1= married 
Nominal 
Time of HIV Diagnosis Year of diagnosis Interval 
Number of pregnancies Number Interval 
 
Cervical cancer 
screening 
Cervical cancer screening 0= never had 
screening 
1= ever had screening  
Nominal World Health 
Survey (WHS) 
(WHO, 2002) 
Screening method 1= VIA 
2= Pap smear 
Nominal 
Time when screened  1= Before HIV 
diagnosis  
0= After HIV 
diagnosis 
 
Nominal 
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Screening frequency 
 
1= every year 
0= not every year 
Nominal 
Time of last screened Year of last screened Interval 
Individual factors 
 
Knowledge 31 items 
 
Risk factors (13 items) 
Signs and symptoms (11 
items) 
Prevention (3 items) 
Awareness (4)- Translated 
 
 
 
The sum of 4 
subscales 
 
 
 
Nominal 
Cervical Cancer 
Awareness 
Measure 
(Cervical CAM) 
(UCL, 2011).  
Cronbach‟s 
alpha – 0.70 
Attitude 5 items 
Fear:  
-procedure 
-pain,  
-discomfort,  
-bleeding,  
-diagnosis 
 
 
The sum of 5 items 
 
 
Nominal 
- (KAP Survey) 
(WHO, 2008) 
Cronbach‟s 
alpha – 0.79 -
0.84 validated in 
Zimbabwe 
 
 
Social support 
network  
11 items with 3 subscales 
Family: Tries to help, 
emotional support, talk 
about my problem, and 
willing to help 
Friends: Try to help, count 
on friends, share my 
problem, and talk about my 
problem 
Significant others: special 
person around me, share 
my problems, real source of 
comfort and cares about me 
 
 
The sum of 3 
subscales 
 
 
Nominal  
 
Multidimension
al Scale of 
Perceived Social 
Support 
(MSPSS) Scale 
(Zimet et al., 
1988). 
Cronbach‟s 
alpha .83 to .93 
 
 
 
Access to health 
care services 
 
 
 
12 items ( 8 translated) 
with 5 subscales 
Affordability: cost and 
transport, able to get the 
services 
Availability: service 
providers and facilities 
Accessibility: Travel time 
and travel mode 
Accommodation: Provider 
skills, equipment, and 
engagements 
Acceptability: Providers 
gender and privacy 
Acceptability 
 
 
The sum of 5 
subscales 
 
 
Nominal 
World Health 
Survey (WHS) 
(WHO, 2002).  
-Cronbach‟s 
alpha -not 
indicated but it 
is used in 
studies in 
Malawi. 
 
 
 Table 8 describes the major study concepts, variables and measures of the 
instrument.  The primary outcome of the study was cervical cancer screening after HIV 
diagnosis. The independent variables are socio-demographic, knowledge, attitude, social 
support network, and access to health care support. The operational definitions of variables 
are as follows: 
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 Socio-demographics. The socio-demographic characteristics of the respondents were 
obtained to have a sociodemographic background of the study sample. Additionally, the 
demographic characteristics variables have been empirically reported to influence bahavior in 
health issues. There were 8 questions on socio-demographic details of HIV-positive women 
which include age, marital status, education level, occupation, income, religion, number of 
pregnancies, and when they were diagnosed with HIV. For marital status, the respondents 
reported their marital status and included single, married, divorced or widowed. In age 
category, the respondents report their age in years at their last birthdate. In education level, 
the respondents reported their highest education attainment. For occupation, the respondents 
reported their occupation in terms of current employment status. For income, the women 
reported their monthly income status. For duration of having HIV disease, the respondents 
reported the year they were diagnosed HIV positive. The respondents also reported the 
number of pregnancies they had ever had.  
 Cervical Cancer Screening. The primary outcome of the study was cervical cancer 
screening which was obtained from two sources: self-report and medical record check of the 
receipt of vaginal examination from a cervical cancer health care provider after HIV 
diagnosis. The participants were asked if they had ever had a vaginal examination using a 
speculum to examine the cervix or if a pap smear was taken. In this study, self-report was 
verified by the review of women‟s health passport record of cervical cancer screening as 
some women are not able to differentiate digital vaginal examination and screening. 
Triangulating self-report and record review gives reliable baseline data regarding screening 
rate among women living with HIV infection in Malawi. If the women had ever been 
screened, there were follow-up questions:  If the screening method was either by VIA or Pap 
smear or both. Then the woman was asked if the screening was done before HIV diagnosis or 
after HIV diagnosis.    
 45 
 
 Individual Factors. The individual factors were assessed in terms of participant‟s 
knowledge and attitude regarding cervical cancer and screening.  
Knowledge. The knowledge about cervical cancer and screening was measured using 
Cervical Cancer Awareness Measure (Cervical CAM) Toolkit Version 2.1 (UCL, 2011) The 
Cervical CAM has 9 subscales and it is possible to separate the questions into distinct 
subscales that can be used on their own or in conjunction with additional questions from the 
researchers. To retain reliability or validity of the measure, it is advisable that all the items of 
each subscale that is adapted must be retained (UCL, 2011). The Cervical CAM is a validated 
instrument that was developed by the UCL Health Behavior Research Centre, in 
collaboration with the Department of Health Cancer Team and The Eve Appeal. It forms part 
of the Cervical Cancer Awareness and Symptoms Initiative (CCASI). It is based on a generic 
CAM developed by Cancer Research UK, University College London, King‟s College 
London and Oxford University in 2007-2008. The CAM was developed in UK and the 
revised by UCLS so that researchers could systematically assess the impact of interventions 
designed to target gaps in public awareness of cancer either in whole populations or specific 
sub-groups. Psychometric evaluation indicated that the instrument has satisfactory internal 
consistency with Cronbach‟s alpha above 0.7 for all components (McCrae, Kurtz, Yamagata, 
& Terracciano, 2011). Test-retest reliability was good with all correlations above 0.7 (Kline, 
1993), Construct validity was done by cervical cancer experts, university administration staff, 
and students.  
The adapted knowledge instrument had 31 questions and consisted of 4 sub-scales 
which included risk factors (13 items), signs and symptoms of cervical cancer (11 items), 
prevention of cervical cancer (4 items) and awareness of cervical cancer, screening and HIV 
(4 items). Out of the 31adapted knowledge items, 27 items were already translated into 
Chichewa, the local language (Hami, Ehlers, & Van de Wal, 2012). The awareness sub-item 
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consisted of 4 questions which were not translated including frequency of cervical cancer 
examination in HIV-positive women; if the cancer can be cured and not HIV; and association 
between HIV and cervical cancer. The knowledge about signs and symptoms of cervical 
cancer include 11 questions about: vaginal bleeding, vaginal mass, weight loss, back pain, 
and loss of appetite. The questions on risk factors include 13 questions on hormonal family 
planning use, HIV/AIDS, washing/putting traditional medicine inside the vagina, family 
history, smoking, early age of starting sex, and multiple sexual partners. The questions on 
prevention of diseases included 3 questions about male circumcision, screening, and proper 
and regular condom use.  
Attitudes: The attitude about cervical cancer screening was measured by using 
Knowledge, Attitude, and Practices Survey (KAP survey) developed by WHO (2008). The 
KAP survey was developed as a sample guide questionnaire for conducting KAP surveys to 
produce desired behavioral change and increased use of health services. The tool can be 
adapted to a specific cultural context, different populations and behavioral change studies. 
The tool has mostly been used in TB programs worldwide, including Malawi and in raising 
awareness of the association between HIV and other communicable diseases WHO (2008). 
The instrument was adapted in cervical cancer screening studies and validated in Kenya, 
Malawi and Zimbabwe and the Cronbach‟s alpha ranged from 0.79-0.84 for all components 
(Hami et al, 2012; Rositch et al, 2012; Matangaidze et al., 2016). In this study, the attitudes 
about cervical cancer and screening were measured by adapting 5 attitude questions that were 
included in the questionnaire. The questions were: if they fear screening procedure, feel shy 
to expose private parts, afraid of pain or discomfort, afraid of bleeding, and afraid of 
diagnosis. The adapted 5 items had already been translated into local language cervical 
cancer studies in Malawi (Hami et al, 2012). These items were answered with responses of 
“Yes,” “No,” or “Don‟t know.”  
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 Social Support Network. The studies done in developed countries like the U.S have 
widely used a social network index (SNI) to understand social network and health behavior 
studies (DalMaso et al., 2010; Wigfal et al., 2015). The SNI instrument assigns scores to the 
participants based on the number or frequency of contacts and types of ties between the 
respondent and members within the network (Cohen & Syme, 1985). The instrument does not 
provide information regarding the characteristics of the members within the network. This 
study adapted the Multidimensional Scale of Perceived Social Support (MSPSS) that was 
developed by Zimet et al., 1988 in the USA. The MSPSS is a 12 item, self- administered 
scale that assesses the perceived social support and includes emotional and instrumental 
support to help make decisions. The internal consistency of the total scale and subscales is 
consistently above .85 across studies with diverse samples. The scale has been used in 
culturally and linguistically diverse samples including low-income populations, both in the 
U.S. and Sub-Saharan Africa including Malawi (Bruwer, Emsley, Kidd, Lonchner, & Seedat, 
2007; Malde et al., 2015; Nakigudde et al., 2009; Stewart et al., 2014). In Malawi, the generic 
scale that was developed from the USA was validated among women attending an antenatal 
clinic in Malawi. The total scale for Chichewa version had good internal consistency and the 
Cronbach‟s alpha was 0.88 and was deemed to be a reliable scale to measure social support 
networks within the Malawi setting (Stewart et al.,  2014). The scale is already translated and 
is available in local Chichewa language, but it was reviewed based on findings of the pilot 
study to add the social networks that women living with HIV consider important for cervical 
cancer screening. The instrument measures only positive dimensions of social support 
networks in influencing behavior change. The instrument had 3 sub-scales which included 1) 
Family with 4 items; 2) Friends with 4 items; and 3) health care providers with 3 items. The 
scale uses a 7-point Likert scale: (1) very strongly disagree to (7) very strongly agree. The 
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scoring of the MSPSS varies based on culture. For this study, the participants answered 
“Yes” or “No” or “Don‟t know” to the question.  
 Access to Health Care Services. The access to cervical cancer screening services 
was measured by World Health Survey instrument (WHO, 2002). The tool was developed by 
WHO to compile comprehensive baseline health information of the population for 70 
countries in the world including Malawi. The instrument was intended to be used in different 
cultures and settings. There was no evidence that the tool was validated in Malawi, but the 
instrument had been used in most health care access studies in Malawi and Sub-Saharan 
Africa (Akinyemiju, McDonald, & Lantz, 2015). The adapted access to health care services 
has 5 subscales with 12 items. The 5 sub-scales include affordability with 1 item; availability 
with 2 items; accessibility with 2 items; accommodation with 4 items; and acceptability with 
3 items. The 8 items were translated into Chichewa and pretested. These items are answered 
with responses of “Yes,” “No,” or “Don‟t know.”  
Consent Procedure  
The initial consenting was done in person by the researcher and the trained research 
assistants (RAs). Five RAs were recruited and two days of training (Refer to Attachment E) 
was offered to educate the RAs on research methods, to support eligible research participants 
to make informed decisions about participation in the study, and to practice interviewing 
participants. The training was conducted by the researcher and supervised by the research 
supervisor to ensure the quality of training. Participants were given a written informed 
consent (Refer to Attachment F) to sign for participation after determining that they met the 
inclusion criteria in their prefered language. The researcher and RAs provided a verbal 
explanation of the study that described the study purposes, processes, confidentiality of 
information, benefits and risks, and the right to withdraw from the study. The participants 
were asked to repeat the information to ensure that they understand the study‟s purpose.  
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Participants signed an informed consent statement after all their questions about the study 
were answered to their satisfaction. For participants who could not write, a thumb stamp 
served as a signature. The signed consents were kept in a locked cupboard separate from 
other records at the study site. 
Risks and Benefits. The primary risk associated with this study was no more than 
minimal, but some questions might have caused discomfort, embarrassment or psychological 
harm. There were no direct medical benefits to participating in this study, but the results from 
the study will help to develop an evidence-based intervention to promote cervical cancer 
screening programs among HIV-positive women to prevent cervical cancer so that HIV-
positive women may live a more productive life. Participants were offered indirect benefit of 
the value of MK4, 000 equivalents to $5 US dollars in the form of a gift card in recognition 
of their commitment of time and their submission to the discomfort caused by some 
questions. The United States Commission‟s Belmont Report (1978) indicated that indirect 
benefits of financial incentives for the participants are indirect as they do not stem from the 
research interventions themselves, but the subjects may view them as very important and may 
be acknowledged but should not be assigned heavy weight (USA, Belmont Report, 1878). 
Data Collection 
 A 30 to 45 minute face-to-face interviewer-administered questionnaire (Refer to 
Attachment G) was conducted  in local Chichewa language or English based on participants‟ 
preference time and dates. Recruitment anouncements (Refer to Attachment H) and 
appointments regarding the research purposes, confidentiality of information, the right to 
withdraw from the study, contacts and where the interview would take place were made 
during  HIV support group meeting days by the expert client or support group coordinator. 
Volunteers who showed up for participation in the study during the scheduled days were 
recruited consecutively. The survey was administered by the researcher and RAs after 
 50 
 
obtaining women‟s signature on the informed consent form. The interviewer read the 
questions and responses to the questions exactly as they were worded in the questionnaire to 
the participants to make sure that the participants understood the question and were given 
time to give a response to the question before proceeding to the next question. The 
interviewer marked the response to the question on behalf of the respondent. The women 
could not answer the questions on their own as most of them could not read and write. The 
advantage of face-to-face interviewer adminstered questionnare was that the interviewer 
could help the participant understand the question, therefore, more accurate information and 
quality data were collected (Polit & Beck, 2011). The disavantages of face-to-face interviews 
include interviewer bias, it is time consuming, and participants might feel uneasy about the 
confidentiality of their responses (Polit & Beck, 2011).  Inorder to overcome these 
challenges, five RAs were trained and assisted in data collection, data was collected at the 
support group planned meeting day, participation was voluntary, results were reported using 
code numbers and in aggregate form. The data collection process continued until the sample 
size was reached. 
Ethical Considerations 
 Ethical clearance to conduct a study was saught from Lilongwe Rural and Lilongwe 
Urban district offices, University of Massachusetts Boston, and National Health Sciences 
Research Committee (NHSRC) in Malawi (Refer to Attachement I). Permission to access the 
register of the list of all HIV positive support groups was obtained first from the Lilongwe 
Rural and Lilongwe Urban district offices (Refer to Attachement J). Then permission was 
obtained University of Massachusetts Boston and lastly from the National Health Sciences 
Research Committee (NHSRC) in Malawi. In Malawi, the National IRB approves protocols 
after the protocol has been approved by the student‟s training institution and or research site. 
All eligible women were informed that their decision to participate in this study was not to 
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affect their access to healthcare services. To ensure confidentiality, each participant was 
assigned a code number, which was stored in a locked desk. There was no link between 
names, codes, and responses.  
Data Analysis  
 
The data were analyzed using Statistical Package for Social Science (SPSS 
Version21; IBM, Armonk, NY) software. To maintain high quality data, the collected data 
was cleaned and checked for completeness. Frequencies were computed on all variables and 
checked for distribution, missing values, and errors (Enders, 2010).  
Data was analyzed according to concepts of the framework including participant‟s 
demographic characteristics, cervical cancer screening rate, level of knowledge, attitudes, 
social support networks, and access to cervical cancer screening.  
Demographic characteristics. There were 8 questions on socio-demographic details 
of HIV-positive women which include age, marital status, education level, occupation, 
income, religion, number of pregnancies, and when they were diagnosed with HIV. During 
the analysis, the marital status was categorized as 1) married and 2) single (this category 
included not married, divorced, and others). Age was treated as a continuous variable and as a 
categorical variable. There were two categories including 18-29 and above 30 years. 
Education level was categorized as an ordinal variable with category option of: 1) never 
attended or primary level, 2) secondary level and university level. Occupation was 
categorized as 1 implying not working and 2 implying working. Women‟s monthly income 
status was treated a categorical variable 1) <$100 and 2) >$100. The number of years since 
HIV diagnosis was treated as a continuous variable.   The number of pregnancies that the 
women had ever had was treated as a continuous variable. Religion was categorized as 1) 
Christian and 2) Other which included Moslems, Gulewamkulu, and those not going to 
church. 
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Cervical Cancer Screening. Cervical cancer screening was the primary outcome of 
the study and was dichotomous response indicating whether the respondents had ever had 
cervical cancer screening or not. It was coded 1 to indicate ever had screened after HIV 
diagnosis and 0 never had screening.  
Individual Factors. The individual factors had two sub-scales: knowledge and 
attitude. The overall score for knowledge regarding cervical cancer and cervical cancer 
screening was calculated. Each correct response scored one point and wrong response or “I 
do not know” response scored zero. The individual correct scores varied between 0-31. The 
composite score of knowledge was used to measure knowledge level.  The cumulative mean 
score of knowledge of participants about cervical cancer and screening was estimated using 
mean score as a cut-off point. The total correct scores less than the mean score meant that the 
women had low levels of knowledge regarding cervical cancer and screening. Scores above 
the mean score meant that the women had high levels of knowledge regarding cervical cancer 
and screening.   
Attitudes: An overall score of attitude about cervical cancer and screening were 
calculated as the sum of positive responses. If the individual response was positive towards 
cervical cancer screening, one point was given. If the response was negative or “I do not 
know,” zero point were given. The individual correct scores varied between 0-6. The 
descriptive and inferential statistics were calculated, and the mean score was reported. The 
scores less than the mean score meant that the women had a negative attitude regarding 
cervical cancer screening and scores above the mean score, meant that the women have a 
favorable attitude regarding cervical cancer screening. 
Social Support Network. The overall score for social support staff regarding cervical 
cancer screening was calculated. Each response indicating the availability of social support 
regarding cervical cancer screening scored one point and those with no social support 
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response or “I do not know” response scored zero. The individual scores were summed for 
the total score. The individual scores varied between 0-11. The descriptive and inferential 
statistics were calculated, and the mean scale score was reported. The higher the score above 
the mean indicated higher levels of perceived social support from networks (Calvete & 
Cannor-Smith, 2006).  
Access to Health Care Services. The overall score for access to health care services 
regarding cervical cancer screening was calculated. Each response indicating having access to 
cervical cancer screening scored one point and those with no access to screening or “I do not 
know” response scored zero. The individual correct scores varied between 0-12. The 
descriptive and inferential statistics were calculated, and the mean score was reported. The 
higher the score above the mean indicated easy access to health care services and the scores 
below the mean indicated difficulties accessing health care services (WHO, 2002).  
Reliability analysis was performed to measure the overall consistency of the items of 
the instrument. Figure 5 is the statistical model for data analysis for specific aims 1 to 3. 
 
Figure 5.  Statistical Model of Cervical Cancer Screening among HIV Positive Women 
 
Specific Aim 1. Descriptive statistics were computed to describe the status of cervical 
cancer screening behavior and level of knowledge and attitude among Malawian women 
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living with HIV infection on all variables. The sum of each scale, means with standard 
divisions or percentages were computed as appropriate to each measure. Using paired t-test or 
Chi-square when appropriate, we explored the extent to the screened and non-screened 
women differed from each other in their awareness, knowledge, attitudes, social support 
networks, and accessto cervical cancer screening. The significance level was set at p <0.05.  
groups.  
Specific Aim 2. Bivariate logistic regression analysis were conducted to explore the 
relationship between each determinant (age, education, marital status, employment, income, 
knowledge, attitudes, social support network, and access to health care) with cervical cancer 
screening. The adjusted Odds Ratios (OR) and their corresponding 95 percent CI were used 
to measure the strength of associations between independent variables and outcome variable 
(cervical cancer screening). A two-tailed p-value of < .05 was considered statistically 
significant.  
Specific Aim 3. To examine whether knowledge and attitudes are independently 
associated with cervical cancer screening after controlling for other determinants of cervical 
cancer screening (occupation, income, social support network, and access to health care 
services). Multivariable logistic regression analyses were conducted by entering into the 
model the independent variables that were statistically significant in bivariate analysis. The 
adjusted Odds Ratios (OR) and their corresponding 95 percent CI were used to measure the 
strength of associations between knowledge and attitudes, and cervical cancer screening after 
adjusting for other covariates.  
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CHAPTER 4 
RESULTS 
 This chapter presents information of the study participants‟ basic demographic 
characteristics, screening behavior, knowledge and attitude regarding screening, social 
support networks, and access to screening services following the study specific aims.   
Specific Aim 1.  The specific aim 1 was to describe the status of cervical cancer 
screening behavior and level of knowledge and attitude among Malawian women living with 
HIV infection.  
Socio-demographic Characteristics of the Respondents 
The study approached 291participants and all women agreed to be interviewed giving 
a response rate of 100%. A 100% response rate might be due to conducting interviews during 
their meeting days within their community, gift cards, and face-to-face interviews with the 
respondents. The participants‟ socio-demographic characteristics are summarized in Table 9. 
Table 9  
 
Basic Characteristics of the of Respondents 
 
Variable N=291   (%) 
 
Geographical location     
Rural 116  39.9 
Urban 175  60.1 
Occupation     
Working 10  3.4 
Not Working 281  96.6 
Religion     
Christian 267  91.8 
Others 24  8.2 
Marital Status     
Single (Never married) 33 11.3 
Married 137  47.1 
Divorced/widowed 121 41.6 
Education Level     
Never attended school 61 21 
Primary Level 170 58.4 
Secondary level 55 18.9 
College 5 1.7 
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Monthly Family Income     
< $100 258 88.7 
>$100 33  11.3 
Age in years     
18-29 years 117  40.2 
30-60 years 174  59.8 
      
  Range Mean (SD) 
Age 18-60 34.81 ± 9.85 
Pregnancies 0-15 4.5± 2.58 
Time since HIV diagnosis (years) 1 to 19 7.16 ± 4.2 
 
The results in Table 9 indicate that the age of the respondents ranged from 18 – 60 
years (M 34.81, SD = 9.85). Out of the total 291 respondents, 117 (40.2%) were aged18-29 
years and 174 (59.8%) were aged 30-60 years. The number of years since diagnosed with 
HIV infection ranged from 1to 19 years (M=7.16, SD 4.2). The number of pregnancies 
reported ranged from 0-15 (M 4.50, SD = 2.58). Out of the 291 women, 137 (47.1%) were 
married, 121 (41.6%) were either divorced or widowed, and the remaining 33 (11.3%) were 
single, which is they had never been married before. The majority: 281 (96.6%) of the 
respondents were not working; 267 (91.8%) were Christians; 175 (60.1%) were from urban; 
and 255 (88.5%) their monthly family income was <$100. The education level varied: 61 
(21%) never attended; 170 (58.4%) had primary education; 55 (18.9%) had secondary 
education; and 5 (1.7%) went to college. The majority of the respondents were from urban 
areas, aged between 30-60 years, single, not working, low monthly family income, and of 
low education level. 
Cervical Cancer Screening Behavior 
Cervical cancer screening behavior was assessed by screening status, screening 
method, and when the screening was done (before HIV diagnosis or after HIV diagnosis) as 
in Figure 6.  
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Figure 6. Cervical Cancer Screening Behavior 
 
The results in Figure 6 shows that 96 (33%) of the respondents had cervical screening 
while 195 (67%) of the respondents did not have screening. Further the results indicated that 
only 81 (27.8%) had cervical cancer screening after HIV diagnosis. Therefore, the prevalence 
of cervical cancer screening in women living with HIV infection in Lilongwe was 27.8%, 
with confidence interval (22.7%, 32.9%).  Out of the 96 respondents who received cervical 
cancer screening, 94 (97.9%) had VIA as a screening method and 2 (2.1%) had both VIA and 
Pap smear as screening methods. 
Knowledge about Cervical Cancer and Screening 
Knowledge regarding cervical cancer screening included risk factors of developing 
cervical cancer, signs and symptoms of cervical cancer, prevention of cervical cancer, and 
awareness of cervical cancer as indicated in Table 10.   
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     Table 10  
 
       Knowledge about Cervical Cancer and Screening 
  
  
A. Risk factors of developing cervical cancer = N (%) 
    
Do you think the following factors may increase the 
woman’s chance of developing cervical cancer? 
 
Overall 
291 (%) 
 
Screened 
81(%) 
Not 
screened 
210 (%) 
Smoking 146(50.2) 42 (51.9) 104 (49.5) 
Having many sexual partners 259(89) 79(97.5) 180 (85.7) 
Having a sexual partner with many previous sexual 
partners 
259(89) 80 (98.8) 179 (85.2) 
Having a sexual partner who is not circumcised 258(88.7) 78 (96.3) 180 (85.7) 
Having sex at an early age 242(83.2) 75 (92.6) 167 (79.5) 
Having a weakened immune system (because of 
HIV/AIDS) 
267(91.8) 80 (98.8) 187 (89) 
Infection with HPV (Human Papilloma Virus) 252(86.6) 79 (97.5) 173 (82.4) 
Having sexually transmitted infection 264(90.7) 80 (98.8) 184 (87.6) 
Having a family member diagnosed with cancer 152(52.2) 50 (61.7) 102 (48.6) 
Inserting traditional medicine into the vagina 260(89.3) 79 (97.5) 181 (86.2) 
Taking family planning pills for a long time 165(56.7) 51 (63) 114 (54.3) 
Having many children 249(85.6) 71 (87.7) 178 (84.8) 
Not going for regular screening 209(71.2) 64 (79) 145 (69) 
  
 
Mean +SD 
(range) 
 
Mean +SD 
(range) 
 
Mean +SD 
(range) 
Knowledge regarding risk factors 
10.25+3.12 
(0-13) 
11.21+1.66 
(5-13) 
9.88+3.46 
(0-13) 
Cronbach‟s Alpha (13 items) 0.87     
 
B. Signs and Symptoms of Cervical Cancer = N (%) 
   
Do you think the following are signs and symptoms of 
cervical cancer? 
Overall 
291 (%) 
Screened 
81(%) 
Not 
screened 
210 (%) 
Vaginal bleeding between periods 258(88.7) 80 (98.8) 178 (84.8) 
Menstrual periods that are heavier or longer than usual 261(89.7) 78 (96.3) 183 (87.1) 
Vaginal bleeding after the menopause 260(89.3) 76 (93.8) 184 (87.6) 
Vaginal bleeding during or after sex 257(88.3) 78 (96.3) 179 (85.2) 
Excessive vaginal discharge that smells unpleasant 269(92.4) 81 (100) 188 (89.5) 
Vaginal itching or irritation 250(85.9) 73 (90.1) 177 (84.3) 
Pain or discomfort during sexual intercourse 262(90) 80 (98.8) 182 (86.7) 
Lower back pain 235(80.8) 71 (87.7) 164 (78.1) 
Pelvic pain 248(85.2) 77 (95.1) 171 (81.4) 
Frequent urination 187(64.3) 59 (72.8) 128 (61) 
Unexplained weight loss 176(60.5) 53 (65.4) 123 (58.6) 
    
 
Mean +SD 
(range) 
Mean +SD 
(range) 
Mean +SD 
(range) 
Knowledge regarding signs and symptoms 
9.15+2.82 
(0-11) 
9.95+1.60 
(4-11) 
8.84+3.12 
(0-11) 
Cronbach‟s Alpha (11 items) 0.9     
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    C: Prevention of Cervical Cancer = N (%) 
   
Can the following actions prevent cervical cancer? 
Overall 
291 (%) 
Screened 
81(%) 
Not 
screened 
210 (%) 
Male circumcision 265(91.1) 80 (98.8) 185 (88.1) 
Cervical cancer screening (examining the cervix) 254(87.3) 78 (96.3) 176 (83.8) 
Proper and regular condom use 257(88.3) 77 (95.1) 180 (85.7) 
HPV Vaccination 240(82.5) 68 (84) 172 (81.9) 
    
Knowledge regarding prevention of cervical cancer 
Mean +SD 
(range) 
Mean +SD 
(range) 
Mean +SD 
(range) 
 
3.49+1.05 
(0-4) 
3.74+0.61 
(1-4) 
3.40+1.16 
(0-4) 
    D: Awareness about Cervical Cancer, screening and HIV = N (%) 
  
Overall 
291 (%) 
Screened 
81(%) 
Not 
screened 
210 (%) 
A woman who is HIV positive should undergo cervical 
cancer screening at least once per year.  
271(93.1) 77 (95.1) 194 (92.4) 
A woman who is HIV positive is at higher risk of 
developing cervical cancer than a woman who is HIV 
negative.  
278(95.5) 80 (98.8) 198 (94.3) 
Cervical cancer develops slowly and can be cured if 
detected early 
247(84.9) 75 (92.6) 172 (81.9) 
Awareness regarding cervical cancer and screening 
Mean +SD 
(range) 
Mean +SD 
(range) 
Mean +SD 
(range) 
 
2.74+0.64 
(0-3) 
2.86+0.44 
(1-3) 
2.69+0.70 
(0-3) 
    
Overall Knowledge 
Mean +SD 
(range) 
Mean +SD 
(range) 
Mean +SD 
(range) 
Knowledge regarding cervical cancer and screening 
25.63+6.35 
(0-31) 
27.77+3.03 
(18-31) 
24.80+7.07 
(0-31) 
Cronbach’s Alpha (31 items) 0.93     
 
 
The results in Table 10 show that the overall knowledge score ranged from 0-31of 
correct answers (M =25.63, SD = 6.35) with minimum total score of 0 and maximum score of 
31. The overall results show that the respondents were knowledgeable about cervical cancer 
and screening. However, knowledge of the respondents was higher in respondents who were 
screened (M = 27.77, SD = 3.03) with a range of 18-31scores of correct responses than the 
respondents who were not screened (M = 24.80, SD = 7.07) with a range of 0-31 scores of 
correct responses.  
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The overall results show that most women knew the risk factors for developing 
cervical cancer (M = 10.25, SD = 3.12). The knowledge score about the risk factors of 
cervical cancer was higher in respondents who were screened (M = 11.21, SD = 1.66) with a 
range of 5-13 of correct responses than the respondents who were not screened (M = 9.88, SD 
= 3.46) with a range of 0-13 of correct responses. The majority of the respondents, 264 
(91.8%), indicated that having a weakened immune system because of HIV/AIDS and having 
sexually transmitted infection, 264 (90.7%), have increased risk for developing cervical 
cancer. On the other hand, almost half of the respondents identified that smoking, 146 
(50.2%), having a family member diagnosed with cancer, 152 (52.2%), and taking family 
planning pills for a long time, 165 (56.7%), increases the woman‟s risk of developing 
cervical cancer.  
The overall respondent‟s knowledge about the signs and symptoms of cervical cancer 
ranged from 0-11scores (M = 9.15, SD = 2.82). This shows that, overall, the respondents were 
knowledgeable about the signs and symptoms of cervical cancer. However, the knowledge 
about the signs and symptoms about cervical cancer was higher in women who were screened 
(M = 9.95, SD = 1.60) with a range of 4-11scores than those who were not screened (M = 
8.84, SD = 3.12) with a range of 0-11 scores. A majority, 269 (92.4%) of the respondents 
indicated that excessive vaginal discharge that smells unpleasant and pain or discomforts 
during sexual intercourse, 262 (90%), were the main signs and symptoms of cervical cancer. 
In addition, 261 (89.7%), of the respondents indicated that menstrual periods that are heavier 
or longer than usual and vaginal bleeding after menopause, 260 (89.3%), were also signs and 
symptoms of cervical cancer.  On the other hand, only 176 (60.5%), of the participants were 
able to identify that unexplained weight loss was a possible sign of cancer.  
The overall respondent‟s knowledge of possible prevention strategies for cervical 
cancer ranged from 0-4 scores (M = 3.49, SD = 1.05). The overall results indicate that the 
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women were knowledgeable about the prevention strategies of cervical cancer. However, the 
mean knowledge score was higher in women who were screened (M = 3.74, SD = 0.61) with 
a range of 1-4 scores than those who were not screened (M = 3.40, SD = 1.16) with a range of 
0-4 scores. A majority, 265 (91.1%), of the respondents identified male circumcision 
correctly as a prevention strategy of cervical cancer, followed by proper and regular condom 
use 257 (88.3%), cervical cancer screening 254 (87.3%), and HPV vaccination 240 (82.5%).  
 The overall participant‟s awareness score about cervical cancer, screening, and HIV 
ranged from 0-3 (M = 2.74, SD = 0.64). The overall results indicate that the respondents were 
aware of the link between cervical cancer and HIV. However, the awareness about cervical 
cancer, screening, and HIV was higher for respondents who were screened (M = 2.86, SD = 
0.44) with a range of 1-3 scores than the respondents who were not screened (M = 2.69, SD = 
0.70) with a range of 0-3 scores. A majority, 278 (95.5%) correctly indicated that a woman 
who is HIV positive is at a higher risk of developing cervical cancer than a woman who is 
HIV negative. Further, a majority, 271 (93.1%), identified that a woman who is HIV positive 
should undergo screening at least once per year. Lastly, a majority, 247 (84.9%) identified 
that cervical cancer develops slowly and can be cured if detected early. 
The internal consistency of the instrument was measured by Cronbach‟s alpha. The 
Cronbach‟s alpha for knowledge of participants on cervical cancer, screening, and HIV were: 
for risk factors for 13 items, Cronbach‟s alpha was 0.87; signs and symptoms for 11 items 
Cronbach‟s alpha was 0.90. The internal consistency for sub-items of knowledge about 
awareness and prevention about cervical cancer was not measured as they had items of less 
than 5. The overall Cronbach‟s alpha for the instrument for knowledge with 31 items was 
0.93. This means that all items for knowledge regarding cervical cancer and screening had 
good internal consistency. 
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Attitude Regarding Cervical Cancer Screening 
The attitude regarding cervical cancer screening is summarized in Table 11. 
Table 11  
 
Attitude Regarding Cervical Cancer Screening 
 
    N (%) 
  What is your opinion on these questions 
 
Overall 
291 (100) 
 
Screened 
81(00) 
Not 
screened 
210 (100) 
1 Do you fear cervical Cancer screening procedure? 54(18.6) 8 (9.9) 46 (21.9) 
2 
Do you feel shy to expose your private parts during the 
procedure to young or male service providers? 
49(16.8) 11 (13.6) 38 (18.1) 
3 
Are you afraid of pain/discomfort during cervical cancer 
screening procedure? 
54 (18.6) 5 (6.2) 49 (23.3) 
4 
Are you afraid of bleeding during and after cervical cancer 
screening procedure? 
54 (18.6) 6 (7.4) 48 (22.9) 
5 
Are you afraid of being diagnosed with cervical cancer after 
undergoing the screening? 
45 (15.5) 11 (13.6) 34 (16.2) 
          
  
  
Mean 
+SD 
(range) 
Mean 
+SD 
(range) 
Mean +SD 
(range) 
  
Attitude regarding cervical cancer screening 
4.12+1.33 
(0-5) 
4.49+1.04 
(0-5) 
3.98+1.41 
(0-5) 
  Cronbach’s Alpha (5 items) 0.74     
 
 
The findings in Table 11 indicate that the overall respondent‟s attitude score about 
cervical cancer screening ranged from 0-5 (M = 4.12, SD = 1.33). This shows that, overall, 
the respondents had a positive attitude regarding screening. However, the respondent‟s 
attitude regarding screening, was higher in women who were screened (M = 4.49, SD = 1.04) 
with a range of 0-5 scores of correct responses than those who were not screened (M = 3.98, 
SD = 1.41). The overall results indicate that few, 54 (18.6%) feared cervical cancer 
procedure, were afraid of pain/discomfort during screening procedure, and were afraid of 
bleeding during or after the procedure. However, comparing the respondents who were 
screened to those who were not screened, those who were not screened, 46 (21.9%), feared 
cervical cancer screening procedure compared to respondents who were screened, 8 (9.9%). 
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Overall, the majority of the respondents did not fear the procedure, were not shy to expose 
the private parts, were not afraid of the diagnosis, and were willing to be screened.  
The internal consistency of the instrument for attitude scale with 5 items had a 
Cronbach‟s alpha of0.74. This means that all the items for attitude regarding screening had 
acceptable reliability measures. The possible reason for low Cronbach‟s alpha might be due 
to less number of items. 
           Comfortability during screening. Women were further asked whom they would be 
comfortable to perform screening on them between male and female service providers. The 
women‟s responses are illustrated in Figure 7. 
 
Figure 7.  Whom women would be comfortable with 
 
        The results in Figure 7 indicate that the majority, 204 (70.1%) of the respondents would 
be comfortable to be screened by both male and female providers, 75 (25.8%) by female 
service providers, 12 (4.1%) were not comfortable with either of them (male or female 
providers).  
Social Support Networks 
Table 12 describes respondent‟s social support networks regarding cervical cancer 
and screening. 
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    Table 12  
 
    Social Support Networks  
  
   Item Yes = N (%) 
  
 
Overall 
291 (%) 
Screened 
81(%) 
Not 
screened 
210 (%) 
  Health care providers       
1 
Is the health care provider always available when you need 
cervical cancer screening services?  166 (57) 63 (77.8) 103 (49) 
2 
Can you share your concerns about cervical cancer screening 
with a health care provider?  
214 
(73.5) 65 (80.2) 149 (71) 
3 
Have health care providers ever counseled (talked to) you 
about cervical cancer screening? 
224 (77) 72 (88.9) 152 (72.4) 
  Family members       
4 
Does your family try to help you with financial support to go 
for cervical cancer screening?  
66 (22.7) 33 (40.7) 33 (15.7) 
5 
Do you get the emotional help and support you need from 
your family regarding HIV and cervical cancer screening?  
157 (54) 58 (71.6) 99 (47.1) 
6 
Can you discuss about cervical cancer screening with your 
family? 
236 
(81.1) 
71 (87.7) 165 (78.6) 
7  Have your family members ever encouraged you to go for 
cervical cancer screening?  
213 
(73.2) 
69 (85.2) 144 (68.6) 
  Friends       
8 Have your friends ever recommended to you cervical cancer 
screening? 
221 
(75.9) 
67 (82.7) 154 (73.3) 
9 
Can your friends provide social support when found 
(diagnosed) with cervical cancer?  
235 
(80.8) 
69 (85.2) 166 (79) 
10 Do you have friends with whom you can share your results 
of screening (examination)? 
268 
(92.1) 
77 (95.1) 191 (91) 
11 Can you encourage your friend to go for cervical screening?  
277 
(95.2) 
79 (97.5) 198 (94.3) 
          
  
  
Mean 
+SD 
(range) 
Mean 
+SD 
(range) 
Mean +SD 
(range) 
  
Social Support Networks 
7.82+2.67 
(0-11) 
8.93+2.21 
(0-11) 
7.40+2.71 
(0-11) 
  Cronbach‟s Alpha (11 items)  0.81     
 
The results in Table 12 indicate that the overall respondent‟s social support networks 
score about cervical cancer screening ranged from 0-11 (M = 7.82, SD = 2.67). This shows 
that, overall, the respondents had social support networks that influence screening bahavior. 
However, the respondent‟s social support networks score regarding screening, was higher in 
women who were screened (M = 8.93, SD = 2.21) with a range of 0-11 scores than those who 
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were not screened (M = 7.40, SD = 2.71). For the women who were screened, a majority, 66 
(77.8%) indicated that the health care providers were always available when they needed 
screening services whilst those not screened, almost half of the respondents, 103 (49%) 
indicated that the health care providers were not always available when they needed 
screening services. The overall results indicate that only one-fifth, 66 (22.7%), of the 
participants indicated that family members tried to help them with financial support, and 157 
(54%) of the women got emotional support from family members. The results indicate that 
family members may not be able to provide all the financial and emotional support that might 
be needed. 
The internal consistency of the instrument for social support network scale with 11 
items had a Cronbach‟s alpha of 0.81. This means that all the items for social support 
network regarding screening had good reliability measures. 
Access to Cervical Cancer Screening Services 
Table 13 describes respondent‟s access to cervical cancer screening services. 
    Table 13  
 
     Women's Access to Cervical Cancer Screening 
  
 
What are the reasons that best explain why you did not get the examination for cervical 
cancer?  
 
 N (%) 
 
 
Affordability 
 
Overall 
291 (%) 
 
Screened 
81(%) 
Not 
screened 
210 (%) 
1 
 
No money for transport 
116 (39.9) 17 (21) 99 (47) 
 
Availability 
   
2 Did not know where to go for screening 59 (20.3) 9 (11.1) 50 (23.8) 
3 Screening sites are far (distance) 79 (27.1) 11 (13.6) 68 (32.4) 
 
Accessibility 
   
4 Previously, I was badly treated 19 (6.5) 3 (3.7) 16 (7.6) 
5 Long waiting time 67 (23) 18 (22.2) 49 (23.3) 
 
Accommodation 
   
6 The health care providers are inadequate 21 (7.2) 5 (6.2) 16 (7.6) 
7 There were no equipment and supplies 24 (8.2) 6 (7.4) 18 (8.6) 
8 I thought I was not sick 78 (26.8) 12 (14.8) 66 (31.4) 
9 
Could not take time off my work/had other 
commitments/laziness 
46 (15.8) 7 (8.6) 39 (18.6) 
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Acceptability 
   
10 There is no privacy at the clinic 2 (0.7) 0 2 (1) 
11 Providers are males 14 (4.8) 4 (4.9) 10 (4.8) 
12 
I do not see the reason to go for screening as I am too 
old/too young 
18 (6.2) 2 (2.5) 16 (7.6) 
 
 
 
Mean +SD 
(range) 
 
Mean +SD 
(range) 
Mean+SD 
(range) 
 
Access to screening 
10.13+1.93 
(3-12) 
10.84+1.98 
(4-12) 
9.86+1.84 
(3-12) 
 
Cronbach‟s Alpha (12 items) 0.67     
 
The overall findings in Table 13 show that only 96 (33%) of the women received 
screening the last time they needed it. Some women did not access cervical cancer screening 
services due to no money for transport 116 (39.9%) (affordability), long distance to screening 
facility 79 (27.1%) and some did not know where to go 59 (20.3%) (availability), thought that 
they were not sick 78 (26.8%) (accommodation), and long waiting time 67 (23.0%) 
(accessibility). Very few 18 (6.2%) stated that they did not see the reason to go for screening 
as they were either too old or too young and 14 (4.8%) indicated that service providers are 
males (acceptability).  
The overall respondent‟s score to access to screening services ranged from 3-12 (M = 
10.13, SD = 1.93). This shows that, overall, the respondents had access to screening services. 
However, the respondent‟s access to screening services score was higher in women who were 
screened (M = 10.84, SD = 1.98) with a range of 4-12 scores than those who were not 
screened (M = 9.86, SD = 1.84). The internal consistency of the instrument for access to 
screening services scale with 12 items had a Cronbach‟s alpha of 0.67. The possible reason 
for low Cronbach‟s Alpha might be due to the wording of the questions as they were 
negatively worded as compared to knowledge and social support network domains.  
The internal consistency of the instrument for whole instrument with 4 subscales: 
knowledge with 31 items, attitude with 5 items, social support network with 11 items, and 
access to screening with 12 items had Cronbach‟s alpha of 0.88. This means that the overall 
instrument had good Cronbach‟s alpha. 
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Mode of transport and travel time. The women were asked how they travel (mode 
of transport) to clinics for HIV and screening services, and how long they take to reach a 
health facility as indicated in Table 14.   
    Table 14  
 
        Mode of Transport and Travel Time  
 
  
How do you travel when going to the clinics (HIV and 
cervical cancer screening)? 
 
n % 
  Bicycle/walk 187 64.3% 
  Public transport 104 35.7 
  
How long does it take to get to the clinic from where you 
live? n % 
  Less than 30 minutes 52 17.9% 
  More than 30 minutes 239 82.1 
 
The results in Table 14 indicate that the common mode of transport was 
bicycle/walking 187 (64.3%) seconded by public transport 104 (35.7%). The majority, 239 
(82.1%) of the respondents took more than 30 minutes to go to a health care facility and 52 
(17.9%) took less than 30 minutes. The results indicate that the majority walk and takes more 
than 30 minutes to access health care services. 
Type of a facility. For respondents who had screening, they were asked where they 
go for screening services as indicated in Table 15.  
Table 15  
 
Type of facility  
 
     
  Where did you go for cervical cancer screening?      n=96 n %   
 Government Health Facility 76 79.2%  
 Non-Government 20 20.8%  
 
The findings in Table 15 indicate that the majority 76 (79.2%) who were screened 
went to Government health facilities and few 20 (20.8%) went to Non-Governmental, either 
CHAM or private health facilities. 
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Specific Aim 2: To explore the factors associated with cervical cancer screening 
behavior among Malawian women with HIV infection.  
Factors Associated with Cervical Cancer Screening Behavior 
Table 16 presents  the odds ratio associated with cervical cancer screening behavior 
for unadjusted and adjusted models. Model 1 presents the raw effect for unadjusted simple 
logistic regression and model 2 presents the adjusted multivariate logistic regression.  
Table 16  
 
                Odds Ratio Associated with Screening 
 OR (CI)  
Raw Mode 1 
P-value Adjusted 
OR Model 2 
P-value 
Location      
Rural Reference    
Urban 1.59 
(0.92, 2.72) 
0.094   
Religion 
 
Other religion 
Christian 
  
 
Reference 
0.49 
(0.16, 1.49) 
0.211   
     
Age       
18-29 years Reference     
30-60 years 1.12 
(0.66, 1.89) 
0.676   
Marital Status     
Single Reference    
Married 1.06 
(0.64, 1.77) 
0.820   
Education Level       
Never attended/ Primary Reference     
Secondary/College 1.39 
(0.76, 2.57) 
0.287   
Occupation      
Not Working Reference     
        Working 6.53 
(1.65, 25.90) 
0.008 5.12 
(1.07, 24.43) 
0.041 
Monthly Income      
 
1.65 
(0.56, 4.12) 
 
<$100 Reference   0.289 
>$100 2.23 
(1.01, 4.72) 
0.04  
Time since HIV diagnosis (Years) 1.05 
 (0.99, 1.12) 
 0.099   
Number of Pregnancies 1.07 
(0.97, 1.18) 
0.166   
Knowledge 1.12 
(1.05, 1.20) 
0.001 1.10 
(1.02, 1.19) 
0.012 
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In Table 16, the results for the unadjusted model 1 of the logistic regression indicate 
that geographical location (OR=1.59; 95% CI: .92, 2.72), religion (OR=0.49; 95% CI: 0.16, 
1.49), age (OR=1.12; 95% CI: 0.66, 1.89), marital status (OR=1.06, 95% CI: 0.64, 1.77), 
education level (OR=1.39; 95% CI: 0.76, 2.57), number of years with HIV diagnosis 
(OR=1.05, 95% CI: 0.99, 1.12), and number of children (OR=1.07, 95% CI: 0.97, 1.18) were 
not statistically significantly associated with cervical cancer screening behavior.  
 Women who were working were 5.5 times more likely to undergo screening than 
women who were not working (OR=6.53; 95% CI: 1.65, 25.90).   Women who had monthly 
income of more than $100 were 1.2 times more likely to undergo screening than women who 
had monthly income of less than $100  (OR=2.23; 95% CI: 1.1, 4.72).  
When the knowledge score increases by 1 unit, the women are 12% more likely to go 
for screening services (OR=1.12; 95% CI: 1.05, 1.20). With 1 point increase in attitude score, 
the women are 45% more likely to go for cervical cancer screening services (OR=1.45; 95% 
CI: 1.14, 1.84). When social support network score increases by 1 unit, the women are 34% 
times more likely to have cervical cancer screening (OR=1.34; 95% CI: 1.17, 1.53). With 1 
unit increase in access to screening services, the women are 40% more likely to go for 
screening services (OR=1.40; 95% CI: 1.17, 1.68).  
Therefore, in the unadjusted model, the likelihood of cervical cancer screening was 
associated with occupation, income, knowledge, attitude, social support network, and access 
to health care services. On the other hand, geographical location, religion, age, marital status, 
Attitude 1.46 
(1.14, 1.84) 
0.002 1.36 
(1.04, 1.76) 
0.023 
Social Support Network 1.14 
(1.17, 1.53) 
0.001 1.14 
(0.99, 1.32) 
0.075 
Access 1.40 
(1.17, 1.68) 
0.001 1.21 
(1.01, 1.44) 
0.036 
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education, number of years with HIV diagnosis, and number of children were not found to be 
associated with screening uptake. 
Specific aim 3. To examine whether knowledge and attitudes are independently 
associated with cervical cancer screening after controlling for other determinants of cervical 
cancer screening.  
In adjusted Models 2, the model examined whether knowledge and attitudes are 
independently associated with cervical cancer screening after controlling for other 
determinants of cervical cancer screening (occupation, income, social support network, and 
access to health care services). 
Knowledge of cervical cancer and screening. In the adjusted model 2, the odds ratio 
of screening for knowledge was 1.10 (95% CI: 1.02, 1.19). It means that with 1 unit increase 
in knowledge score, the women are 10% more likely to go for screening services. Therefore, 
knowledge is independently associated with cervical cancer screening after adjusting for 
occupation, income, social support network, and access to health care services.  
Attitude. In the adjusted model 2, the odds ratio of screening for attitude was 1.36 
(95% CI: 1.04, 1.76). It means that with 1 unit increase in attitude score, the women are 36% 
more likely to go for screening services. Attitude is independently associated with cervical 
cancer screening after adjusting for occupation, income, social support network, and access to 
health care services.  
Access to cervical cancer screening services. In the adjusted model 2, the odds ratio 
of screening for access to screening services was 1.21 (95% CI: 1.01, 1.44).    It means that 
with 1 unit increase in access to screening services, women are 21% more likely to go for 
screening services.  Therefore, access to screening services was independently associated 
with cervical cancer screening after adjusting for other covariates. 
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Social support networks. In the adjusted model 2, the odds ratio of screening for 
social support network was1.14 (95% CI: 0.99, 1.32). Social support network is marginally 
significant after adjusting for respondents‟ occupation, knowledge, attitude, income, and 
access to screening services.  
Therefore, in the full model 2, occupation (OR=5.12; 95% CI: 1.07, 24.43), 
knowledge (OR=1.1; 95% CI: 1.02, 1.19), attitude (OR=1.36; 95% CI: 1.04, 1.76), and 
access to screening services (OR=1.21; 95% CI: 1.01, 1.44) were independently associated 
with cervical cancer screening.   
Improving Screening Services 
 Women were asked on how the screening uptake can be improved. Figure 8 indicates 
the women‟s responses. 
 
 
Figure 8. Suggestions on increasing screening uptake 
 
The results in Figure 8 indicate that women suggested that to increase screening 
uptake, more health care providers should be trained in screening so that screening should be 
done in HIV support groups or in the community, 177 (60.82%); others,108 (37.1%), 
indicated that health education regarding cancer and screening should be intensified in the 
community. Few, 4 (1.38%) indicated that government should provide cervical cancer 
screening resources in all CHAM facilities.  
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Summary of Study Findings 
The findings of the study were: 
1. The prevalence of cervical cancer screening in women living with HIV infection in HIV 
support groups in Lilongwe District in Malawi was 27.8% (95% CI:22.7%, 32.9%) 
2. The overall knowledge range score of the respondents was 0-31 correct answers (M = 
25.63, SD = 6.35). The overall results in the table show that the respondents were 
knowledgeable about cervical cancer and screening. However, the mean values and 
standard deviation of knowledge of the respondents was higher in respondents who were 
screened (M = 27.77, SD = 3.03) with a range of 18-31scores than those who were not 
screened (M = 24.80, SD = 7.07).  
3. The overall respondent‟s attitude score about cervical cancer screening ranged from 0-5 
with (M = 4.12, SD = 1.33). This shows that, overall, the respondents had positive attitude 
regarding screening. However, the mean values and standard deviation of respondent‟s 
attitude regarding screening, was higher in women who were screened (M = 4.49, SD = 
1.04) with a range of 0-5 scores than the mean knowledge of those who were not screened 
3.98+1.41 (0-5). 
4. The overall respondent‟s social support networks score about cervical cancer screening 
ranged from 0-11 (M = 7.82, SD = 2.67). This shows that, the respondents who had social 
support networks that influence screening bahavior. However, the respondent‟s social 
support networks score regarding screening, was higher in women who were screened (M 
= 8.93, SD = 2.21) with a range of 0-11 scores than the mean social support networks 
score of those who were not screened (M = 7.40, SD = 2.71) with a range of 0-11 .  
5. The overall respondent‟s score for access to screening services ranged from 3-12 (M = 
10.13, SD = 1.93). However, the respondent‟s access to screening services score was 
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higher in women who were screened (M = 10.84, SD = 1.98) with a range of 4-12 scores 
than those who were not screened (M = 9.86. SD = 1.84) with a range of 3-12 score.  
6. The factors associated with cervical cancer screening include occupation OR = 6.53 (95% 
CI: 1.65, 25.90), income OR = 2.23 (95% CI: 1.1, 4.72), knowledge OR = 1.12 (95% CI: 
1.05, 1.20), attitude OR = 1.45 (95% CI: 1.14, 1.84), social support network OR = 1.34 
(95% CI: 1.17, 1.53), and access to health care services OR = 1.40 (95% CI: 1.17, 1.68). 
7. Factors independently associated with cervical cancer screening services include 
knowledge OR = 1.1 (95% CI: 1.02, 1.19) and attitude OR = 1.36 (95% CI: 1.04, 1.76 
after adjusting for occupation, income, social support networks, and access to screening 
services.  
8. The Cronbach‟s alpha for whole instrument with 59 items and 4 subscales: knowledge 
with 31 items, attitude with 5 items, social support network with 11 items, and access to 
screening with 12 items was 0.88. This means that the overall instrument had good 
internal consistency (reliability).  
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CHAPTER 5 
DISCUSSION 
The discussion section of the study findings has been presented in relation to the 
concepts of the situation specific concepts which include participant‟s socio-demographic 
characteristics, cervical cancer screening, knowledge, attitude, social support network, and 
access to screening services. During discussion, study findings have been presented first then 
discussion, supported by relevant literature. 
Socio-demographic Characteristics 
The study sample was predominantly by women who had never attended or had 
primary education (79%). This is consistent with the findings of the Malawi Demographic 
and Health Survey 2015-17, which indicated that 86% of females have ever attended school 
(MDHS, 2017). Additionally, this report indicated that to a majority of the women, primary 
education is the highest level of schooling and only 5% have completed secondary school. 
This supports the finding that the majorities (96.6%) of the participants were not working and 
had low monthly income of less than 100 US dollars. Further, this supports the idea that 
working is a strong factor for screening as women get paid and can afford transport to go for 
screening services. Even though the screening services are free in Malawi, women who are 
not working with low monthly income of less than $100 cannot afford to pay for transport to 
go for screening services which are only offered in few health facilities in Malawi.  
Cervical Cancer Screening  
The proportion of women screened after HIV diagnosis was 27.8%. In a study 
conducted by Msyamboza and colleagues (2016), the screening rate for HIV-positive women 
in Malawi was 15.9%. The screening rate increased by 11.9% for HIV-positive women. This 
increase might be due to the fact that women living with HIV infection are exposed to health 
information during their doctor appointments to get their ART drugs in addition to nation-
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wide campaigns that call for all women to undergo screening. Despite HIV-positive women 
visiting ART clinics regularly to access drugs, the screening rate for HIV positive women is 
still low.  This finding is in line with literature review study which was conducted in African 
countries where it was found that the screening rate in HIV-positive women was also low, for 
instance: Nigeria 9.4%, South Africa 22.3%, and Zimbabwe 9% (Ezechi et al., 2013; Maree 
& Moitse, 2014; Matangaidze et al., 2016). There is need for health care providers to follow 
up with these women during the ART appointment visits and provide them with the screening 
services. Additionally, the Malawi cervical cancer screening guidelines recommend that HIV-
positive women should have annual cervical screening or at least once to have baseline data 
for evaluation for their follow-up annual screening for those with normal results (MOH, 
2017). This indicates that there is noncompliance with cervical cancer screening guidelines 
for HIV-positive women in Malawi. If Malawi is to fight cervical cancer, the guidelines must 
be followed. Furthermore, the guidelines indicate that VIA targets women aged 30-45 years 
(Malawi, MOH, 2017). In studies, VIA positive rate and cancer suspects have been detected 
in women aged less than 30 years and above 45 (Msyamboza et el., 2016). This may be due 
to high HIV-prevalence rate among women aged 15-49 years. This calls for review of 
screening guidelines in the country and further research in VIA accuracy among post-
menopausal women.  
Additionally, 70% of the working women had been screened compared to 26.3% of 
those who were not working. Working in most Malawi community means a paid up job and 
not substance farming. The results indicated that 10 (3.4%) of the women were working. This 
is inconsistent with the findings in Malawi demographic health survey which has indicated 
that 63% of the women are working (MDHS, 2017). This may mean that 3.4% of the sample 
size is not the representation of the larger population of working women in Lilongwe, Malawi 
or the MDHS data is not correct as it is based on estimates.  
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Knowledge Regarding Cervical Cancer and Screening 
The study findings revealed that women had t knowledge regarding cervical cancer 
and screening (M = 25.63, SD 6.35). This is inconsistent with previous studies conducted in 
Malawi on all women that reported that women had inadequate knowledge regarding cervical 
cancer signs and symptoms, risk factors, and preventive strategies (Maseko et al., 2015; 
Munthali et al., 2015; Mtengezo & Lee, 2018). This finding could reflect of the impact of 
health promotion messages that HIV positive women receive during their OPD appointment 
visits and the ongoing mass campaign about cancer and screening services on the radio and 
meetings by the First Lady and through the health talks at clinics by health care providers. 
Most radio stations and television in Malawi have public service announcements where the 
First Lady of Malawi campaigns for cervical cancer screening. She talks about the benefits of 
screening and disadvantages of not screening. And she calls for all women to go for 
screening. On the other hand, the impact of messages on the media needs to be evaluated. In 
Malawi, the urban households are more likely than rural households to own a television (45% 
versus 6%) and a radio (65% versus 36%) (MDHS, 2017). This may mean that those living in 
urban area get the information and more likely go for screening than those living in rural 
areas. On the other hand, even those living in urban areas, they may tune to other channels 
and miss the information. The impact of media announcement on cervical cancer screening 
uptake needs to be evaluated in both urban and rural areas.  
Using logistic regression, knowledge is independently associated with screening. In 
the adjusted model, it showed that with 1 unit increase in knowledge score, women are 10% 
more likely to undergo cervical cancer screening services [OR = 1.10 (95% CI: 1.02, 1.19)] 
but the difference was not statistically significance between the non-screened and screened 
women. Both groups had high knowledge regarding cervical cancer and screening but their 
cervical cancer screening uptake was still very low.  This may mean that knowledge is not 
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translating into practice or the respondents were answering questions in a manner that would 
be viewed favorable by the researcher. This finding concurred with the study conducted in 
South Africa by Maree and Meitse (2014) which found that women had knowledge regarding 
cervical cancer and screening, but the screening uptake was low (22.3%). The possible reason 
for not going for screening may be related to attitude, beliefs, and misinformation about 
screening procedure being painful (Mtengezo & Lee, 2018).   
On the other hand, even though women had high knowledge regarding cancer and 
screening. On the other hand, almost half of the respondents were not aware that smoking, 
having a family member diagnosed with cancer, and taking family planning pills for a long 
time increases the woman‟s risk of developing cervical cancer. Previous studies in Malawi 
revealed that lack of knowledge and awareness about risk factors impacted screening uptake 
(Maseko et al, 2015; Munthali et al., 2015). Additionally, almost half of the respondents were 
not aware that there is treatment for cervical cancer. This finding is in line with a qualitative 
study done in Malawi which found that women were aware that there is no treatment for 
cervical cancer (Mtengezo & Lee, 2018).  
On the other hand, the current found out that 84% of the women indicated that VIA is 
a means of receiving cervical cancer treatment if diagnosed early. This high knowledge may 
also indicate weakness in the closed ended questions as women could just guess responses. 
There is need to develop culturally targeted educational intervention programs for HIV 
positive women so that women become knowledgeable regarding cervical cancer signs and 
symptoms, risk factors, preventive strategies; and risks and benefits of screening.  
Attitude Regarding Screening 
The respondent‟s attitude score about cervical cancer screening ranged from 0-5 (M = 
4.12, SD = 1.33). However, the respondent‟s attitude regarding screening, was higher in 
women who were screened (M = 4.49, SD = 1.04) with a range of 0-5 scores than those who 
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were not screened (M = 3.98, SD = 1.41).  This finding is in line with a study conducted in 
Zimbambwe where it was found that 96.2% of the women indicated that they would like to 
undergo screening. However, this study identified several factors that could have prevented 
them from undergoing screening. Some women indicated that they feared the procedure 54 
(18.6%). Some women felt shy to expose their private parts 49 (16.8%). Some were afraid of 
being diagnosed with cancer 45 (15.5%); and some were afraid of pain during the procedure 
54 (18.6%). These findings are in line with studies conducted in Malawi and South Africa on 
barriers to screening where women believed that cervical cancer is caused by the exposure to 
the VIA process and that the procedure is painful (Maree & Moitse, 2014; Munthali et al., 
2015, Mtengezo & Lee, 2018). However, in the current study, feeling shy to expose private 
parts to male service providers was not associated with screening as other studies found 
(Munthali et al., 2015, Mtengezo & Lee, 2018). Respondents further indicated that they 
would be comfortable to be screened by either male or female service providers. This reflects 
that women view screening as a health procedure that doctors of either sex can perform. 
Further, the logistic regression model showed positive association between attitude and 
screening. With 1 unit increase in attitude score, women are 36% more likely to undergo 
screening (OR= 1.36, 95% CI: 1.04-1.76). These results indicate that there is need for 
continued efforts to address women‟s attitude to promote screening uptake.  
Social Support Networks 
In simple logistic regression, the results indicate that the odds for screening were 
associated with social support networks (OR = 1.16, 95% CI: 1.01-1.34). In multivariate 
logistic regression, the odds of screening lost significance. Therefore, social support network 
in not independently associated with screening. It means that the variable exists but its 
influence on screening could not be directly detected in this study. Studies have indicated that 
friends offer information and advice relating to behavior change (Wigfall et al., 2015). The 
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reasons for protective effects of social support networks and income on screening needs to be 
further studied. The possible reasons would be that the instrument measured only positive 
dimensions of social support networks in influencing behavior change rather than the 
negative aspects of network like stigma. Only one-fifth (22.7%) of the participants indicated 
that family members tried to help them with financial support, and 54% of the women got 
emotional support from family members. The next study should consider measuring the 
negative dimension of social support network like exploring and understanding the meaning 
and lived experiences of stigma among women or individuals living with HIV/AIDS and 
their family members in Malawi. Understanding the negative aspect is critical for improving 
screening uptake and compliance. 
Access to Screening Services 
Only 96 (33%) of the women indicated that they received screening the first time they 
needed it from Government and Non-Governmental (CHAM and private) health facilities. 
The WHO indicated that access is related to affordability, availability, accommodation, 
accessibility, and acceptability (WHO, 2002). In terms of affordability, there are no user fees 
to access cervical cancer services in public and private-not-for-profit health facilities in 
Malawi, but the screening sites are far. This indicates that screening services are not 
integrated into HIV services. All HIV-positive women access the ART clinics for their 
treatment monthly or every three months in health facilities. If the services were integrated, it 
would lessen frequent hospital visits for preventive services as most women travel long 
distance to access screening services. The findings indicated that the majority, 239 (82.1%) of 
the respondents took more than 30 minutes to go to a health care facility.  When women were 
asked if they travel less than or more than 30 minutes, most women reported more than an 
hour. This means that in the next study, the measure should be one hour as 30 minutes is 
considered as a short distance. This is in line with a case study report conducted in Malawi on 
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a woman who travelled 60 km for the whole day for post-VIA treatment at another facility 
(Lee et al., 2015). This means that women in rural areas cannot afford transport money. In 
this study, women could not afford transport money 116 (39.9%) to go for screening when 
they already had a hospital visit.  On the other hand, there are screening sites in CHAM 
facilities close to them and they charge a small service fee like one dollar (Maseko et al., 
2015; Munthali et al., 2015). But the women think this is payment for the services and they 
prefer to go to public health facilities and may pay as much as two dollars for transport 
(Mtengezo & Lee, 2018). This shows that screening services are not yet integrated with the 
ART services to prevent frequent hospital visits and to different facilities.  
 In terms of availability, the majority of the women (82%) reported that they travel 
more than 30 minutes to screening sites and they wait for a long time to be screened. These 
findings are in line with the study done in Malawi that showed that there were only 130 
screening sites in the country (Msyamboza et al., 2015) and the women were dissatisfied with 
screening services in Malawi due to distance and waiting time (Maseko et al., 2014). In 
logistic regression, it showed that with 1 unit increase in access to screening services, women 
are 25% more likely to go for screening [OR = 1.25 (95% CI: 1.05, 1.48)]. This is in line with 
a qualitative study finding as respondents suggested that to increase access to screening 
services, there was need to integrate screening services with ART services so that women are 
screened as they start ART as part of comprehensive physical assessment and baseline data 
(Mtengezo & Lee, 2018). Unfortunately, the services are not integrated; therefore, women are 
unlikely to travel to the clinic just for screening if they are not having signs and symptoms of 
cancer. This may be a possible reason that women visit the clinic when they have signs and 
symptoms of cancer (Msyamboza et al., 2016). A possible explanation for this is that the 
majority of the women (96.6%) are not working and 88.7% of the women have a monthly 
income less than $100. They might not be in a position to have sufficient financial resources 
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to go for preventive services when they are not sick. The Sustainable Development Goal 
(SDG) number 3 promises to “ensure healthy lives and promote well-being for all at all 
ages”. Specifically goal 3.4 which emphasize “reducing premature mortality from non-
communicable diseases (NCDs)” and goal 3.7 which stipulates “ensuring universal access to 
sexual and reproductive health care services” (https://sustainabledevelopment.un.org/sdgs). 
As stipulated in a qualitative study, there is need to have targeted follow up screening dates 
together with ART visits (Mtengezo & Lee, 2018). Health care providers should check and 
remind the women on follow up screening dated at every hospital appointment visit. There is 
evidence in Kenya that showed that with targeted interventions for HIV-positive women, the 
screening rate was as high as 84% (Rosser et al., 2015). If we are to promote healthy lives of 
women with low income and living with HIV infection, opportunistic screening in the 
community and in health facilities should be encouraged to improve screening uptake. This 
calls for review of sexual and reproductive health and ART policies to deal with cervical 
cancer screening and follow-ups in all ART sites, health facilities and in the community.  
In terms of accommodation, the study found that there were no equipment and the 
service providers were inadequate in most clinics where women visit for ART drug supply. 
The clinics could not accommodate women if they needed screening due to lack of trained 
health care providers and equipment. This is in line with a study done on health systems 
challenges in cervical cancer prevention program in Malawi. The study found that 52% of the 
facilities reported stock outs of supplies and in some facilities, women contributed money to 
buy acetic acid (Maseko et al, 2015). Additionally, the cervical cancer screening guidelines 
stipulate that the cervical cancer screening providers must be certified to conduct screening 
and treatment activities. There are only 272 active service providers in Malawi (MOH, 2017). 
The number of providers is inadequate, and not all preventive services might be provided. 
There is a shortage of health personnel and these same providers are also providing curative 
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and other services. The shortage of health workers is worse in rural areas than in urban areas 
and this might contribute to low screening rate (22.4%) in rural compared in urban (31.4%) 
areas. This calls for training all ART providers on VIA.  The VIA is the recommended 
approach for cervical cancer screening by CDC for developing countries where there are 
resource constraints (CDC, 2013). On the other hand, almost all women (99%) had cervical 
cancer screening in either Government or CHAM facilities. In most of the Government or 
CHAM health facilities in Malawi, there is inadequate budgetary allocation which results in 
frequent stock outs of supplies for cervical screening like vinegar, speculums, cryotherapy 
unit, CO2 cylinders, thermos-coagulators, and infection prevention supplies (Msiyamboza et 
al., 2016). With all these challenges facing Malawi health care including the new cervical 
cancer guideline to extend the screening interval for HIV-positive women from one to three 
years (MOH, 2017) is counter-productive given the higher risk for cervical cancer among 
women living with HIV infection. Considering the HIV prevalence in the country, annual 
screening remains the recommended interval for women living with HIV infection. In the 
United States, to ensure that cervical cancer prevention remains a priority in HIV positive 
women, refined screening criteria such that HIV positive women undergo three consecutive 
annual screening. If women have normal Pap tests in three consecutive annual screening, 
thereafter, follow-up is recommended every three years (HIV/AIDS Treatment Guidelines, 
2015).  
 In terms of acceptability, few women did not see the reason to go for screening 
because they thought that they were not sick. Others stated that they were too old and feared 
male service providers. This is in line with a qualitative study conducted by the researcher in 
Malawi on perceptions of women on screening. Women indicated that they did not see the 
reason for screening as they were either old or were already HIV positive, and others feared 
male service providers. These results indicate a need to address issues relating to 
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acceptability in preventive sexual and reproductive health services in elderly women and 
HIV-positive women on the benefits of screening and the disease process. 
Reliability of the Measurement 
The instrument was developed based on literature review and qualitative pilot study. 
The instrument covered the demographic characteristics and the five major concepts of the 
study: Knowledge, attitude, social support network, and access to screening services 
Knowledge had 31 items with 4 subscales. The subscales included knowledge regarding risk 
factors of cervical cancer with 13 items and the Cronbach alpha was 0.87. Knowledge 
regarding signs and symptoms of cervical cancer with 11 items and the internal consistency 
for knowledge subscale had a Cronbach alpha of 0.90. Knowledge regarding prevention 
strategies of cervical cancer with 4 items and the internal consistency was not computed as it 
had few (4) questions. Awareness of cervical cancer, screening, and HIV/AIDS with 3 items 
and the internal consistency of the awareness sub-scale were not computed as it had few 
questions. Attitude regarding cervical cancer screening had 5 items and the internal 
consistency for attitude subscale had Cronbach alpha of 0.74. Social support network 
regarding cervical cancer screening had 11 items and the internal consistency for social 
support network had a Cronbach alpha of 0.81.  Access to cervical cancer screening services 
had 12 items and the internal consistency for access to screening services had a Cronbach 
alpha of 0.88.  The overall instrument had 59 items and the internal consistency for the 
overall instrument had a Cronbach alpha of 0.88. This means that the overall instrument had 
satisfactory internal consistency (reliability). 
Summary of Discussion 
This was the first empirical study to examine the prevalence of cervical cancer 
screening, the level of knowledge and attitude regarding cervical cancer and screening in 
Malawi; and to determine factors associated with screening behavior among Malawian HIV 
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positive women in Malawi. The prevalence of cervical cancer screening in women living with 
HIV infection in HIV support groups in Lilongwe District in Malawi was still low. In 
general, both women, those who received screening and women who were not screened had 
high knowledge regarding cervical cancer and screening. But women who were screened, had 
higher knowledge score (M = 27.77, SD = 3.03) compared to those who were not screened (M 
= 24.80, SD = 7.07) even though the difference was not statistically significant.   
The respondents had a positive attitude regarding screening. The respondent‟s attitude 
regarding screening, was higher in women who were screened (M = 4.49, SD = 1.04) than 
those who were not screened (M =3.98. SD = 1.41). This could be, the questions about VIA 
was asked to all women who were exposed to VIA procedure or not exposed. However, the 
majority were willing to be screened.  
The respondents had social support networks that influence screening bahavior. 
However, the mean values and standard deviation of respondent‟s social support networks 
score regarding screening, was higher in women who were screened (M = 8.93, SD = 2.21) 
with a range of 0-11 scores  than those who were not screened  (M = 7.40, SD = 2.7) . The 
respondents had access to screening services. However, the respondent‟s access to screening 
services score was higher in women who were screened (M = 10.84, SD 1.98) with a range of 
4-12 scores than those who were not screened (M = 9.86, SD 1.84). The factors independently 
associated with cervical cancer screening services include occupation OR = 5.12 (95% CI: 
1.07, 24.43), knowledge OR = 1.1 (95% CI: 1.02, 1.19), attitude OR = 1.36 (95% CI: 1.04, 
1.76), and access to screening services OR = 1.21 (95% CI: 1.01, 1.44). Respondents further 
suggested that efforts to promote screening uptake should focus on offering screening 
services in HIV support groups or within their communities, and to continue educating 
women on the benefits of screening. The Cronbach‟s alpha for whole instrument with 59 
items and 4 subscales: knowledge with 31 items, attitude with 5 items, social support network 
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with 11 items, and access to screening with 12 items was 0.88. This means that the overall 
instrument was reliable to be used for women living with HIV infection in support groups.  
Study Limitations 
The study had methodological  limitations which include: 1) The study focused on 
women enrolled in HIV support groups. This means that women were exposed to health 
information messages hence increased knowledge regarding cervical cancer and screening, 
Additionaaly, the sample may not be representative of all HIV positive women in Malawi, as 
a result, the findings cannot be generalised to all HIV positive women in Malawi. 2) For 
those women who were screened, there was limited data on what or who influenced them to 
undergo screening, family stigma and the role of spouses in screening was not investigated. 
3) Descriptive correlational design creates a snapshot and results cannot be used to draw 
inferences about causal relationships between and among the variables. 4) Self-reports studies 
creates response bias. 5) The study instrument was developed based on literature review and 
qualitative study. The study adapted the demographic measures used in literature like 
occupation and income which is measured differently within Malawian cobtext. In malawi, 
occupation means paid job and income is measured by comodities that a person has like  
cattle, goats, bicycle and so on. Since the instrument was purpose designed, therefore, there is 
need to validate the tool in a larger sample. 
Recommendations 
The Malawi Ministry of Health vision is “Malawian women free from cervical 
cancer” and a screening coverage rate of 80% for all women aged 25-49 years…”. If this 
dream is to be realized, there is need to have synergetic efforts at a policy level, health 
facilities, nursing education and research. 
Policy level. The policy level should ensure that adequate resources for cervical 
cancer prevention and control activities are available in all health facilities in the country. 
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The ART and SRH policies should be reviewed to facilitate universal and multiple access to 
screening services. Before introduction of ART, there should be a routine of cervical cancer 
screening among HIV positive women.  
Health facilities. The health facilities as implementing agents for HIV and screening 
should integrate screening services into ART/HIV care and in HIV/AIDS programing 
activities. The health facilities incharges should budget for the procurement of screening 
supplies, and integrate the delivery of the supplies for VIA with monthly delivery of other 
drugs to all health facilities. There is need to promote screening services in the community by 
improving health posts to provide screening services. The health facilities should train more 
cervical cancer service providers. Community advocacy and awareness on the benefits of 
screening and the disease process should be increased by using existing Village Health 
Committee and Community Health Action Groups. 
Nursing education. The training institutions should review pre-service curricula and 
incoorporate cervical cancer screening core competencies in nursing and medical curricula. 
Future research.  
The study targeted only women living with HIV infection in support groups, there is 
need to have a comparison study for three groups: women living with HIV infection not in 
support groups, those in support groups, and HIV negative women. Since the instrument was 
purpose designed, there is need to validate the instrument and to test hypothesis (theory) in a 
larger sample. There is need to conduct a study on the role of social support networks 
(including spouces) in influencing screening behavior. Lastly, the negative dimension of 
social support network like family stigma regarding screening should further be explored. 
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Conclusion 
Cervical cancer is a preventable and curable disease when detected early through 
screening. Despite frequent visits to ART clinics, having knowledge and positive attitude 
regarding screening among HIV-positive women, screening rates remained low. This means 
that knowledge and a positive attitude regarding screening did not translate into practice. 
Efforts to ensure timely screening among HIV positive women may require community-
based intervention such as health education messages regarding disease processes, risk 
factors, and benefits of screening and to promote screening uptakes in women living with 
HIV infection in Malawi.  
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 C. EVIDENCE TABLE FOR CERVICAL CANCER SCREENING. 
 
 
 
 
  
Author Purpose Design and 
place 
Screen
ing 
rate 
and 
Test 
Knowledge Attitude Social 
Influe
nce 
Access to 
health care 
1 Chadza, 
2012 
To 
explore 
factors, 
those 
contribut
e to 
delay in 
seeking 
early 
diagnosis 
and 
treatment 
of 
cervical 
cancer 
among 
women 
in 
Malawi. 
Qualitative 
-In-depth 
interviews 
using a 
semi-
structured 
interview 
guide (24 
women -25 
- 60 years) 
diagnosed 
with 
cervical 
cancer) 
VIA Limited 
knowledge 
on:   
-Symptoms 
and signs of 
cancer 
    Limited 
accessibility: 
-Unavailability 
of cancer 
screening 
facilities  
-Financial 
resources for 
transport 
2 Chidyao
nga-
Maseko 
et al., 
2015 
To 
identify 
barriers 
to 
utilizatio
n of 
cervical 
cancer 
preventio
n 
services 
in low 
and 
middle-
income 
countries 
Document 
review 
VIA Lack of 
awareness, 
and 
knowledge: 
-Risk factors 
- Prevention 
of cancer 
Stigma in 
discussin
g 
reproduct
ive 
health 
issues 
    
3 Fort et 
al., 2011 
Investiga
ted how 
women 
in rural 
Malawi 
make 
health-
seeking 
decisions 
regarding 
cervical 
cancer 
screening 
Qualitative 
study-in-
depth 
interviews. 
Used semi-
structured 
interview 
guide (20 
Women in 
two sites of 
rural 
Malawi -10 
each site, 
aged 20 - 
50) 
VIA  Facilitators
: 
 -Having 
symptoms of 
cervical 
cancer.  
Barriers:  
-Low 
knowledge 
levels 
 Barriers
:  
 -Low 
perceive
d 
susceptib
ility  
-Low 
perceive
d 
benefits 
from the 
service. 
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4 Lee et 
al., 
(2015) 
To 
highlight 
the 
difficulti
es at a 
grassroot
s level of 
obtaining 
appropria
te 
treatment  
Qualitative 
study-case 
study (25 
years, HIV 
negative 
woman 
who was 
detected 
with a pre-
cancerous) 
VIA       lack of access 
to screening 
and treatment 
due to 
socioeconomic 
problems 
-Unavailability 
of services   
5 Maseko 
et al., 
2015 
Explorin
g health 
system 
gaps 
responsib
le for the 
poor 
performa
nce of 
the 
cervical 
cancer 
preventio
n 
program 
in 
Malawi. 
Mixed 
methods 
cross-
sectional 
quantitative 
and 
qualitative 
approach- 
survey -
Checklist -
Interview 
guide (14 
districts. 
Service 
providers- 
41 service 
providers 
from 21 
health 
facilities 
and nine 
district 
coordinator
s) 
VIA       -Inadequate 
service 
providers who 
are poorly 
supervised;  
-lack of basic 
equipment and 
stock-outs of 
basic medical 
supplies  
-inadequate 
funding of the 
program 
6 Maseko 
et al., 
2014 
To assess 
client 
satisfacti
on 
among 
women 
who had 
been 
screened 
for 
cervical 
cancer  
Cross 
sectional 
study and 
quantitative 
approaches 
(120 
women 
mean age 
of 33.7 
(SD=10.1) 
who were 
screened 
for cervical 
cancer) 
VIA Satisfaction 
was 
predicted by 
having 
previous 
knowledge 
of the 
- VIA test, 
K 
    Satisfaction 
was predicted 
by: 
- having an 
appointment 
before the 
screening with 
adjusted odd 
ratio of 
5.71(95% CI: 
1.75. 18.63), 
-distance from 
the home to 
the health 
facility 
AOR = 0.11 
(95% CI: 0.02, 
0.65) 
-Waiting time 
AOR = 0.09 
(95% CI: 0.09, 
0.83).  
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7 Munthali 
et al., 
2015 
To assess 
service 
provider'
s 
perceptio
ns about 
women‟s 
barriers 
to 
cervical 
cancer 
screening 
and 
treatment 
Qualitative
- in-depth 
interviews 
(13 district 
coordinator
s and 40 
Service 
Providers 
service 
providers 
of cervical 
cancer 
screening) 
VIA Lack of 
awareness of 
the disease 
Misconc
eptions 
about the 
disease 
that it is 
caused 
by 
exposure 
to the 
VIA 
process 
Lack 
of 
involv
ement 
of 
husban
ds, 
-Shortage of 
staff,  
-lack of 
equipment 
and supplies,  
-lack of 
supervision, 
-use of male 
service 
providers,  
-long distance,  
8 Msyamb
oza et al., 
(2016) 
To 
evaluate 
the 
uptake 
and 
challenge
s of 
screening 
services 
by age, 
HIV 
sero-
status 
and 
trends 
over a 
five-year 
period 
(2011–
2015) in 
Malawi. 
Program 
data 
analysis 
(2011–
2015). 28.1 
% were 
aged 29 or 
less, 56.1 
%) were 
between 
30–45, and 
15.8 % 
were 46 
years or 
more 
-
26.5% 
(HIV+ 
and - 
women
. 
-
15.9% 
HIV+ 
women
. -VIA 
      Failure to treat 
VIA positive 
women 
eligible for 
cryotherapy 
due to stock 
out of gas, 
faulty/broken 
cryotherapy 
machine or no 
cryotherapy 
machine.  
-For cancer 
suspect, lack 
of 
loop 
electrosurgical 
excision 
procedure 
(LEEP) 
machine or 
inadequate 
gynecologists 
at the referral 
center. Cancer 
radiotherapy 
services were 
not available. 
    
   Evidence Table for cervical cancer screening in HIV positive women African countries 
 
  Author Purpose Design and 
place 
Screen
ing 
rate 
and 
Test 
Knowledge Attitude Social 
Influe
nce 
Access to 
health care 
1 Ezechi, 
Gab-
Okafor, 
Ostergr
en, & 
Odberg 
Petterss
on, 
(2013) 
To assess 
the 
willingnes
s and 
acceptabil
ity of 
cervical 
cancer 
screening 
Cross-
sectional 
study in 
Nigeria 
(1517 HIV 
positive 
women) 
9.4%.  
Pap 
Smears 
56.2% were 
aware of 
cervical 
cancer 
79.8% 
accepted 
to take 
the test 
in the 
future 
  Barriers: Cost 
of the test 
Religious 
denial. 
Facilitators: 
Tertiary 
education 
level, aware of 
cervical 
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among 
HIV 
positive 
Nigerian 
women 
cancer, no 
living child, 
recent HIV 
diagnosis 
2 Maree 
& 
Moitse, 
(2014). 
To 
determine 
what 
women 
being 
treated for 
HIV and 
AIDS in 
South 
Africa 
knew 
about 
cervical 
cancer and 
cervical 
screening 
 Cross-
sectional 
study in 
South 
Africa 
(315 HIV 
positive 
women) 
22.3%. 
Pap 
Smears 
78.7% had 
heard of 
cervical 
cancer, 
62.9% knew 
about the 
Pap smear,  
Fear the 
procedur
e. 
Social 
netwo
rk: 
Source 
of 
inform
ation: 
Health 
care 
worker
s 
  
3 Matang
aidze et 
al., 
(2016) 
To 
determine 
the 
knowledg
e, attitude 
and 
practices 
of HIV 
infected 
women on 
cervical 
cancer and 
cervical 
cancer 
screening 
in 
Zimbabwe
.  
Mixed 
methods -A 
cross 
sectional 
survey and 
qualitative 
in 
Zimbabwe 
(208 HIV 
positive 
women) 
9%. 
VIA 
21.6% knew 
cervical 
cancer 
disease.  
-55.3% 
knew that 
cervical 
cancer is 
preventable.  
-92.8% did 
not know 
screening 
tests 
77.4% 
felt at 
risk of 
cervical 
cancer. 
 -96.2% 
reported 
they 
would 
like to 
undergo 
screening 
in the 
future. 
    
4 Rositch 
et al., 
(2012) 
To assess 
adult 
women‟s 
knowledg
e of 
human 
papilloma
virus 
(HPV) 
and 
cervical 
cancer, 
and 
characteri
ze their 
attitudes 
towards 
potential 
screening 
and 
prevention 
Cross 
sectional 
study- Pre-
and post in 
Kenya 
(409: 268 
HIV 
positive 
and 141 
HIV 
negative 
women 
median age 
29 years 
67% of 
HIV 
positiv
e 
women
. Pap 
Smears 
18% had 
ever heard 
of HPV 
-69% new 
that Pap 
smears 
detect 
cervical 
cancer.  
-18% knew 
that routine 
Pap 
screening is 
the main 
way to 
prevent it 
 Most 
women 
reported: 
-high 
level of 
cultural 
acceptabi
lity for 
screening 
- low 
level of 
discomfo
rt during 
Pap 
smear 
collectio
n 
  -Over 80% of 
women 
reported that 
they would 
feel 
comfortable 
using a self-
sampling 
device  
-82% would 
prefer at-home 
sample 
collection  
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strategies 
5 Rosser 
et al., 
(2015) 
To assess 
cervical 
cancer 
knowledg
e, 
personal 
risk, 
perception
, stigma, 
and 
screening 
uptake 
among 
women 
enrolled in 
the HIV 
Study 
clinic in 
Kenya 
Cross-
sectional 
study in 
Kenya 
(106 HIV 
positive 
women) 
84%. 
VIA 
99% had 
heard of 
screening.  
-70% felt 
at risk.  
- Feeling 
at risk 
and 
screening
. was 
associate
d with 
duration 
of HIV 
diagnosis 
  48% would not 
get screened if 
they had to 
pay for it 
6 Wake et 
al., 
(2009) 
To 
ascertain 
the 
perception 
of cervical 
screening 
practices 
among 
HIV-
positive 
women 
attending 
an ART 
clinic in 
urban 
South 
Africa 
Mixed 
methods- 
prospective 
cross-
sectional 
study and 
Qualitative 
study in 
South 
Africa 
(113 HIV 
positive 
women 
aged 21-64: 
randomly 
selected 
from the 
register) 
59%. 
Pap 
Smears 
-78% had 
never heard 
of cervical 
cancer.  
-40% had no 
correct 
knowledge 
about 
screening 
-84.95 % 
expresse
d the 
desire to 
undergo 
screening 
in the 
future.  
-15% had 
fear and 
misunder
standing 
on 
screening  
Reason
s for 
not 
screeni
ng 
include 
they 
had 
never 
been 
asked 
to.  
The time or 
place 
of the test 
meant that 
they were 
unable to 
attend.   
 
 
   Evidence Table for cervical cancer screening in HIV positive women in other 
developed       
  countries. 
  Author Purpose Design and 
place 
Screen
ing 
rate 
and 
Test 
Knowledge Attitude Social 
Influe
nce 
Access to 
health care 
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1 Bynum, 
et al., 
(2013) 
To assess 
the 
influence 
of health 
literacy on 
women 
living 
with HIV 
cervical 
cancer 
screening 
knowledg
e and 
behaviors 
in the 
southeaste
rn USA. 
Cross-
sectional 
study (145 
HIV 
positive 
women) in 
USA 
Pap 
Smears 
No 
difference in 
cervical 
cancer or 
HPV 
knowledge 
among those 
with low 
versus high 
health 
literacy.  
      
2 Dal 
Maso et 
al., 
(2010) 
To 
evaluate 
the history 
of Pap-
smear in 
HIV-
positive 
women 
and to 
examine 
the socio-
demograp
hic, 
clinical, 
and 
organizati
onal 
factors 
associated 
with 
adherence 
to cervical 
cancer 
screening 
in Italy. 
Cross 
sectional 
study (1002 
HIV 
positive 
women. 
Median age 
41 years in 
Italy. 
90.9%. 
Pap 
Smears 
Lack of 
knowledge 
on follow-up 
care.  
 
 -Non-
complian
ce to 
cervical 
cancer 
screening 
protocol 
due to 
low CD4 
count 
Social 
netwo
rk- 
better 
screeni
ng 
partici
pation 
was 
associa
ted 
with 
getting 
advice 
from 
gyneco
logist 
Difficulties in 
following the 
recommended 
protocol of 
combining 
routine follow-
up of HIV 
infection with 
gynecological 
examination 
3 Leece, 
Kendall, 
Touchie
, Pottie, 
Angel, 
& 
Jaffey, 
(2010) 
To 
determine 
the rate of 
cervical 
screening 
among 
HIV-
positive 
women, 
and to 
determine 
whether 
screening 
rates were 
influenced 
by having 
a primary 
care 
Retrospecti
ve Chart 
review 
(218 
women) in 
Canada 
58%. 
Pap 
smears 
and 
cytolo
gy 
      -Women with 
insurance 
coverage and 
with 
gynecological 
visits were 
more likely to 
receive 
screening 
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provider. 
4 Sichanh
, 2014 
To 
determine 
the 
knowledg
e, 
awareness 
and 
attitudes 
about 
cervical 
cancer 
among 
Lao 
women 
attending 
or not an 
HIV 
treatment 
center 
A cross-
sectional 
case–
control (32
0 women 
aged 25 to 
65, living 
with HIV –
Controls 
were 320 
women 
matched 
for age and 
place of 
residence, 
not 
attending 
an HIV 
treatment 
center) in 
Asia 
3.9%. 
Pap 
Smears 
Reasons for 
not 
screening 
include: 
-the absence 
of symptoms  
-lack of 
information 
and 
ignorance of 
screening 
usefulness 
  Social 
netwo
rk: 
Source 
of 
inform
ation: 
Health 
care 
profess
ionals 
  
5 Wigfall 
et al., 
(2015) 
To 
examine 
associatio
ns 
between 
WLHA‟s 
cervical 
cancer 
prevention 
knowledg
e and 
abnormal 
Pap test 
history in 
USA 
Cross-
sectional 
study (106 
urban and 
rural 
WLHA 
from Ryan 
White-
funded 
clinics and 
AIDS 
service 
organizatio
ns. Mean 
age 
46.3±10.9 
in the 
South-
Eastern 
USA. 
83%. 
Pap 
Smears 
-84 % knew 
that WLHA 
should have 
a Pap test 
every year.  
- Women 
who had an 
abnormal 
Pap test 
knew 
follow-up 
care. 
  Social 
netwo
rks: 
Those 
who 
had 
friends 
with 
an 
abnor
mal 
Pap 
test, 
knew 
the 
screeni
ng 
period 
for 
HIV 
positiv
e 
women 
yearly. 
  
6 William
s et al., 
(2015 
To 
examine 
sociocultu
ral and 
structural 
factors 
associated 
with 
cervical 
cancer 
screening 
among 
HIV-
Qualitative 
study- in-
depth 
interviews 
(20 
African-
American 
women) 
in USA 
Pap 
Smears 
Lack of 
knowledge 
about 
cervical 
cancer and 
screening,  
Lack of 
perceive
d 
susceptib
ility to 
cervical 
cancer 
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infected 
African 
American 
in 
Alabama 
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D. CONCEPTUAL-THEORETICAL-EMPIRICAL STRUCTURE 
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E. RESEARCH ASSISTANTS TRAINING PROGRAM PLAN 
 
                                                                          Day 1 
Time Activity Responsible person 
8.00-10.00 am Study overview: Objectives, Confidentiality and IRB, 
survey consent form 
Mtengezo 
10.00-10.15 am Tea Break 
 
 
10.15- 12.00 pm Review of survey instrument by RA and content experts 
 
Mtengezo 
Dr. MarySue Makin 
12.00- 1.00 pm Lunch 
 
 
1.00- 2.00 pm Cognitive interviews by conducting FGD with 5 HIV 
positive women 
 
Mtengezo 
 
3.00- 4.00 pm Debriefing 
 
Mtengezo  
Dr. MarySue Makin 
4.00- 4.15 pm Tea Break 
 
 
4.15- 4.30 pm Making corrections on the survey instrument Mtengezo 
 
Day 2 
Time Activity Responsible person 
8.00-10.00 am Recap  
 
Mtengezo 
10.00-10.15 am Tea Break 
 
 
10.15- 12.30 pm Survey administration practice and pretesting the 
instrument to 5 HIV positive women 
RAs 
12.30- 1.30 pm Lunch 
 
 
1.30- 2.30 pm Report observation on the survey instrument 
 
RAs 
2.30 pm Close 
 
 
2.30- 5.00 The researcher makes corrections and prints copies of the 
survey instrument  
 
Mtengezo 
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F. INFORMED VOLUNTARY CONSENT FORMS 
 
English 
 
University of Massachusetts, Boston     Daeyang Luke Hospital  
Department of Nursing       P.O. Box 30330 
100 Morrissey Boulevard Boston, MA. 02125-3393                         Lilongwe 
 
Please read this form and feel free to ask questions. 
 
Study Title: Knowledge and Attitudes Regarding Cervical Cancer Screening among 
Women Living with HIV/AIDS in Malawi: A Cross-sectional Study 
 
Principal Investigator: Jasintha Mtengezo, PhD candidate 
Supervisors: Haeok Lee, RN, PhD, Professor: University of Massachusetts Boston 
                      Mary Cooley, RN, PhD, Professor: University of Massachusetts Boston 
                      Ling Shi, Bio-Statistician, PhD, Professor: University of Massachusetts Boston 
                      MarySue Makin, MD, Obstetrician/Gynecologist: Daeyang Luke Hospital 
 
Description of the Project 
You are asked to take part in a research project to explore your views about cervical 
examination to detect cervical cancer in women who are living with HIV infection. The study 
will help to develop ways of promoting cervical cancer examination program for women who 
are living with HIV infection to prevent cervical cancer and live a quality life. 
 
What will happen if you join the study? 
If you agree to take part in this study, you will be asked to answer the health survey 
questions about yourself, your knowledge and attitudes regarding cervical cancer and 
screening, your social support networks, and access to cervical cancer screening services and 
verify your cervical cancer screening status. Responding to the questions will take 
approximately 30 to 45 minutes and will be done at your support group meeting place and 
using your preferred language.  
 
Risks and Discomfort 
The primary risks associated with this study are that some questions may be 
discomforting to you or that answering questions may make you tired. You may refuse to 
answer any questions or stop at any time due to discomfort, fatigue or distress.  
 
Benefits 
There are no direct medical benefits in participating in this study but the results from 
the study will help to develop ways of promoting cervical cancer examination programs 
among HIV-positive women to prevent cervical cancer so that HIV-positive women live 
more productive life.  
Confidentiality and Anonymity: 
Your part in this research is confidential. That is, the information gathered for this 
project will not be published or presented in a way that would allow anyone to identify you. 
You will be identified by a number code. A record of your data will be kept in a locked 
cabinet in the researcher‟s office and only the research team will have access to the data. The 
computer information will be protected by providing a code number and password only to the 
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research team and research assistant who will enter information into the computer. All printed 
materials will be stored by Ms. Mtengezo for a period of five years and then destroyed. 
 
 Voluntary Participation: 
The decision to take part in this research study is voluntary. If you do decide to take 
part in this study, you may stop participation at any time without any fear of any kind of 
penalty.  If you wish to stop participation, you should let the interviewer know immediately. 
The decision to participate or not participate in this study will not affect your health care 
services.  
  
Rights: 
You have the right to ask questions about this research before you sign this form and at 
any time during the interview and study. You can reach Ms. Mtengezo by telephone at 01-
711-361. If you have any questions or concerns about your rights as a research participant, 
please contact: 
1. The National Health Sciences Research Committee (NHSRC), Ministry of Health, 
P.O. Box 30377, Lilongwe 3. Telephone: +265 1-726 422/418 (Malawi). Email: 
mohdoccentre@gmail.com 
2. The University of Massachusetts Boston, Quinn Administration Building-2-080, 100 
Morrissey Boulevard, Boston, MA 02125-3393. Telephone: 617-287-5370 (U.S.A). 
 
Study Consent Form 
I have read the study information sheet. My questions have been answered. My 
signature on this form indicates that I understand the information and I consent to participate 
in this study and for the researcher to use my information in the presentations and written 
products as an aggregate data.  
 
........................................           ............................................ 
 …………………….. ____________________                 ______________________                   
_________________ 
    Printed Name                          Signature of Participant        Date 
 
........................................           ............................................ 
 …………………….. ____________________                 ______________________                   
_________________ 
    Printed Name                          Signature of Researcher        Date 
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Chichewa 
 
Ndondomeko ya kafukufuku ndi Pepala lopempha chilolezo mutauzidwa ndondomeko 
yonse bwino bwino 
 
University of Massachusetts Boston     Daeyang College of 
Nursing  
Department of Nursing       P.O. Box 30330 
100 Morrissey Boulevard Boston, MA. 02125-3393   Lilongwe 
 
Chonde werengani pepalali bwino bwino ndipo muli omasuka kufusa.  
 
Mutu wakafukufukuyu: Kafukufuku ofuna kumva maganizo kwa amayi amene ali ndi 
kachilombo ka HIV pakhani yogwiritsa ntchito chithandizo choyezetsa khansa 
yakhomo la chibelekelo kuno ku Malawi. 
 
Kafukufukuyi akupangidwa ndi: Jasintha Mtengezo- Amene akupanga maphunziro 
aukachenjede ku dziko la Amereka. 
Woyang’anira: Haeok Lee, Mary Cooley, ndi Ling Shi: Aphunzitsi aku sukulu ya 
ukachenjede  
     ku dziko la Amereka. 
     Dokotala wamukulu amenene amathandiza azimayi kuchipatala cha 
Daeyang. 
                          MarySue Makin. 
 
Ndondomeko ya ntchito 
Mukupemphedwa kutenga nawo mbali pa kafukufuku wofuna kudziwa zomwe mukudziwapo 
ndi chilingaliro chogwiritsa ntchito chithandizo choyezetsa khansa yakhomo la chibelekelo. 
Kafukufukuyi anthandiza kupititsa patsogolo mwayi wa amayi amene ali ndi kachilombo ka 
HIV kuti aziyezetsa komaso kuti chisamaliro chimenene chimaperekedwa kwa amayi amene 
ali ndi kachilombo ka HIV chithe kuchepetsa imfa zobwera kuzera mu matenda a khansa 
yakhomo la chibelekelo.  
 
Kodi chidzachitike ndi chani ngati mungatenge nawo mbali mu kafukufukuyu? 
Ngati muvomere kutenga nawo mbali mu kafukufukuyu, mudzapemphedwa kuti muyankhe 
mafuso pa zomwe mukuziwapo za khansa yakhomo la chibelekelo komaso za chilingaliro 
chanu chogwiritsa ntchito chithandizo choyezetsa khansa yakhomo la chibelekelo. Izi 
zidzatenga pakatikakti pa mphindi makhumi atatu (30) ndi makumi anayi ndi asanu (45) 
ndipo kudzachitikira komwe mumakumana pa gulu lanu komanso mchilankhulo chomwe 
mungakonde. 
 
Zodandaulitsa ndi zoopsa  
Zodandaulitsa ndi zoopsa za kafukufukuyu ndi zoti, mafunso ena akhoza kukhala 
osasangalatsa komanso kuyankha mafunso kukhoza kutopetsa. Mukhoza kukana kuyankha 
mafunso kapena kusiya nthawi ina iliyonse ngati inu kapena ofunsa siali omasuka, kapena 
mwatopa kapena mwapanikizika.  
 
Ndiphindu lanji limene ndigapedze pakafukufuku ameneyu 
Palibe chimene ndingapeze panopa pa kafukufukuyi. Koma anthandiza kupititsa patsogolo 
mwayi wa amayi amene ali ndi kachilombo ka HIV kuti aziyezetsa komaso kuti chisamaliro 
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chimenene chimaperekedwa chithe kuchepetsa matenda a khasa komaso imfa zobwera kuzera 
mu matenda a khansa yakhomo la chibelekelo.  
 
Chinsinsi cha kafukufukuyu   
Mbali yanu mu kafukufukuyu ndi ya chinsinsi; izi zikusonyeza kuti, china chilichonse 
mutatiuze mu kafukufukuyu sichidzaulutsidwa kapena kuonetsedwa mu njira yoti anthu atha 
kukuzindikirani. Mbali yanu idzadziwika kudzera mu ma nambala.  
 
Kudzipereka pa kutenga mbali   
Chiganizo chotenga nawo mbali kapena ayi pa kafukufukuyu ndi chosakakamiza. Ngati 
mungafune kusiya kutenga nawo mbali pa kafukufukuyu, mutha kusiya nthawi ina iliyonse 
mopanda mantha. Ngati mwafuna kusiya kutenga nawo mbali mu kafukufukuyu, 
mudziwitseni amene akupatsani mafunsowa kapena amene akukufunsani mafunso. Chiganizo 
chotenga nawo mbali kapena ayi mu kafukufukuyu sichisokoneza chisamaliro chanu ndi 
achipatala.  
 
Ufulu 
Muli ndi ufulu ofusa mafuso okhudzana ndikafukufukuyu musanasayinire pepalali komaso 
nthawi ina iliyose mkatikati mwakafukufukuyu. Mukhoza kulankhura ndi mayi Mtengezo pa 
nambala ya lamya iyi 01 711 361. Ngati muli ndi fuso lina lilirose kapena madandaulo 
okhudza ufulu wanu ngati munthu otenga nawo mbali pakafukufukuyu, chonde yankhurani 
ndi oyimirira: 
1. National Health Sciences Research Committee (NHSRC), Ministry of Health, P.O. 
Box 30377, Lilongwe 3, Malawi. Pa nambalayi: +265 1-726 422/418 (Malawi). 
Email: mohdoccentre@gmail.com 
2. University of Massachusetts Boston, 100 Morrissey Boulevard, Boston, Quinn 
Administration Building-2-080, MA 02125-3393. U.S.A. Pa nambalayi: 617-287-
5370. 
 
Pepala lopempha chilolezo 
Ndawerenga pepalali bwino lomwe. Mafuso anga ayankhidwa. Kusayina kwanga 
kukusonyeza kuti ndavetsetsa zose zomwe zakambidwa mu pepalali ndipo ndikulola kutenga 
nawo mbali mu kafukufukuyu. Komaso pakusayinira chikalatachi ndavomera kuti 
zolembedwazo zikagwiritsiddwe ntchito poulutsa zotsatira zakafukufukuyu. 
 
........................................           ............................................ 
 …………………….. ____________________                 ______________________                   
_________________ 
    Dzina                                 Kusayinira kwa oyankha mafuso              Tsiku 
 
........................................           ............................................ 
 …………………….. ____________________                 ______________________                   
_________________ 
   Dzina                       Kusayinira kwa ofufuza                 Tsiku 
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G. QUESTIONNAIRES 
English 
 
Knowledge and Attitudes Regarding Cervical Cancer Screening among Women Living 
with HIV/AIDS in Malawi 
 
 
 
 
 
 
 Time at beginning of interview:  [___][___]  [___][___] AM / PM  
 Date…………………………… 
                    Hour           Minutes 
 
 
 
Code Number:  E                                 .  
 
 
Name of Support Group: ………………………………………………… 
 
 
 
Geographical Location:     Urban …………………. 1 
                                  Rural …………………. 2 
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I would like to ask you some questions to help us analyze the data.  Your responses to these 
questions will remain confidential, and be used for research purposes only. 
 
Part 1: Socio-demographic Information 
 
Q1. What is your occupation?  
House wife … ......................................................1 
                                                    Working (write your work)  ................................2 
                                                     Don‟t know/not sure  .........................................88 
 
Q2. What is your religion?   
                                                            Christian ..............................................................1 
                                                    Moslem ...... .........................................................2 
                                                    Others (Indicate) ...... ...........................................3 
                                                              Don‟t know/not sure  ........................................88 
 
Q3. How old are you?                                                                              Years 
           
                                                      Don‟t know/not sure .........................................88 
Q4. What is your marital status?  
              Single ...........................................1 
              Married.........................................2 
              Divorced/widowed .......................3 
              Other ..........................................66
  ........................................................................ 
Q5. What is your highest education level you attained?  
 Never attended school ..................1 
 Primary level ................................2 
 Secondary level ............................3 
 University level ............................4 
  Don‟t know/not sure  .................88 
 
Q6. What is your monthly household income from all sources? 
  Less than K75, 000 ......................1 
  K75, 000- less than K 200,000 ....2 
  Over K200, 000............................3 
   Don‟t know/not sure  .................88 
 
Q7. In which year were you diagnosed with HIV infection?  ……………………………                                           
 
                                                                                                                       Years now 
            
                                                                            Don‟t know/not sure ...................88 
 
Q8.  How many pregnancies have you ever had? ………………. 
                                                                              Don‟t know/not sure ...................88 
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Part II: Cervical Cancer Screening Behavior 
 
Q9. Have you ever had cervical cancer screening (examined for cervical cancer)?   
                                                                        Yes ......................... 1 (Continue Q.10) 
                                                                        No  ................................ 2 (go to Q.14) 
                                                                              Don‟t know/not sure ........................88 
 
Q10.  If yes, when was the screening (examination) done?  
                                                                         Before HIV diagnosis .......................1  
                                                                         After HIV diagnosis  ........................2 
    
                                                                               Don‟t know/not sure .......................88 
 
Q11.  If yes, how often have you been going for screening (examination)?  
                                                                          Every year........................................1  
                                                                          Not every year  ................................2 
    
                                                                                Don‟t know/not sure ......................88 
 
Q12.  When did you have your most recent screening (examination)? 
                                                                          Less than year  .................................1  
                                                                          More than year ................................2 
    
                                                                                Don‟t know/not sure ......................88 
 
Ask for a woman’s permission to check for the screening uptake in health passport. 
 
Q13. What was the cervical cancer screening method?                                  
                                                                                VIA ..................................................1  
                                                          Pap Smear …………...…………… 2   
                                                                                 Other (specify) …………………… 3  
 
Part 111: Knowledge about Cervical Cancer and Screening  
 
A: Risk Factors of Developing Cervical Cancer (Respond to each item) 
Q. Do you think the following factors may increase the 
woman’s chance of developing cervical cancer? 
1 2 88 
14 Smoking Yes No Do not know/ 
Not sure 
15 Having many sexual partners  Yes No Do not know/ 
Not sure 
16 Having a sexual partner with many previous sexual 
partners 
Yes No Do not know/ 
Not sure 
17 Having a sexual partner who is not circumcised  Yes No Do not know/ 
Not sure 
18 Having sex at an early age  Yes No Do not know/ 
Not sure 
19 Having a weakened immune system (because of 
HIV/AIDS)  
Yes No Do not know/ 
Not sure 
20 Infection with HPV (Human Papilloma Virus) Yes No Do not know/ 
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Not sure 
21 Having sexually transmitted infection Yes No Do not know/ 
Not sure 
22 Having a family member diagnosed with cancer  Yes No Do not know/ 
Not sure 
23 Inserting traditional medicine into the vagina  Yes No Do not know/ 
Not sure 
24 Taking family planning pills for a long time Yes No Do not know/ 
Not sure 
25  Having many children Yes No Do not know/ 
Not sure 
26 Not going for regular screening Yes No Do not know/ 
Not sure 
 
B: Signs and Symptoms of Cervical Cancer. (Respond to each item) 
 
 Do you think the following are signs and symptoms 
of cervical cancer? 
1 2 88 
27 Vaginal bleeding between periods Yes No Do not know/ 
Not sure 
28 Menstrual periods that are heavier or longer than usual Yes No Do not know/ 
Not sure 
29 Vaginal bleeding after the menopause Yes No Do not know/ 
Not sure 
30 Vaginal bleeding during or after sex Yes No Do not know/ 
Not sure 
31 Excessive vaginal discharge that smells unpleasant Yes No Do not know/ 
Not sure 
32 Vaginal itching or irritation Yes No Do not know/ 
Not sure 
33 Pain or discomfort during sexual intercourse Yes No Do not know/ 
Not sure 
34 Lower back pain Yes No Do not know/ 
Not sure 
35 Pelvic pain Yes No Do not know/ 
Not sure 
36 Frequent urination Yes No Do not know/ 
Not sure 
37 Unexplained weight loss Yes No Do not know/ 
Not sure 
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C: Prevention of Cervical Cancer (Respond to each item) 
 
Q Can the following actions prevent cervical 
cancer? 
1 2 88 
38 Male circumcision Yes No Do not know/ 
Not sure 
39 Cervical cancer screening (examining the cervix) Yes No Do not know/ 
Not sure 
40 Proper and regular condom use Yes No Do not know/ 
Not sure 
41 HPV Vaccination Yes No Do not know/ 
Not sure 
 
D: Awareness about Cervical Cancer, screening and HIV (Respond to each item) 
 
  1 2 88 
42 A woman who is HIV positive should undergo 
cervical cancer screening at least once per year.   
 
Yes No Do not know/ 
Not sure 
43 A woman who is HIV positive is at higher risk of 
developing cervical cancer than a woman who is HIV 
negative.   
Yes No Do not know/ 
Not sure 
44 Cervical cancer develops slowly and can be cured if 
detected early 
Yes No Do not know/ 
Not sure 
 
Q45.  There is no treatment for cervical cancer?   
  Yes …………. ………………. 01  
   No ……………..……………..02  
                                                                                        Don‟t know/not sure…………..88 
 
Q46.  Is there cervical cancer screening services nearby or at the same location where you are  
          getting ARVs?   
  Yes …………. ………………. 01  
   No ……………..……………..02  
                                                                                        Don‟t know/not sure…………...88 
 
Q47.  Who performs cervical cancer screening?   
  Male providers ……………..…. 01  
   Female providers…………...…..02  
                                                                                         Both Male and Female providers.03  
  Don‟t know/not sure………….....88 
 
Q55. How did you get the information about cervical cancer and screening? (Tick all that 
apply) 
  Family member……………………..01 
  Friends  ………………………….....02 
  Health care providers………..……..03 
  Media (radio/TV)……..……………04 
  Pamphlets/Newspapers …………...05 
                                                                            Others (specify)…………………..06 
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Attitude regarding cervical cancer screening (Respond to each item) 
Q48.  Whom would you be comfortable to perform cervical cancer screening on you?   
                                                                                   Male providers………………….1  
                                                                                          Female providers……………….2  
                                                                                          Both Male and Female providers3  
                                                                                          None of the above………………4 
 
Q. What is your opinion on these questions 1 2 88 
49 If an opportunity is given to you to do the 
screening (examination), would you be willing to 
do the examination?   
Yes No Do not know/ 
Not sure 
50 Do you fear cervical Cancer screening procedure? Yes No Do not know/ 
Not sure 
51 Do you feel shy to expose your private parts 
during the procedure to young or male service 
providers? 
Yes No Do not know/ 
Not sure 
52 Are you afraid of pain/discomfort during cervical 
cancer screening procedure? 
Yes No Do not know/ 
Not sure 
53 Are you afraid of bleeding during and after 
cervical cancer screening procedure? 
Yes No Do not know/ 
Not sure 
54 Are you afraid of being diagnosed with cervical 
cancer after undergoing the screening? 
Yes No Do not know/ 
Not sure 
 
Part VI: Social Support Networks (Respond to each item) 
 
 Item 1 2 88 
 Health care providers    
56 Is the health care provider always available when you 
need cervical cancer screening services?  
Yes No Do not know/ 
Not sure 
57 Can you share your concerns about cervical cancer 
screening with a health care provider?  
Yes No Do not know/ 
Not sure 
58 Have health care providers ever counselled (talked to) 
you about cervical cancer screening?  
Yes No Do not know/ 
Not sure 
 Family members    
59 Does your family try to help you with financial support to 
go for cervical cancer screening?  
Yes No Do not know/ 
Not sure 
60 Do you get the emotional help and support you need from 
your family regarding HIV and cervical cancer 
screening?  
Yes No Do not know/ 
Not sure 
61 Can you discuss about cervical cancer screening with 
your family?  
Yes No Do not know/ 
Not sure 
62  Have your family members ever encouraged you to go 
for cervical cancer screening?  
Yes No Do not know/ 
Not sure 
 Friends    
63 Have your friends ever recommended to you cervical 
cancer screening?  
Yes No Do not know/ 
Not sure 
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Part V: Access to cervical cancer screening 
 
Q67.  The last time you needed cervical cancer examination, did you get it? 
                                                                                Yes .................................................01 
                                                                                No...................................................02 
                                                                        Do not know/Not sure ...................88 
 
What are the reasons that best explain why you did not get the examination for cervical 
cancer? (Respond to each item) 
 
 Reasons 1 2 88 
 Affordability    
68 No money for transport Yes No Do not 
know/ Not 
sure 
 Availability    
69 Did not know where to go Yes No Do not 
know/ Not 
sure 
70 Screening sites are far (long distance) Yes No Do not 
know/ Not 
sure 
 Accessibility    
71 Previously, I was badly treated Yes No Do not 
know/ Not 
sure 
72 Long waiting time Yes No Do not 
know/ Not 
sure 
 Accommodation    
73 The health care providers are inadequate Yes No Do not 
know/ Not 
sure 
74 There were no equipment and supplies Yes No Do not 
know/ Not 
sure 
75 I thought I was not sick Yes No Do not 
know/ Not 
sure 
76 Could not take time off my work/had other 
commitments/ laziness 
Yes No Do not 
know/ Not 
sure 
64 Can your friends provide social support when found 
(diagnosed) with cervical cancer?  
Yes No Do not know/ 
Not sure 
65 Do you have friends with whom you can share your 
results of screening (examination)?  
Yes No Do not know/ 
Not sure 
66 Can you encourage your friend to go for cervical 
screening?  
Yes No Do not know/ 
Not sure 
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 Acceptability    
77 There is no privacy at the clinic Yes No Do not 
know/ Not 
sure 
78 Providers are males Yes No Do not 
know/ Not 
sure 
79 I do not see the reason to go for screening as I am too 
old/too young  
Yes No Do not 
know/ Not 
sure 
 
Q80.  Where did you go for cervical cancer screening? 
Government Health facility .....................1  
CHAM Health facility .............................2  
Private Health facility ..............................3  
 
Q81.  How do you travel when going to the clinics (HIV Clinic/cervical cancer screening)?  
 
Public transport ........................................1  
 
Private/own car ........................................2  
 
Bicycle/walk ............................................3  
 
Q82.  How long (estimated time) does it take to get to the clinic/examination site from where 
you live? 
 
Less than 30 Minutes ...............................1  
 
More than 30Minutes ...............................2  
 
    
Q83. Any other suggestions on how best cervical cancer screening services would be 
improved to increase uptake? 
…………………………………………………………………………………………………
…………………………………………………………………………………………………
………… 
 
THE END. 
 
THANK YOU!  
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Chichewa 
 
Ndondomeko Yofunsa Mafunso 
 
Kafukufuku ofuna kumva maganizo kwa amayi amene ali ndi kachilombo ka HIV 
pakhani yogwiritsa ntchito chithandizo choyezetsa khansa yakhomo la chibelekelo kuno 
ku Malawi. 
 
 
 
 
Nthawi yoyambira kuyankha mafunso: [____][____] [____][____] M‟mawa/madzulo 
      Hour      Minutes  
 
Nambala ya chinsinsi ya pepalali : C_____________. 
 
Dzina la gulu (support group) ndi _____________________________________. 
 
Dera lochokera:   
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Tsopano tikufuna kukufusani mafunso amene atithandize kutanthauzira kafukufuku 
wathuyu. Mayankho anu adzasungidwa mwachisisi ndipo adzangogwiritsidwa ntchito 
pa pakafukufuku yekhayu basi. 
Gawo loyamba: Mafunso otsatirawa ndi okhudzana ndi inuyo 
Funso 1. Kodi mumagwira ntchito? …………………………………............................... 
Ayi sindigwira ntchito ...…….……………...……………01 
    Eya ndimagwira ntchito (Ntchulani ) …………………     02 
    Sindikudziwa/ Ndikukayikira..............................................88 
Funso 2. Ndinu a chipembedzo chanji? 
                                                Chikhirisithu ……………......................................................1 
                                        Chisilamu  ……......………………………………………...2 
                                        Yakho lina (Ntchulani) ............................................................3 
                                                 Sindikudziwa/ Ndikukayikira ……………….…………………… .....88 
 
Funso 3. Muli ndi zaka zingati?  Zaka………………… 
    Sindikudziwa/ Ndikukayikira...............................................88 
Funso 4. Kodi muli pa banja?  
Ayi sindanakwatiwepo ...…….……………...……………01 
    Eya ndiri pa banja …………………….………………..…02 
    Banja linatha/ Ndine wamasiye…… ……………………..03 
    Yakho lina (Ntchulani)………………….…………………04 
Funso 5. Kodi sukulu munalekeza kalasi yanji? 
    Sindinaphunzirepo……………………..…………………01 
    Pulayimale sukulu...………………………………………02 
     Sekondale sukulu…………………………………………03 
    Yunivesite ………………………………………………..04 
               Sindikudziwa/ Ndikukayikira...……………………………88 
Funso 6. Kodi pa khomo panu, mumapeza ndalama zingati pamwezi? 
    Zochepera K75, 000…………………………………….01 
    Pakati pa K75 000 osapitilira K200 000 ….…………….02 
    Kuposera K200 000…………………………………..…03 
     Sindikudziwa/ Ndikukayikira...………………………….88 
Funso 7. Kodi munapezeka ndi kachirombo koyambitsa Edzi mchaka chiti? ………………… 
                                                 Papita zaka .……………………………..  
            
                                          Sindikudziwa/ Ndikukayikira..………………………….88 
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Funso 8. Kodi munatengapo mimba kangati? …………………………………………… 
                                                  Sindikudziwa/ Ndikukayikira...……………………..88 
 
Gawo Lachiwiri: Mafunso otsatirawa ndi okhudzana ndi Kuyezetsa Khansa Yakhomo 
la Chibelekelo 
A. Zomwe mukuziwapo zokhudzana ndi Khansa Yakhomo la Chibelekelo 
Funso  9. Munayamba mwayezedwapo khasa yakhomo lachibelekelo?  
Eya ………………………………1(Pitirizani Q.10) 
     Ayi …………………………………2(Pitani Q. 14) 
     Sindikudziwa/ Ndikukayikira …………………..88 
Funso 10. Ngati mwabvomera, munayezedwa liti? 
Ndisanayezetse HIV …..…….………..………….1 
     Nditayezetsa kale HIV…….……………..………2
     Sindikudziwa/ Ndikukayikira ………….………88  
Funso 11. Ngati mwabvomera, munayezetsa kangati? 
Chaka chirichonse …..…….……………..…..….1 
     Osati chaka chirichonse ………………….………2
     Sindikudziwa/ Ndikukayikira …...............…..…88  
Funso 12. Ngati mwabvomera, munayezedwa liti komaliza? 
Chaka chisanathe …..…….………………....…….1 
     Chaka chadutsa ……………………..……….……2
      Sindikudziwa/ Ndikukayikira .…………………88  
 
Phephani kuti muwone pamene analemba kuti ayezetsa khasa yakhomo lachibelekelo 
 
Funso 13. Kodi anagwiritsa njira yanji pokuyezani?  
VIA ……………………………………………….1 
     Pap Smear …..…………………………………….2  
     Njira zina (Ntchulani) …………………………….3 
 
Gawo Lachitatu: Mafunso otsatirawa ndi okhudzana ndi zomwe mukudziwapo za 
khansa Yakhomo la Chibelekelo 
A. Kodi zinthu IZI zingayambitse khansa yakhomo lachiberekero? 
Funso Zinthu  1 2 88 
14 Kusuta Eya Ayi Sindikudziwa/ 
Ndikukayikira 
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15 Kugonana ndi athu ochuluka Eya Ayi Sindikudziwa/ 
Ndikukayikira 
16 Kugonana ndi mwamuna amene amagonana ndi 
anthu ochuluka 
Eya Ayi Sindikudziwa/ 
Ndikukayikira 
17 Kugogana ndi mwamuna osadulidwa Eya Ayi Sindikudziwa/ 
Ndikukayikira 
18 Kuyamba kugonana uli wachichepere Eya Ayi Sindikudziwa/ 
Ndikukayikira 
19 Kupezeka ndi kachirombo ka HIV Eya Ayi Sindikudziwa/ 
Ndikukayikira 
20 Kupezeka ndi kachirombo koyambitsa khansa 
ya khomo la chiberekero 
Eya Ayi Sindikudziwa/ 
Ndikukayikira 
21 Kupezeka ndi matenda opatsirana pogonana Eya Ayi Sindikudziwa/ 
Ndikukayikira 
22 Zakumtundu Eya Ayi Sindikudziwa/ 
Ndikukayikira 
23 Muchitidwe woyika makhwala achikuda 
kumasoku 
Eya Ayi Sindikudziwa/ 
Ndikukayikira 
24 Kugwirista ntchito mapiritsi ngati njira yolera Eya Ayi Sindikudziwa/ 
Ndikukayikira 
25 Kubereka kwambiri Eya Ayi Sindikudziwa/ 
Ndikukayikira 
26 Kusayezetsa khansa lakhomo lachiberekero 
pafupi pafupi 
Eya Ayi Sindikudziwa/ 
Ndikukayikira 
 
 
B. Zizindikiro za khansa yakhomo la chibelekero  
 
Funso Kodi zinthu zosatirazi ndi zizindikiro za 
khansa yakhomo la chibelekero? 
1 2 88 
27 Kusamba pafupi pafupi Eya Ayi Sindikudziwa/ 
Ndikukayikira 
28 Kusamba mopitilira komaso kutaya magazi 
ambiri posamba 
Eya Ayi Sindikudziwa/ 
Ndikukayikira 
29 Kuyambiranso kusamba utasiya kaye Eya Ayi Sindikudziwa/ 
Ndikukayikira 
30 Kutuluka magazi pogonana Eya Ayi Sindikudziwa/ 
Ndikukayikira 
31 Kutuluka chikazi chambira komaso chonukha Eya Ayi Sindikudziwa/ 
Ndikukayikira 
32 Kumva kuyabwa kumusi Eya Ayi Sindikudziwa/ 
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Ndikukayikira 
33 Kumva kupweteka pogonana Eya Ayi Sindikudziwa/ 
Ndikukayikira 
34 Kupweteka kwa nsana Eya Ayi Sindikudziwa/ 
Ndikukayikira 
35 Kumva kupweteka muchinena Eya Ayi Sindikudziwa/ 
Ndikukayikira 
36 Kukodza pafupi-pafupi Eya Ayi Sindikudziwa/ 
Ndikukayikira 
37  Kuwonda Eya Ayi Sindikudziwa/ 
Ndikukayikira 
 
C. Kupewa khansa yakhomo la chibelekero  
 
Funso Kodi zinthu zosatirazi zingathandize kupewa 
khansa yakhomo la chibelekero?  
1 2 88 
38 Mudulidwe wa bamboo Eya Ayi Sindikudziwa/ 
Ndikukayikira 
39 Kuyezetsa khansa yakhomo la chibelekero Eya Ayi Sindikudziwa/ 
Ndikukayikira 
40 Kugwiritsa ntchito kondomu moyenera 
pogonana 
Eya Ayi Sindikudziwa/ 
Ndikukayikira 
41 Kulandira katemera wa khansa yakhomo la 
chibelekero 
Eya Ayi Sindikudziwa/ 
Ndikukayikira 
 
D. Zomwe tikudziwapo zankhani yakhansa yakhomo la chibelekero, kuyezesa ndi HIV 
 
Funso Kodi zithu zosatirazi zingathandize kupewa 
khansa yakhomo la chibelekero?  
1 2 88 
42 Mai amene ali ndi kachirombo ka HIV ayenera 
kuyezetsa Khansa yakhomo lachiberekero chaka 
chirichonse 
Eya Ayi Sindikudziwa/ 
Ndikukayikira 
43 Amayi amene ali ndi kachilombo ka HIV ali pa 
chiwopsezo chachikulu chopezeka ndi khansa 
lakhomo lachiberekero 
Eya Ayi Sindikudziwa/ 
Ndikukayikira 
44 Bvuto la Khansa yakhomo lachiberekero 
limayamba pang‟onopang‟no ndipo khansa 
ndiyochilitsika osati HIV 
Eya Ayi Sindikudziwa/ 
Ndikukayikira 
 
Funso  45. Kulibe mankhwala a Khansa yakhomo lachiberekero?  
Eya ……………………………………1 
     Ayi ………………………………………2  
     Sindikudziwa/ Ndikukayikira …………..88 
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Funso  46. Kodi pafupi ndi ART clinic, kumene mumalandira makhwala inuyo, Kuli malo  
                    oyedzerako Khansa yakhomo lachiberekero?  
Eya ……………………………………1 
     Ayi ………………………………………2  
     Sindikudziwa/ Ndikukayikira …………..88 
Q. 47. Kodi ndi ndani amayesa khansa yakhomo la chiberekero? 
 Madokotala amuna ……………………………..1 
 Madokotala achizimayi ………………………...2 
 Madokotala onse amuna ndi achizima…………..3 
 Sindikudziwa/Ndikukayikira ………………….88 
 
Mafunso otsatirawa ndi okhudzana ndi mmene mumayiwonera nkhani yakuyezetsa 
Khansa Yakhomo la Chiberekelo 
Q. 48. Kodi mukhoza kukhala womasuka ndindani pokuyesani khansa yakhomo la 
chiberekero? 
 Madokotala amuna ……………………………..1 
 Madokotala achizimayi ………………………...2 
 Madokotala onse amuna ndi achizima…………..3 
 Sindikudziwa/Ndikukayikira ………………….88 
 
Funso Kufuna kumva maganizo anu pa nkhani izi: 1 2 88 
49 Kodi mutapatsidwa mwawi wosakha kuti 
muyezetse khasa yakhomo la chiberekero, 
mungalore? 
Eya Ayi Sindikudziwa/ 
Ndikukayikira 
50 Kodi muli ndi mantha ndi mmene amayezera 
khasa yakhomo la chiberekero? 
Eya Ayi Sindikudziwa/ 
Ndikukayikira 
51 Kodi mungachite manyazi kukuyezani khansa 
yakhomo la chibelekero ndi dokotala 
wachichepere kapena wamwamuna? 
Eya Ayi Sindikudziwa/ 
Ndikukayikira 
52 Kodi mumawopa kukayezetsa chifukwa choti 
zimapweteka/ kusowa mtendere poyezetsa/ 
ankayetsa khansa yakhomo la chiberekero? 
Eya Ayi Sindikudziwa/ 
Ndikukayikira 
53 Kodi mumawopa kukayezetsa chifukwa choti 
mayi amataya magazi poyezetsa khansa 
yakhomo la chiberekero? 
Eya Ayi Sindikudziwa/ 
Ndikukayikira 
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54 Kodi mumawopa kukayezetsa chifukwa choti 
mukhoza kupezeka ndi khansa yakhomo la 
chiberekero? 
Eya Ayi Sindikudziwa/ 
Ndikukayikira 
 
Chigawo lachinayi: Chithandizo chomwe mwakhala mukulandira kuchokela kwa anthu 
ena 
 
Q. 55. Kodi munamva kwa ndani za khasa yakhomo la chiberekero ndi kuyezetsa? (Mayakho 
angapo atha kuperekedwa) 
 Azimayi anzanga ……..………………………….01 
 Kwa a chibale anga…. …………………………..02 
 Ku Chipatala kwa madokotala ………..…………03 
 Radio/TV/Wayilesi …. ………………………….04 
 Ndinawerenga mu news/pepala………………….05 
 Njira zina (fotokozani) ………………………….06 
 
Tsopano ndikufuna ndikufunseni mafunso okhuzana ndi chithandizo chomwe mwakhala 
mukulandira kuchokela kwa anthu.  
 Item 1 2 88 
 Significant others    
56 Kodi madokotala amapezeka pamene mukufuna 
kuyezetsa khansa la khomo lachiberekero?  
Ayi Eya Sindikudziwa/ 
Ndikukayikira 
57 Kodi muli ndi dokotala amene mungathe kumuudza 
maganizo anu a khansa la khomo lachiberekero?  
Ayi Eya Sindikudziwa/ 
Ndikukayikira 
58 Kodi madokotala amene amakuthandizani 
anakukambiraniponi nkhani yoyezetsa khansa la 
khomo lachiberekero?  
Ayi Eya Sindikudziwa/ 
Ndikukayikira 
 Family    
59 Kodi abale anu amakuthandizani ndi ndalama kuti 
mukayezetse khansa la khomo lachiberekero?  
Ayi Eya Sindikudziwa/ 
Ndikukayikira 
60 Kodi abale anu amakuthandizani kupeza yakho ya 
nkhwawa zanu  zokhuzana ndikuyezetsa khansa la 
khomo lachiberekero?  
Ayi Eya Sindikudziwa/ 
Ndikukayikira 
61 Kodi mukhonza kukamba za mavuto anu  akhansa la 
khomo lachiberekero ndi abale anu?  
Ayi Eya Sindikudziwa/ 
Ndikukayikira 
62 Kodi abale anu amakulimbikitsani kuti mupange 
chiganizo  chokayezetsa khansa la khomo 
lachiberekero?  
Ayi Eya Sindikudziwa/ 
Ndikukayikira 
 Friends    
63 Kodi anzanu amakhala okonzeka kukuthangatirani 
kupanga maganizo  okayezetsa khansa la khomo 
lachiberekero? 
Ayi Eya Sindikudziwa/ 
Ndikukayikira 
64 Kodi anzanu akhodza kukuthandizani  mutapezeka  
ndi khansa la khomo lachiberekero? 
Ayi Eya Sindikudziwa/ 
Ndikukayikira 
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Gawo Lachisanu: Mafunso otsatirawa ndi okhudzana ndi zomwe zingalepheletse mai 
kukayezetsa Khansa Yakhomo la Chiberekelo 
Q. 67. Kodi nthawi imene mumafuna kuyezetsa khasa yakhomo la chiberekero, zinatheka? 
Eya …………………………………………….1 
     Ayi …………………………………………….2 
     Sindikudziwa/ Ndikukayikira …….…………88 
Sankhani zifukwa zomwe zinalepheretsa kuti muyezetse khasa yakhomo la chiberekero  
Funso Zifukwa 1 2 88 
 Affordability    
68 Kusowa ndalama zoti ndiyendere (transport) Eya Ayi Sindikudziwa/ 
Ndikukayikira 
 Availability    
69 Sindikudziwa komwe amayezetsa khasa yakhomo 
la chiberekero 
Eya Ayi Sindikudziwa/ 
Ndikukayikira 
70 Zipatala zoyetsa khasa zili kutali Eya Ayi Sindikudziwa/ 
Ndikukayikira 
 Accessibility    
71 Achipatala sanandisamalire bwino Eya Ayi Sindikudziwa/ 
Ndikukayikira 
72 Timadikira nthawi yayitali Eya Ayi Sindikudziwa/ 
Ndikukayikira 
 Accommodation    
73 Kulibe madokotala woyeza khasa yakhomo la 
chiberekero 
Eya Ayi Sindikudziwa/ 
Ndikukayikira 
74 Kunalibe zipangizo zoyezera khasa yakhomo la 
chiberekero 
Eya Ayi Sindikudziwa/ 
Ndikukayikira 
75 Sindikudwala Eya Ayi Sindikudziwa/ 
Ndikukayikira 
76 Ndimasowa nthwawi/mpata Eya Ayi Sindikudziwa/ 
Ndikukayikira 
 Acceptability    
77 Kulibe chinsinsi ku chipatala Eya Ayi Sindikudziwa/ 
Ndikukayikira 
78 Madokotala ndi amuna Eya Ayi Sindikudziwa/ 
Ndikukayikira 
79 Sindikuwona chifukwa chokayezetsera khasa 
yakhomo la chiberekero chifukwa ndine 
wamkulu/mwana 
Eya Ayi Sindikudziwa/ 
Ndikukayikira 
 
65 Kodi muli ndi anzanu omwe mungawauze zosatira 
zanu mutayezetsa  khansa la khomo lachiberekero?  
Ayi Eya Sindikudziwa/ 
Ndikukayikira 
66 Kodi mukhonza kuwauza anzanu  kuti akayezetse 
khansa la khomo lachiberekero?  
Ayi Eya Sindikudziwa/ 
Ndikukayikira 
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Q. 80. Kodi munakayezetsa kuti khasa yakhomo la chiberekero? 
Kuchipatala cha boma ………………………...….1 
Kuchipatala cha mission ………………………….2 
Kuchipatala cholipira ……………………………..3 
 
Q81. Kodi mmayenda bwanji mukamapita ku clinic ya HIV kapena ya Khansa?  
Ndimakwera minibasi ………………………...….1 
Ndimapita pa galimoto yathu…………………….2 
Ndimakwera njinga/ndimayenda ………………..3 
Q82. Kodi mmatenga nthawi yotalika bwanji kukafika ku clinic ya HIV kapena ya Khansa 
kuchokera kumene mumakhala?  
Mphindi zochepera makumi atatu…………...….1 
Mphindi zopitirira makumi atatu…………....…. 2 
Q83. Kodi mungakhale ndi maganizo ena othandiza kupititsa mtsogolo nkhani yoyezetsa 
khasa yakhomo la chiberekelo?  
…………………………………………………………………………………………………
………………………………………………………………………………………………… 
 
MAFUNSO ATHERA PAMENEPA. 
 
ZIKOMO! 
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H. RECRUITMENT ANNOUNCEMENT 
 
English 
 
……………….………….       SUPPORT GROUP 
 
Research Opportunity: Views about Cervical Cancer Examination 
 
Period: August- December 2017 
 
 If you are a woman aged 18 or more, there will be a research to hear your views about 
cervical cancer examination by Mrs Mtengezo who is studying her degree at the 
University of Massachusetts Boston. 
 The study will help to develop ways of preventing cervical cancer and live a quality 
life. 
 The interview will be done at your support group meeting place at your convenient 
time and language on your agreed dates.  
 The interview will last approximately 30-45 minutes and transport will be provided.  
 Your participation in this study is confidential and the decision whether to take part in 
this research study is voluntary.  
 You are free to withdraw from the study at any time. The decision to participate or not 
in this study will not affect your healthcare services.  
 If you are interested or you have any questions about the study, please contact:  
o Mrs Jasintha Mtengezo on (+265) 0888863080 anytime of the day. 
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Chichewa 
 
CHIDZIWITSO CHA KUFUNA ANTHU KUCHITA NAWO KAFUKUFUKU 
                 
 
……………….………….       SUPPORT GROUP 
 
KAFUKUFUKU: MAGANIZO ANU PA ZAKUYEZETSA KHANSA YAKHOMO LA 
CHIBEREKERO 
 
Nthawi ya Kafukufuku: August mpaka December 2017. 
 
 Ngati ndinu mayi wa zaka 18 kapena kupitilira, kudzchitika kafukufuku wofuna 
kumva maganizo anu pankhani oyezetsa khansa la khomo la chiberekero ndi mai 
Mtengezo amanene akuchita maphunziro awo ku Amereka. 
 Kumwa maganizo anu kudzathandiza kupeza njira zolimbikitsira kuyezetsa khansa 
lakhomo lachiberekero pofuna kupewa khansayi ndi kukhala ndi umoyo wabwino. 
 Kucheza nanu kudzachitikira kumene mumakumana ngati gulu panthawi yomwe ndi 
yabwino kwa inu komanso mchilankhulo chomwe mungakonde. 
 Kucheza nanu kudzatenga mphindi pakatikati pa makhumi atatu (30) ndi makumi 
anayi ndi asanu (45) ndipo mudzabwezeretsedwa ndalama zamayendedwe. 
 Kutengako gawo kwanu mukafukufukuyu kudzakhala kwa chinsinsi ndipo 
mudzakhala omasuka kupanga nawo kapena ayi. 
 Mudzakhala omasuka kusiya kuchita nawo zokambilana nthawi ina ili yonse. Ndipo 
chiganizo chanu chakuchita nawo kapena kusachita nawo sikudzakhudza thandizo 
lanu lomwe mumapeza ku chipatala. 
 Ngati mwasangalatsidwa kuchita nawo kafukufukuyu kapena muli ndi mafunso ena, 
kumanani ndi: 
o Mai Mtengezo poyimba foni pa nambala iyi: (+265) 888863080 nthawi ina ili 
yonse.  
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I. SEEKING PERMISSION LETTERS 
 
Lilongwe City Council (Urban) Office 
University of Massachusetts Boston            Daeyang College of 
Nursing  
Department of Nursing                          P.O. Box 30330 
100 Morrissey Boulevard Boston, MA. 02125-3393           Lilongwe 
                                       March, 2017 
The Chief Executive Officer 
P.O. Box 30396 
Lilongwe City, Malawi 
 
Dear Sir/Madam, 
APPLICATION TO CONDUCT A STUDY 
I write to seek permission to use the Register for HIV support groups in Lilongwe City to 
randomly select 7 HIV support groups to participate in my study should my proposal be 
approved by the National Health Sciences Research Committee (NHSRC). 
 
I am a Doctoral student at the University of Massachusetts Boston and Faculty member at 
Daeyang College of Nursing. I am planning to conduct a study entitled: “Knowledge and 
Attitudes Regarding Cervical Cancer Screening among Women Living with HIV/AIDS 
in Malawi: A Cross-sectional Study” in partial fulfillment of the requirements for the 
Degree of Doctor of Philosophy in Nursing. 
 
The study will invite a minimum of 280 HIV-positive women aged 18 and above from 
randomly selected HIV support groups in Lilongwe City to participate in the study. Women 
will answer the health survey questions about knowledge and attitudes regarding cervical 
cancer and screening behavior. The study specific aims include: 
Specific Aim 1: To describe the status of cervical cancer screening behavior, knowledge and 
attitude among Malawian women living with HIV infection. 
Specific Aim 2: To explore factors associated with cervical cancer screening behavior among 
Malawian women living with HIV infection. 
 
The study involves no more than minimal risk but some questions may be discomforting to 
participants and that answering them may make them tired. There are no direct benefits in 
participating in this study but the results of the study will provide valuable insights for 
informing targeted educational interventions to prevent cervical cancer among this at-risk 
population.  
 
Looking forward to your favorable response.  
 
Sincerely, 
                                                     
-------------------------------------------------                                     ------------------------------------
----    
Mrs. Jasintha Mtengezo (PhD Candidate)                        Dr. Haeok Lee (Dissertation 
Chair) 
Jasintha.Mtengezo001@umb.edu                                          Haeok.Lee@umb.edu 
+265 888 863 080 (Malawi)                                                  +1 720 220 4018 (USA) 
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Lilongwe District Council (Rural) Office 
 
University of Massachusetts Boston            Daeyang College of 
Nursing  
Department of Nursing                          P.O. Box 30330 
100 Morrissey Boulevard Boston, MA. 02125-3393           Lilongwe 
                                       March, 2017 
The District Commissioner 
Lilongwe District Council 
P.O. Box 93 
Lilongwe, Malawi 
 
Dear Sir/Madam, 
APPLICATION TO CONDUCT A STUDY 
I write to seek permission to use the Register for HIV support groups in Lilongwe District 
Council Office to randomly select 5 HIV support groups to participate in my study should my 
proposal be approved by the National Health Sciences Research Committee (NHSRC). 
 
I am a Doctoral student at the University of Massachusetts Boston and Faculty member at 
Daeyang College of Nursing. I am planning to conduct a study entitled: “Knowledge and 
Attitudes Regarding Cervical Cancer Screening among Women Living with HIV/AIDS 
in Malawi: A Cross-sectional Study” in partial fulfillment of the requirements for the 
Degree of Doctor of Philosophy in Nursing. 
 
The study will invite a minimum of 200 HIV-positive women aged 18 and above from 
randomly selected HIV support groups in Lilongwe District to participate in the study. 
Women will answer the health survey questions about knowledge and attitudes regarding 
cervical cancer and screening behavior. The study specific aims include: 
Specific Aim 1: To describe the status of cervical cancer screening behavior, knowledge and 
attitude among Malawian women living with HIV infection. 
Specific Aim 2: To explore factors associated with cervical cancer screening behavior among 
Malawian women living with HIV infection. 
 
The study involves no more than minimal risk but some questions may be discomforting to 
participants and that answering them may make them tired. There are no direct benefits in 
participating in this study but the results of the study will provide valuable insights for 
informing targeted educational interventions to prevent cervical cancer among this at-risk 
population.  
 
Looking forward to your favorable response.  
 
Sincerely, 
                                                     
-------------------------------------------------                                     ------------------------------------
----    
Mrs. Jasintha Mtengezo (PhD Candidate)                        Dr. Haeok Lee (Dissertation 
Chair) 
Jasintha.Mtengezo001@umb.edu                                          Haeok.Lee@umb.edu 
+265 888 863 080 (Malawi)                                                 +1 720 220 4018 (USA) 
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University of Massachusetts Boston 
 
University of Massachusetts Boston     Daeyang College of 
Nursing  
Department of Nursing                     P.O. Box 30330 
100 Morrissey Boulevard Boston, MA. 02125-3393      Lilongwe, Malawi. 
Africa. 
                                 June, 2017. 
 
Dear Sir, 
APPLICATION FOR ETHICAL CLEARANCE 
I kindly request your clearance for me to conduct my proposed study in Malawi in partial 
fulfillment of the requirements for the Degree of Doctor of Philosophy in Nursing.  
 
I am a Doctoral candidate at the University of Massachusetts Boston and Faculty member at 
Daeyang College of Nursing in Malawi.  I am planning to conduct a study entitled: 
“Knowledge and Attitudes Regarding Cervical Cancer Screening among Women Living 
with HIV/AIDS in Malawi: A Cross-sectional Study”  
 
Please note that the National IRB in Malawi approves student protocols after the protocol has 
been approved by the student‟s training institution. The study participants are HIV-positive 
women aged 18 and above. Women will answer the health survey questions about knowledge 
and attitudes regarding cervical cancer and screening behavior and they will also be asked to 
verify record of cervical cancer screening status. The specific aims of the study include: 
 
Specific Aim 1: To describe the status of cervical cancer screening behavior, knowledge and 
attitude among Malawian women living with HIV infection. 
Specific Aim 2: To explore factors associated with cervical cancer screening behavior among 
Malawian women living with HIV infection.  
 
The study involves no more than minimal risk but some questions may be discomforting to 
participants and that answering them may make them tired. There are no direct benefits in 
participating in this study but the results of the study will provide valuable insights for 
informing targeted educational interventions to prevent cervical cancer among this at-risk 
population.  
 
Looking forward to your favorable response.  
 
Sincerely, 
                                                             
-------------------------------------------------                             ----------------------------------------- 
Mrs. Jasintha Mtengezo (PhD Candidate)                    Dr. Haeok Lee (Dissertation 
Chair) 
Jasintha.Mtengezo001@umb.edu                                      Haeok.Lee@umb.edu 
+265 888 863 080 (Malawi)                                             +1 720 220 4018 (USA) 
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National Health Sciences Research Committee (NHSRC) 
 
University of Massachusetts Boston     Daeyang College of 
Nursing  
Department of Nursing                     P.O. Box 30330 
100 Morrissey Boulevard Boston, MA. 02125-3393   Lilongwe 
                                  July, 2017. 
National Health Sciences Research Committee   
Ministry of Health 
P.O. Box 30377, Lilongwe 3 
Malawi. 
 
Dear Sir, 
APPLICATION FOR ETHICAL CLEARANCE 
I kindly request your clearance for me to conduct my proposed study in partial fulfillment of 
the requirements for the Degree of Doctor of Philosophy in Nursing. 
 
I am a Doctoral student at the University of Massachusetts Boston and Faculty member at 
Daeyang College of Nursing.  I am planning to conduct a study entitled: “Knowledge and 
Attitudes Regarding Cervical Cancer Screening among Women Living with HIV/AIDS 
in Malawi: A Cross-sectional Study.” The protocol has already been approved by my 
training institution, University of Massachusetts Boston as per attached documents. 
 
This study involves HIV-positive women aged 18 and above. Women will answer the health 
survey questions about knowledge and attitudes regarding cervical cancer and screening 
behavior and they will also be asked to verify their cervical cancer screening status. The 
specific aims of the study include: 
 
Specific Aim 1: To describe the status of cervical cancer screening behavior, knowledge and 
attitude among Malawian women living with HIV infection. 
Specific Aim 2: To explore factors associated with cervical cancer screening behavior among 
Malawian women living with HIV infection.  
 
The study involves no more than minimal risk but some questions may be discomforting to 
participants and that answering them may make them tired. There are no direct benefits in 
participating in this study but the results of the study will provide valuable insights for 
informing targeted educational interventions to prevent cervical cancer among this at-risk 
population.  
 
Looking forward to your favorable response.  
 
Sincerely, 
                                                             
-------------------------------------------------                             ----------------------------------------- 
Mrs. Jasintha Mtengezo (PhD Candidate)                    Dr. Haeok Lee (Dissertation 
Chair) 
Jasintha.Mtengezo001@umb.edu                                      Haeok.Lee@umb.edu 
+265 888 863 080 (Malawi)                                             +1 720 220 4018 (USA) 
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